export const ColorAssociation = {
  "polifenol-": {
    description: "Polifenol",
    color: "#33BBAF",
  },
  "cancer-": {
    description: "Cancer",
    color: "#FFAB40",
  },
  "gene-": {
    description: "Cancer",
    color: "#133B96",
  },
  "polifenol-cancer": {
    description: "Polifenol and Cancer",
    color: "#B2B2B2",
  },
  "polifenol-gene": {
    description: "Polifenol and Gene",
    color: "#F67652",
  },
  cancer_type_entity_cell: {
    description: "Cancer",
    color: "#FFAB40",
  },
  cancer_type_entity_e: {
    description: "Cancer",
    color: "#FFAB40",
  },
  cancer_type_entity_p: {
    description: "Cancer",
    color: "#FFAB40",
  },
  chemical_entity_e: {
    description: "Polifenol",
    color: "#33BBAF",
  },
  chemical_entity_p: {
    description: "Polifenol",
    color: "#33BBAF",
  },
  gene_entity: {
    description: "Cancer",
    color: "#133B96",
  },
  gene_hgnc_entity: {
    description: "Cancer",
    color: "#133B96",
  },
};

export const Result = [{ "pmid": "11346885", "peso_rules": "1.0", "peso_entities": "0.54", "peso_genes": "0.0", "peso_final": 32.8, "article": { "id": 61798, "title_article": "Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells.", "abstract_article": "We recently showed the inhibitory effect of a flavonoid antioxidant, silymarin, on erbB1-Shc activation in prostate cancer (PCA) DU145 cells. In the present study, we performed more detailed mechanistic and molecular modeling studies with pure silibinin to assess and define its effect on membrane signaling related to erbB1 activation in human PCA LNCaP and DU145 cells. Studies also were performed to establish the biologic responses toward extracellular signal-regulated protein kinase 1/2 (ERK1/2) activation, cell growth, and DNA synthesis. Treatment of serum-starved cells with various doses of silibinin for 2 h followed by (125)I-epidermal growth factor (EGF) showed 30-75% inhibition in ligand binding and 55-95% inhibition in its internalization in LNCaP cells and 20-64% and 12-27% inhibition in these two events in DU145 cells. Time-response studies showed similar effects. In further studies, treatment of serum-starved cultures with silibinin followed by EGF showed strong inhibitory effects on membrane and cytoplasmic signaling molecules. In the case of erbB1 activation, silibinin showed a 58-75% decrease in LNCaP and a 40-100% decrease in DU145 cells at 50, 75, and 100-microg/mL doses. Inhibitory effects of silibinin also were evident on ERK1/2 activation (20-80% inhibition) in both cell lines. Treatment of serum-starved cultures with silibinin resulted in 20-40% and 30-55% inhibition of LNCaP and DU145 cell growth, respectively, at similar doses after 1-3 d of treatment, and 10-50% cell death in both cell lines. Under 10% serum conditions, identical silibinin treatments resulted in 20-65% inhibition of cell growth in LNCaP and DU145 cells but did not cause any cell death. Similar doses of silibinin treatments for 24 h also resulted in 25-60%, 35-40%, and 36-50% inhibition of DNA synthesis when cells were cultured in 10% serum, totally serum starved, and serum starved plus stimulated with EGF, respectively. Molecular modeling of silibinin showed that it is a highly lipophilic compound, suggesting that it interacts with lipid-rich plasma membrane, including binding with erbB1, thereby competing with the EGF-erbB1 interaction. Because the ligand-erbB1 autocrine-loop is causally involved in advanced and androgen-independent PCA, the observed effects of silibinin and its strong lipophilic nature could be useful in developing this agent for the prevention and therapy of PCA. ", "pmid": 11346885, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99987745, "FORESTS_PROB": 0.8666667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.96663606 }, "rule": [{ "id": 255225, "sentence_id": "113468851", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "164", "sentence": "Inhibitory effect of CH& n on ligand binding to G&N 1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human D&S a cells.", "original_sentence": "Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 15, "peso_genes": 3, "entitiesRules": [{ "id": 1581640, "V1": 33623, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 21, "end_pos": 30, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581642, "V1": 33625, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 138, "end_pos": 156, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255226, "sentence_id": "11346885164", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "164", "end_pos": "305", "sentence": "We recently showed the inhibitory effect of a CH& antioxidant, silymarin, on G&N -G&N activation in D&S (D&S) DU145 cells.", "original_sentence": "We recently showed the inhibitory effect of a flavonoid antioxidant, silymarin, on erbB1-Shc activation in prostate cancer (PCA) DU145 cells.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1581646, "V1": 33629, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 271, "end_pos": 286, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581647, "V1": 33630, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 288, "end_pos": 291, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255227, "sentence_id": "11346885306", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "306", "end_pos": "535", "sentence": "In the present study, we performed more detailed mechanistic and molecular modeling studies with pure CH& to assess and define its effect on membrane signaling related to G&N activation in human D&S LNCaP and DU145 cells.", "original_sentence": "In the present study, we performed more detailed mechanistic and molecular modeling studies with pure silibinin to assess and define its effect on membrane signaling related to erbB1 activation in human PCA LNCaP and DU145 cells.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 3, "entitiesRules": [{ "id": 1581648, "V1": 33631, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 408, "end_pos": 417, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581650, "V1": 33633, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 509, "end_pos": 512, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255228, "sentence_id": "11346885710", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "710", "end_pos": "1003", "sentence": "Treatment of serum-starved cells with various doses of CH& for 2 h followed by (125)I-epidermal growth factor (G&N) showed 30-75% inhibition in ligand binding and 55-95% inhibition in its internalization in LNCaP cells and 20-64% and 12-27% inhibition in these two events in DU145 cells.", "original_sentence": "Treatment of serum-starved cells with various doses of silibinin for 2 h followed by (125)I-epidermal growth factor (EGF) showed 30-75% inhibition in ligand binding and 55-95% inhibition in its internalization in LNCaP cells and 20-64% and 12-27% inhibition in these two events in DU145 cells.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1581652, "V1": 33635, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 765, "end_pos": 774, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255229, "sentence_id": "113468851050", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1050", "end_pos": "1218", "sentence": "In further studies, treatment of serum-starved cultures with CH& followed by G&N showed strong inhibitory effects on membrane and cytoplasmic signaling molecules.", "original_sentence": "In further studies, treatment of serum-starved cultures with silibinin followed by EGF showed strong inhibitory effects on membrane and cytoplasmic signaling molecules.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1581654, "V1": 33637, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1111, "end_pos": 1120, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255230, "sentence_id": "113468851219", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1219", "end_pos": "1369", "sentence": "In the case of G&N activation, CH& showed a 58-75% decrease in LNCaP and a 40-100% decrease in DU145 cells at 50, 75, and 100-microg/mL doses.", "original_sentence": "In the case of erbB1 activation, silibinin showed a 58-75% decrease in LNCaP and a 40-100% decrease in DU145 cells at 50, 75, and 100-microg/mL doses.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1581657, "V1": 33640, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1252, "end_pos": 1261, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255231, "sentence_id": "113468851370", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1370", "end_pos": "1480", "sentence": "Inhibitory effects of CH& also were evident on G&N activation (20-80% inhibition) in both cell lines.", "original_sentence": "Inhibitory effects of silibinin also were evident on ERK1/2 activation (20-80% inhibition) in both cell lines.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1581658, "V1": 33641, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1392, "end_pos": 1401, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255232, "sentence_id": "113468851481", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1481", "end_pos": "1703", "sentence": "Treatment of serum-starved cultures with CH& resulted in 20-40% and 30-55% inhibition of LNCaP and DU145 cell growth, respectively, at similar doses after 1-3 d of treatment, and 10-50% cell death in both cell lines.", "original_sentence": "Treatment of serum-starved cultures with silibinin resulted in 20-40% and 30-55% inhibition of LNCaP and DU145 cell growth, respectively, at similar doses after 1-3 d of treatment, and 10-50% cell death in both cell lines.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1581660, "V1": 33643, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1522, "end_pos": 1531, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255233, "sentence_id": "113468851704", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1704", "end_pos": "1866", "sentence": "Under 10% serum conditions, identical CH& treatments resulted in 20-65% inhibition of cell growth in LNCaP and DU145 cells but did not cause any cell death.", "original_sentence": "Under 10% serum conditions, identical silibinin treatments resulted in 20-65% inhibition of cell growth in LNCaP and DU145 cells but did not cause any cell death.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1581661, "V1": 33644, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1742, "end_pos": 1751, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255234, "sentence_id": "113468851867", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1867", "end_pos": "2105", "sentence": "Similar doses of CH& treatments for 24 h also resulted in 25-60%, 35-40%, and 36-50% inhibition of DNA synthesis when cells were cultured in 10% serum, totally serum starved, and serum starved plus stimulated with G&N, respectively.", "original_sentence": "Similar doses of silibinin treatments for 24 h also resulted in 25-60%, 35-40%, and 36-50% inhibition of DNA synthesis when cells were cultured in 10% serum, totally serum starved, and serum starved plus stimulated with EGF, respectively.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1581662, "V1": 33645, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1884, "end_pos": 1893, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255235, "sentence_id": "113468852106", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2106", "end_pos": "2327", "sentence": "Molecular modeling of CH& showed that it is a highly lipophilic compound, suggesting that it interacts with lipid-rich plasma membrane, including binding with G&N, thereby competing with the G&N- G&N interaction.", "original_sentence": "Molecular modeling of silibinin showed that it is a highly lipophilic compound, suggesting that it interacts with lipid-rich plasma membrane, including binding with erbB1, thereby competing with the EGF-erbB1 interaction.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581664, "V1": 33647, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2128, "end_pos": 2137, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255236, "sentence_id": "113468852328", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "2328", "end_pos": "2577", "sentence": "Because the ligand- G&N autocrine-loop is causally involved in advanced and androgen-independent D&S, the observed effects of CH& and its strong lipophilic nature could be useful in developing this agent for the prevention and therapy of D&S.", "original_sentence": "Because the ligand-erbB1 autocrine-loop is causally involved in advanced and androgen-independent PCA, the observed effects of silibinin and its strong lipophilic nature could be useful in developing this agent for the prevention and therapy of PCA.", "pmid_article": 11346885, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1581670, "V1": 33653, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2455, "end_pos": 2464, "entity_type": "chemical_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581669, "V1": 33652, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2426, "end_pos": 2429, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581671, "V1": 33654, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2573, "end_pos": 2576, "entity_type": "cancer_type_entity_p", "entity_pmid": 11346885, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "19578386", "peso_rules": "1.0", "peso_entities": "0.47", "peso_genes": "0.0", "peso_final": 32.2, "article": { "id": 76609, "title_article": "Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.", "abstract_article": "Silibinin is known to exert growth inhibition and cell death together with cell cycle arrest and apoptosis in human prostate cancer cells. Whether silibinin could inhibit the invasion, motility and migration of prostate cancer cells remains largely unknown. This study was designed to evaluate this efficacy and possible mechanisms using a novel highly bone metastatic ARCaP(M) cell model. Four prostate cancer cell lines, LNCaP, PC-3, DU145, and ARCaP(M), were used in this study. These cells were treated with increasing concentrations of silibinin (50, 100, and 200 micromol/L) for different periods of time. After treatment, cell viabilities of four prostate cancer cells were compared by MTT assay. Alterations of ARCaP(M) cell invasion, motility and migration were assessed by cell invasion, motility and wound healing assays. The changes of vimentin expression were observed by Western blotting and immunofluorescence staining, and the expression of MMP-2, MMP-9, and uPA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). ARCaP(M) cells showed less sensitivity to the growth inhibition of pharmacological doses of silibinin than LNCaP, PC-3, and DU145 cells. However, silibinin exerted significant dose- and time-dependent inhibitory effects on the invasion, motility and migration of ARCaP(M) cells. Furthermore, the expression of vimentin and MMP-2, but not MMP-9 or uPA, was down-regulated in a dose- and time-dependent manner after treatment of silibinin. This study shows that silibinin could inhibit the invasion, motility and migration of ARCaP(M) cells via down-regulation of vimentin and MMP-2 and therefore may be a promising agent against prostate cancer bone metastasis.", "pmid": 19578386, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9996807, "FORESTS_PROB": 0.89666665, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9740868 }, "rule": [{ "id": 244674, "sentence_id": "195783861", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "114", "sentence": "CH& inhibits D&S r invasion, motility and migration by suppressing G&N n and G&N 2 expression.", "original_sentence": "Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1525721, "V1": 18138, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1525722, "V1": 18139, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 19, "end_pos": 34, "entity_type": "cancer_type_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244675, "sentence_id": "19578386114", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "114", "end_pos": "257", "sentence": "AIM: CH& is known to exert growth inhibition and cell death together with cell cycle arrest and apoptosis in human D&S cells.", "original_sentence": "AIM: Silibinin is known to exert growth inhibition and cell death together with cell cycle arrest and apoptosis in human prostate cancer cells.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1525725, "V1": 18142, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 119, "end_pos": 128, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1525726, "V1": 18143, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 235, "end_pos": 250, "entity_type": "cancer_type_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244676, "sentence_id": "19578386258", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "258", "end_pos": "376", "sentence": "Whether CH& could inhibit the invasion, motility and migration of D&S cells remains largely unknown.", "original_sentence": "Whether silibinin could inhibit the invasion, motility and migration of prostate cancer cells remains largely unknown.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1525727, "V1": 18144, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 266, "end_pos": 275, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1525728, "V1": 18145, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 330, "end_pos": 345, "entity_type": "cancer_type_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244677, "sentence_id": "19578386610", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "610", "end_pos": "739", "sentence": "These cells were treated with increasing concentrations of CH& (50, 100, and 200 micromol/L) for different periods of time.", "original_sentence": "These cells were treated with increasing concentrations of silibinin (50, 100, and 200 micromol/L) for different periods of time.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1525731, "V1": 18148, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 669, "end_pos": 678, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244678, "sentence_id": "195783861181", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1181", "end_pos": "1326", "sentence": "RESULTS: ARCaP(M) cells showed less sensitivity to the growth inhibition of pharmacological doses of CH& than D&S, PC-3, and DU145 cells.", "original_sentence": "RESULTS: ARCaP(M) cells showed less sensitivity to the growth inhibition of pharmacological doses of silibinin than LNCaP, PC-3, and DU145 cells.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 9, "peso_genes": 1, "entitiesRules": [{ "id": 1525737, "V1": 18154, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1282, "end_pos": 1291, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1525738, "V1": 18155, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 1297, "end_pos": 1302, "entity_type": "cancer_type_entity_cell", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244679, "sentence_id": "195783861327", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1327", "end_pos": "1468", "sentence": "However, CH& exerted significant dose- and time-dependent inhibitory effects on the invasion, motility and migration of ARCaP(M) cells.", "original_sentence": "However, silibinin exerted significant dose- and time-dependent inhibitory effects on the invasion, motility and migration of ARCaP(M) cells.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1525739, "V1": 18156, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1336, "end_pos": 1345, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244680, "sentence_id": "195783861469", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1469", "end_pos": "1627", "sentence": "Furthermore, the expression of G&N and G&N, but not G&N or G&N, was down-regulated in a dose- and time-dependent manner after treatment of CH& .", "original_sentence": "Furthermore, the expression of vimentin and MMP-2, but not MMP-9 or uPA, was down-regulated in a dose- and time-dependent manner after treatment of silibinin.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1525744, "V1": 18161, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1617, "end_pos": 1626, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244681, "sentence_id": "195783861628", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1628", "end_pos": "1862", "sentence": "CONCLUSION: This study shows that CH& could inhibit the invasion, motility and migration of ARCaP(M) cells via down-regulation of G&N and G&N and therefore may be a promising agent against D&S.", "original_sentence": "CONCLUSION: This study shows that silibinin could inhibit the invasion, motility and migration of ARCaP(M) cells via down-regulation of vimentin and MMP-2 and therefore may be a promising agent against prostate cancer bone metastasis.", "pmid_article": 19578386, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 10, "peso_genes": 3, "entitiesRules": [{ "id": 1525745, "V1": 18162, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1662, "end_pos": 1671, "entity_type": "chemical_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1525748, "V1": 18165, "pubtatot_term": "prostate cancer bone metastasis", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1830, "end_pos": 1861, "entity_type": "cancer_type_entity_p", "entity_pmid": 19578386, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }] }, { "pmid": "19147767", "peso_rules": "1.0", "peso_entities": "0.74", "peso_genes": "0.0", "peso_final": 28.3, "article": { "id": 76614, "title_article": "Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.", "abstract_article": "Silibinin is currently under phase II clinical trial in prostate cancer patients; however, its antitumor effects and mechanisms are not completely understood. Herein, we studied the efficacy and associated mechanisms of silibinin against orthotopically growing advanced human prostate carcinoma PC-3 tumors. Athymic male mice were orthotopically implanted with PC-3 cells in prostate and 1 week later after surgical recovery were gavaged daily with silibinin (100 mg/kg body weight) for 7 weeks. Silibinin treatment reduced the lower urogenital weight (including tumor, prostate, and seminal vesicle) by 40% (P < 0.05) without any toxicity in mice. Silibinin decreased proliferating cell nuclear antigen expression and proliferating cells (P < 0.001) but increased cleaved caspase-3-positive cells (P < 0.01) and apoptotic cells (P < 0.001) and suppressed tumor microvessel density (P < 0.001) and vascular endothelial growth factor expression (P = 0.02). Decreased levels of cyclin-dependent kinases 2, 4, and 6, CDC2, and cyclins D1, D3, E, and A were observed, indicating an inhibitory effect of silibinin on cell cycle progression. Silibinin showed a tremendous increase in extracellular signal-regulated kinase 1/2 phosphorylation but decreased c-Jun NH(2)-terminal kinase 1/2 and p38 mitogen-activated protein kinase phosphorylation. A moderate decrease in phosphorylated and total levels of Akt was also noted. A marked inhibitory effect of silibinin on signal transducers and activators of transcription (STAT) 1 (Tyr(701)), STAT1 (Ser(727)), STAT3 (Tyr(705)), STAT3 (Ser(727)), and STAT5 (Tyr(794)) phosphorylation together with a decrease in their total levels was also observed. These findings provide evidence for antitumor efficacy of silibinin against orthotopically growing prostate tumor in mice with multitargeted mechanistic insights and support its clinical investigation in prostate cancer.", "pmid": 19147767, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9954962, "FORESTS_PROB": 0.85, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999992, "med": 0.96137387 }, "rule": [{ "id": 261252, "sentence_id": "191477671", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "222", "sentence": "CH& suppresses growth of human D&S aG&N 3 orthotopic xenograft via activation of G&N 2 and inhibition of signal transducers and activators of transcription signaling.", "original_sentence": "Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 15, "peso_genes": 3, "entitiesRules": [{ "id": 1611958, "V1": 7087, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611959, "V1": 7088, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 37, "end_pos": 55, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261253, "sentence_id": "19147767222", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "222", "end_pos": "389", "sentence": "PURPOSE: CH& is currently under phase II clinical trial in D&S patients; however, its antitumor effects and mechanisms are not completely understood.", "original_sentence": "PURPOSE: Silibinin is currently under phase II clinical trial in prostate cancer patients; however, its antitumor effects and mechanisms are not completely understood.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1611962, "V1": 7091, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 231, "end_pos": 240, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611963, "V1": 7092, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 287, "end_pos": 302, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261254, "sentence_id": "19147767390", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "390", "end_pos": "538", "sentence": "Herein, we studied the efficacy and associated mechanisms of CH& against orthotopically growing advanced human D&S .", "original_sentence": "Herein, we studied the efficacy and associated mechanisms of silibinin against orthotopically growing advanced human prostate carcinoma PC-3 tumors.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1611964, "V1": 7093, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 451, "end_pos": 460, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611965, "V1": 7094, "pubtatot_term": "prostate carcinoma PC-3 tumors", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 507, "end_pos": 537, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261255, "sentence_id": "19147767539", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "539", "end_pos": "747", "sentence": "EXPERIMENTAL DESIGN: Athymic male mice were orthotopically implanted with G&N cells in prostate and 1 week later after surgical recovery were gavaged daily with CH& (100 mg/kg body weight) for 7 weeks.", "original_sentence": "EXPERIMENTAL DESIGN: Athymic male mice were orthotopically implanted with PC-3 cells in prostate and 1 week later after surgical recovery were gavaged daily with silibinin (100 mg/kg body weight) for 7 weeks.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1611967, "V1": 7096, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 701, "end_pos": 710, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261256, "sentence_id": "19147767748", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "748", "end_pos": "909", "sentence": "RESULTS: CH& treatment reduced the lower urogenital weight (including D&S, prostate, and seminal vesicle) by 40% (P < 0_05) without any toxicity in mice.", "original_sentence": "RESULTS: Silibinin treatment reduced the lower urogenital weight (including tumor, prostate, and seminal vesicle) by 40% (P < 0_05) without any toxicity in mice.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1611968, "V1": 7097, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 757, "end_pos": 766, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611969, "V1": 7098, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 824, "end_pos": 829, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261257, "sentence_id": "19147767910", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "910", "end_pos": "1212", "sentence": "CH& decreased proliferating cell nuclear antigen expression and proliferating cells (P < 0_001) but increased cleaved caspase-3-positive cells (P < 0_01) and apoptotic cells (P < 0_001) and suppressed D&S microvessel density (P < 0_001) and G&N expression (P = 0.", "original_sentence": "Silibinin decreased proliferating cell nuclear antigen expression and proliferating cells (P < 0_001) but increased cleaved caspase-3-positive cells (P < 0_01) and apoptotic cells (P < 0_001) and suppressed tumor microvessel density (P < 0_001) and vascular endothelial growth factor expression (P = 0.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1611970, "V1": 7099, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 910, "end_pos": 919, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611971, "V1": 7100, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1117, "end_pos": 1122, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261258, "sentence_id": "191477671217", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1217", "end_pos": "1396", "sentence": "Decreased levels of cyclin-dependent kinases 2, 4, and 6, G&N, and cyclins D1, D3, E, and A were observed, indicating an inhibitory effect of CH& on cell cycle progression.", "original_sentence": "Decreased levels of cyclin-dependent kinases 2, 4, and 6, CDC2, and cyclins D1, D3, E, and A were observed, indicating an inhibitory effect of silibinin on cell cycle progression.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1611974, "V1": 7103, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1360, "end_pos": 1369, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261259, "sentence_id": "191477671397", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1397", "end_pos": "1600", "sentence": "CH& showed a tremendous increase in G&N phosphorylation but decreased c-Jun NH(2)-terminal kinase 1/2 and G&N mitogen-activated protein kinase phosphorylation.", "original_sentence": "Silibinin showed a tremendous increase in extracellular signal-regulated kinase 1/2 phosphorylation but decreased c-Jun NH(2)-terminal kinase 1/2 and p38 mitogen-activated protein kinase phosphorylation.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1611975, "V1": 7104, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1397, "end_pos": 1406, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261260, "sentence_id": "191477671679", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1679", "end_pos": "1950", "sentence": "A marked inhibitory effect of CH& on signal transducers and activators of transcription (G&N ) 1 (Tyr(701)), G&N (Ser(727)), G&N (Tyr(705)), G&N (Ser(727)), and G&N (Tyr(794)) phosphorylation together with a decrease in their total levels was also observed.", "original_sentence": "A marked inhibitory effect of silibinin on signal transducers and activators of transcription (STAT) 1 (Tyr(701)), STAT1 (Ser(727)), STAT3 (Tyr(705)), STAT3 (Ser(727)), and STAT5 (Tyr(794)) phosphorylation together with a decrease in their total levels was also observed.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1611979, "V1": 7108, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1709, "end_pos": 1718, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261261, "sentence_id": "191477671951", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1951", "end_pos": "2184", "sentence": "CONCLUSIONS: These findings provide evidence for antitumor efficacy of CH& against orthotopically growing D&S in mice with multitargeted mechanistic insights and support its clinical investigation in D&S.", "original_sentence": "CONCLUSIONS: These findings provide evidence for antitumor efficacy of silibinin against orthotopically growing prostate tumor in mice with multitargeted mechanistic insights and support its clinical investigation in prostate cancer.", "pmid_article": 19147767, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1611985, "V1": 7114, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2022, "end_pos": 2031, "entity_type": "chemical_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611986, "V1": 7115, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2063, "end_pos": 2077, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1611987, "V1": 7116, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2168, "end_pos": 2183, "entity_type": "cancer_type_entity_p", "entity_pmid": 19147767, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }] }, { "pmid": "12479270", "peso_rules": "0.78", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 27.6, "article": { "id": 76657, "title_article": "Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.", "abstract_article": "Several studies have identified silibinin as an anticarcinogenic agent. Recently, we showed that silibinin inhibits cell growth via G1 arrest, leading to differentiation of androgen-dependent human prostate carcinoma LNCaP cells (X. Zi and R. Agarwal, Proc. Natl. Acad. Sci. USA, 96: 7490-7495,1999). Here, we extend this study to assess the effect of silibinin on total retinoblastoma protein (Rb) levels and its phosphorylation status, levels of E2F family members, and Rb-E2F binding in LNCaP cells. Compared with controls, silibinin resulted in an increase in total Rb levels that was largely attributable to an increase in unphosphorylated Rb (up to 4.1-fold). This effect of silibinin was mainly attributable to a large decrease (70-97%) in the amount of Rb phosphorylated at specific serine sites. In other studies, silibinin showed a moderate effect on E2F1 but up to 98 and 90% decreases in E2F2 and E2F3 protein levels, respectively. Silibinin treatments also resulted in an increase in the amount of Rb binding to E2F1 (3.8-fold), E2F2 (2.2-fold), and E2F3 (2.2-fold). Cyclin-dependent kinases (CDKs), together with their catalytic subunit cyclins, phosphorylate Rb, which makes transcription factor E2Fs free from Rb-E2F complexes, resulting in cell growth and proliferation. Conversely, CDK inhibitors inhibit this phosphorylation, maintaining E2Fs bound to Rb, which causes growth inhibition. On the basis of our data showing that silibinin induces both unphosphorylated Rb levels and Rb-E2F binding, we also assessed its effect on upstream cell cycle regulators. Silibinin-treated cells showed up to 2.4- and 3.6-fold increases in Cip1/p21 and Kip1/p27 levels, respectively, and a decrease in CDK2 (80%), CDK4 (98%), and cyclin D1 (60%). Consistent with these results, silibinin showed both G1 arrest and growth inhibition. Together, these findings identify modulation of Rb levels and its phosphorylation status as a molecular mechanism of silibinin-induced neuroendocrine differentiation of human prostate carcinoma LNCaP cells and suggest that this could be a novel approach for prostate cancer prevention by silibinin.", "pmid": 12479270, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9976705, "FORESTS_PROB": 0.8666667, "LOGITBOOST_PROB": 0.9999546, "MAXENTROPY_PROB": 0.99999803, "med": 0.96607244 }, "rule": [{ "id": 256003, "sentence_id": "124792701", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "227", "sentence": "Inhibition of D&S a protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by CH& n in androgen-dependent human D&S a D&S P cells: role in D&S r prevention.", "original_sentence": "Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 17, "peso_genes": 3, "entitiesRules": [{ "id": 1585611, "V1": 37594, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 121, "end_pos": 130, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585610, "V1": 37593, "pubtatot_term": "retinoblastoma", "db_term": "Retinoblastoma", "db_equivalence": "Retinoblastoma", "mesh_id": "D012175", "term_id": "522", "start_pos": 14, "end_pos": 28, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585612, "V1": 37595, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 159, "end_pos": 177, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585613, "V1": 37596, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 178, "end_pos": 183, "entity_type": "cancer_type_entity_cell", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585614, "V1": 37597, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 199, "end_pos": 214, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256004, "sentence_id": "12479270227", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "227", "end_pos": "298", "sentence": "Several studies have identified CH& as an anticarcinogenic agent.", "original_sentence": "Several studies have identified silibinin as an anticarcinogenic agent.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1585615, "V1": 37598, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 259, "end_pos": 268, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256005, "sentence_id": "12479270299", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "299", "end_pos": "459", "sentence": "Recently, we showed that CH& inhibits cell growth via G1 arrest, leading to differentiation of androgen-dependent human D&S D&S cells (X.", "original_sentence": "Recently, we showed that silibinin inhibits cell growth via G1 arrest, leading to differentiation of androgen-dependent human prostate carcinoma LNCaP cells (X.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1585616, "V1": 37599, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 324, "end_pos": 333, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585617, "V1": 37600, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 425, "end_pos": 443, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585618, "V1": 37601, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 444, "end_pos": 449, "entity_type": "cancer_type_entity_cell", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256006, "sentence_id": "12479270528", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "528", "end_pos": "729", "sentence": "Here, we extend this study to assess the effect of CH& on total D&S protein (Rb) levels and its phosphorylation status, levels of E2F family members, and Rb-E2F binding in D&S cells.", "original_sentence": "Here, we extend this study to assess the effect of silibinin on total retinoblastoma protein (Rb) levels and its phosphorylation status, levels of E2F family members, and Rb-E2F binding in LNCaP cells.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1585619, "V1": 37602, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 579, "end_pos": 588, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585620, "V1": 37603, "pubtatot_term": "retinoblastoma", "db_term": "Retinoblastoma", "db_equivalence": "Retinoblastoma", "mesh_id": "D012175", "term_id": "522", "start_pos": 598, "end_pos": 612, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585621, "V1": 37604, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 717, "end_pos": 722, "entity_type": "cancer_type_entity_cell", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256007, "sentence_id": "12479270730", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "730", "end_pos": "884", "sentence": "Compared with controls, CH& resulted in an increase in total Rb levels that was largely attributable to an increase in unphosphorylated Rb (up to 4.", "original_sentence": "Compared with controls, silibinin resulted in an increase in total Rb levels that was largely attributable to an increase in unphosphorylated Rb (up to 4.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1585622, "V1": 37605, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 754, "end_pos": 763, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256008, "sentence_id": "12479270893", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "893", "end_pos": "1031", "sentence": "This effect of CH& was mainly attributable to a large decrease (70-97%) in the amount of Rb phosphorylated at specific serine sites.", "original_sentence": "This effect of silibinin was mainly attributable to a large decrease (70-97%) in the amount of Rb phosphorylated at specific serine sites.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1585623, "V1": 37606, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 908, "end_pos": 917, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256009, "sentence_id": "124792701032", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1032", "end_pos": "1170", "sentence": "In other studies, CH& showed a moderate effect on G&N but up to 98 and 90% decreases in G&N and G&N protein levels, respectively.", "original_sentence": "In other studies, silibinin showed a moderate effect on E2F1 but up to 98 and 90% decreases in E2F2 and E2F3 protein levels, respectively.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1585624, "V1": 37607, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1050, "end_pos": 1059, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256010, "sentence_id": "124792701171", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1171", "end_pos": "1260", "sentence": "CH& treatments also resulted in an increase in the amount of Rb binding to G&N (3.", "original_sentence": "Silibinin treatments also resulted in an increase in the amount of Rb binding to E2F1 (3.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1585628, "V1": 37611, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1171, "end_pos": 1180, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256011, "sentence_id": "124792701634", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1634", "end_pos": "1804", "sentence": "On the basis of our data showing that CH& induces both unphosphorylated Rb levels and Rb-E2F binding, we also assessed its effect on upstream cell cycle regulators.", "original_sentence": "On the basis of our data showing that silibinin induces both unphosphorylated Rb levels and Rb-E2F binding, we also assessed its effect on upstream cell cycle regulators.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 2, "entitiesRules": [{ "id": 1585632, "V1": 37615, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1672, "end_pos": 1681, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256012, "sentence_id": "124792701980", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1980", "end_pos": "2065", "sentence": "Consistent with these results, CH& showed both G1 arrest and growth inhibition.", "original_sentence": "Consistent with these results, silibinin showed both G1 arrest and growth inhibition.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1585641, "V1": 37624, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2011, "end_pos": 2020, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 256013, "sentence_id": "124792702066", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2066", "end_pos": "2364", "sentence": "Together, these findings identify modulation of Rb levels and its phosphorylation status as a molecular mechanism of CH& -induced neuroendocrine differentiation of human D&S D&S cells and suggest that this could be a novel approach for D&S prevention by CH&.", "original_sentence": "Together, these findings identify modulation of Rb levels and its phosphorylation status as a molecular mechanism of silibinin-induced neuroendocrine differentiation of human prostate carcinoma LNCaP cells and suggest that this could be a novel approach for prostate cancer prevention by silibinin.", "pmid_article": 12479270, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1585642, "V1": 37625, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2183, "end_pos": 2192, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585646, "V1": 37629, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2354, "end_pos": 2363, "entity_type": "chemical_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585643, "V1": 37626, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2241, "end_pos": 2259, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585644, "V1": 37627, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 2260, "end_pos": 2265, "entity_type": "cancer_type_entity_cell", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585645, "V1": 37628, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2324, "end_pos": 2339, "entity_type": "cancer_type_entity_p", "entity_pmid": 12479270, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "17341659", "peso_rules": "1.0", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 26.6, "article": { "id": 74712, "title_article": "Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.", "abstract_article": "Transcription factor signal transducer and activator of transcription (Stat)-3 is activated constitutively in prostate cancer (PCA) suggesting that its disruption could be an effective approach to control this malignancy. Here we assessed whether silibinin, a flavanone from Silybum marianum with proven anticancer efficacy in various cancer models, inhibits Stat3 activation in DU145 cells, and if it does, what is the biological fate of the cells? At 50 muM or higher concentrations for 24 or 48 h, silibinin concentration dependently reduced constitutive Stat3 phosphorylation at Tyr705 and Ser727 residues under both serum and serum-starved conditions. Constitutively active Stat3-DNA binding was also inhibited concentration dependently by silibinin; however, apoptotic death together with caspase and poly(ADP-ribose) polymerase (PARP) cleavage was observed by silibinin only under serum-starved conditions suggesting that additional survival pathways are active under serum conditions. In other studies, cells were treated with various specific pharmacological inhibitors where phosphorylation of Stat3 was not reduced by epidermal growth factor receptor and Mitogen activated protein/extracellular signal regulate kinase kinase (MEK1/2) inhibitors, suggesting lack of significant roles of these in Stat3 activation in DU145 cells. Janus kinase (JAK)-1 and JAK2 inhibitors strongly reduced Stat3 phosphorylation but did not result in apoptotic cell death. Interestingly, JAK1 inhibitor only in combination with silibinin resulted in a complete reduction in Stat3 phosphorylation at Tyr705, activated caspase-9 and caspase-3, and caused strong PARP cleavage and apoptotic death of DU145 cells. Given a critical role of Stat3 activation in PCA, our results showed that silibinin inhibits constitutively active Stat3 and induces apoptosis in DU145 cells, and thus might have potential significance in therapeutic intervention of this deadly malignancy.", "pmid": 17341659, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9998831, "FORESTS_PROB": 0.87333333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9683041 }, "rule": [{ "id": 253139, "sentence_id": "173416591", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "144", "sentence": "CH& inhibits constitutive activation of G&N 3, and causes caspase activation and apoptotic death of human D&S a DU145 cells.", "original_sentence": "Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 15, "peso_genes": 3, "entitiesRules": [{ "id": 1570962, "V1": 22945, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1570964, "V1": 22947, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 112, "end_pos": 130, "entity_type": "cancer_type_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253140, "sentence_id": "17341659366", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "366", "end_pos": "593", "sentence": "Here we assessed whether CH&, a CH& from Silybum marianum with proven anticancer efficacy in various D&S models, inhibits G&N activation in DU145 cells, and if it does, what is the biological fate of the cells?", "original_sentence": "Here we assessed whether silibinin, a flavanone from Silybum marianum with proven anticancer efficacy in various cancer models, inhibits Stat3 activation in DU145 cells, and if it does, what is the biological fate of the cells?", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1570968, "V1": 22951, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 391, "end_pos": 400, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1570970, "V1": 22953, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 479, "end_pos": 485, "entity_type": "cancer_type_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253141, "sentence_id": "17341659594", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "594", "end_pos": "800", "sentence": "At 50 muM or higher concentrations for 24 or 48 h, CH& concentration dependently reduced constitutive G&N phosphorylation at Tyr705 and Ser727 residues under both serum and serum-starved conditions.", "original_sentence": "At 50 muM or higher concentrations for 24 or 48 h, silibinin concentration dependently reduced constitutive Stat3 phosphorylation at Tyr705 and Ser727 residues under both serum and serum-starved conditions.", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1570972, "V1": 22955, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 645, "end_pos": 654, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253142, "sentence_id": "17341659801", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "801", "end_pos": "1136", "sentence": "Constitutively active G&N -DNA binding was also inhibited concentration dependently by CH& ; however, apoptotic death together with caspase and G&N (G&N ) cleavage was observed by CH& only under serum-starved conditions suggesting that additional survival pathways are active under serum conditions.", "original_sentence": "Constitutively active Stat3-DNA binding was also inhibited concentration dependently by silibinin; however, apoptotic death together with caspase and poly(ADP-ribose) polymerase (PARP) cleavage was observed by silibinin only under serum-starved conditions suggesting that additional survival pathways are active under serum conditions.", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1570975, "V1": 22958, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 889, "end_pos": 898, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1570978, "V1": 22961, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1011, "end_pos": 1020, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253143, "sentence_id": "173416591607", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1607", "end_pos": "1843", "sentence": "Interestingly, G&N inhibitor only in combination with CH& resulted in a complete reduction in G&N phosphorylation at Tyr705, activated G&N and G&N, and caused strong G&N cleavage and apoptotic death of DU145 cells.", "original_sentence": "Interestingly, JAK1 inhibitor only in combination with silibinin resulted in a complete reduction in Stat3 phosphorylation at Tyr705, activated caspase-9 and caspase-3, and caused strong PARP cleavage and apoptotic death of DU145 cells.", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1570986, "V1": 22969, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1662, "end_pos": 1671, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253144, "sentence_id": "173416591844", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1844", "end_pos": "2100", "sentence": "Given a critical role of G&N activation in PCA, our results showed that CH& inhibits constitutively active G&N and induces apoptosis in DU145 cells, and thus might have potential significance in therapeutic intervention of this deadly D&S.", "original_sentence": "Given a critical role of Stat3 activation in PCA, our results showed that silibinin inhibits constitutively active Stat3 and induces apoptosis in DU145 cells, and thus might have potential significance in therapeutic intervention of this deadly malignancy.", "pmid_article": 17341659, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 10, "peso_genes": 3, "entitiesRules": [{ "id": 1570992, "V1": 22975, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1918, "end_pos": 1927, "entity_type": "chemical_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1570994, "V1": 22977, "pubtatot_term": "malignancy", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 2089, "end_pos": 2099, "entity_type": "cancer_type_entity_p", "entity_pmid": 17341659, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }] }, { "pmid": "12386921", "peso_rules": "1.0", "peso_entities": "0.61", "peso_genes": "0.0", "peso_final": 26.5, "article": { "id": 61603, "title_article": "Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.", "abstract_article": "The tremendous impact of prostate cancer (PCA) on the US male population has led to an increased attention on its prevention and on therapeutic intervention. Short-term models are needed to quickly screen the efficacy of promising agents against PCA. We have established recently several rat PCA cell lines from primary PCA in rats induced by a MNU-testosterone protocol, but their usefulness as a model for screening PCA preventive and therapeutic agents remains to be established. With the rationale that agents found effective in these cells could be promising for efficacy testing in long-term in vivo experiments, e.g., with MNU-testosterone-induced PCA in rats, the major goal of our study was to assess the antiproliferative and apoptotic efficacy in rat PCA cell lines of silibinin, a major active flavonoid component of silymarin, which consists of a group of flavonoid antioxidants occurring in milk thistle (Silybum marianum). Three rat PCA cell lines, namely H-7, I-8, and I-26, were treated with silibinin or silymarin, a crude silibinin-containing preparation, at various doses for varying lengths of time. Cell growth and viability studies were carried out by using hemocytometer and Trypan blue dye exclusion methods. Cell cycle distribution studies were conducted by using PI staining and flow cytometry analysis, and DNA synthesis was assessed by bromodeoxyuridine incorporation. Apoptotic cell death was assessed as DNA damage by using an enzyme-linked immunosorbent assay method and by annexin V and PI staining followed by flow cytometry analysis. Silibinin resulted in a significant growth inhibition and reduction in cell viability in each cell line studied in both a dose- and a time-dependent manner. Silibinin treatment of H-7 and I-8 cells at 100 microM dose for 12 and 24 hr resulted in a G1 arrest but caused S phase arrest after a 48-hr treatment period in each cell line studied. Similar silibinin treatment of I-26 cells resulted in a slight S phase arrest at all time points studied. Consistent with these findings, silibinin showed a strong inhibition of DNA synthesis. Silibinin also induced a substantial apoptotic death in each cell line studied. Similar to silibinin, silymarin induced growth inhibition and reduced viability in a dose- and time-dependent manner. This study demonstrates that silibinin as well as silymarin induce growth inhibition and apoptosis in rat PCA cells. These results form a strong rationale for PCA prevention and therapeutic intervention studies with silibinin and silymarin in animal models, such as the MNU-testosterone rat PCA model, to establish their efficacy and to further define their mechanisms of action under in vivo conditions. ", "pmid": 12386921, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99987805, "FORESTS_PROB": 0.82666665, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9566362 }, "rule": [{ "id": 265760, "sentence_id": "123869211", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "83", "sentence": "Antiproliferative and apoptotic effects of CH& n in rat D&S r cells.", "original_sentence": "Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 12, "peso_genes": 0, "entitiesRules": [{ "id": 1634716, "V1": 12114, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 43, "end_pos": 52, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634717, "V1": 12115, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 60, "end_pos": 75, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265761, "sentence_id": "12386921718", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "718", "end_pos": "1032", "sentence": ", with MNU-testosterone-induced D&S in rats, the major goal of our study was to assess the antiproliferative and apoptotic efficacy in rat D&S cell lines of CH&, a major active CH& component of silymarin, which consists of a group of CH& antioxidants occurring in milk thistle (Silybum marianum).", "original_sentence": ", with MNU-testosterone-induced PCA in rats, the major goal of our study was to assess the antiproliferative and apoptotic efficacy in rat PCA cell lines of silibinin, a major active flavonoid component of silymarin, which consists of a group of flavonoid antioxidants occurring in milk thistle (Silybum marianum).", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1634726, "V1": 12124, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 875, "end_pos": 884, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634724, "V1": 12122, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 750, "end_pos": 753, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634725, "V1": 12123, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 857, "end_pos": 860, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265762, "sentence_id": "123869211033", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1033", "end_pos": "1224", "sentence": "METHODS: Three rat D&S cell lines, namely H-7, I-8, and I-26, were treated with CH& or CH&, a crude CH& -containing preparation, at various doses for varying lengths of time.", "original_sentence": "METHODS: Three rat PCA cell lines, namely H-7, I-8, and I-26, were treated with silibinin or silymarin, a crude silibinin-containing preparation, at various doses for varying lengths of time.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1634730, "V1": 12128, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1113, "end_pos": 1122, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634732, "V1": 12130, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1145, "end_pos": 1154, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634729, "V1": 12127, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1052, "end_pos": 1055, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265763, "sentence_id": "123869211673", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1673", "end_pos": "1838", "sentence": "RESULTS: CH& resulted in a significant growth inhibition and reduction in cell viability in each cell line studied in both a dose- and a time-dependent manner.", "original_sentence": "RESULTS: Silibinin resulted in a significant growth inhibition and reduction in cell viability in each cell line studied in both a dose- and a time-dependent manner.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 7, "peso_genes": 2, "entitiesRules": [{ "id": 1634734, "V1": 12132, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1682, "end_pos": 1691, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265764, "sentence_id": "123869211839", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1839", "end_pos": "2023", "sentence": "CH& treatment of H-7 and I-8 cells at 100 microM dose for 12 and 24 hr resulted in a G1 arrest but caused S phase arrest after a 48-hr treatment period in each cell line studied.", "original_sentence": "Silibinin treatment of H-7 and I-8 cells at 100 microM dose for 12 and 24 hr resulted in a G1 arrest but caused S phase arrest after a 48-hr treatment period in each cell line studied.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1634735, "V1": 12133, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1839, "end_pos": 1848, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265765, "sentence_id": "123869212024", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2024", "end_pos": "2129", "sentence": "Similar CH& treatment of I-26 cells resulted in a slight S phase arrest at all time points studied.", "original_sentence": "Similar silibinin treatment of I-26 cells resulted in a slight S phase arrest at all time points studied.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1634736, "V1": 12134, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2032, "end_pos": 2041, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265766, "sentence_id": "123869212130", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2130", "end_pos": "2216", "sentence": "Consistent with these findings, CH& showed a strong inhibition of DNA synthesis.", "original_sentence": "Consistent with these findings, silibinin showed a strong inhibition of DNA synthesis.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1634737, "V1": 12135, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2162, "end_pos": 2171, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265767, "sentence_id": "123869212217", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2217", "end_pos": "2296", "sentence": "CH& also induced a substantial apoptotic death in each cell line studied.", "original_sentence": "Silibinin also induced a substantial apoptotic death in each cell line studied.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1634738, "V1": 12136, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2217, "end_pos": 2226, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265768, "sentence_id": "123869212297", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2297", "end_pos": "2414", "sentence": "Similar to CH&, silymarin induced growth inhibition and reduced viability in a dose- and time-dependent manner.", "original_sentence": "Similar to silibinin, silymarin induced growth inhibition and reduced viability in a dose- and time-dependent manner.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 2, "entitiesRules": [{ "id": 1634739, "V1": 12137, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2308, "end_pos": 2317, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265769, "sentence_id": "123869212415", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2415", "end_pos": "2543", "sentence": "CONCLUSION: This study demonstrates that CH& as well as silymarin induce growth inhibition and apoptosis in rat D&S cells.", "original_sentence": "CONCLUSION: This study demonstrates that silibinin as well as silymarin induce growth inhibition and apoptosis in rat PCA cells.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1634740, "V1": 12138, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2456, "end_pos": 2465, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634741, "V1": 12139, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2533, "end_pos": 2536, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 265770, "sentence_id": "123869212544", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2544", "end_pos": "2831", "sentence": "These results form a strong rationale for D&S prevention and therapeutic intervention studies with CH& and CH& in animal models, such as the MNU-testosterone rat D&S model, to establish their efficacy and to further define their mechanisms of action under in vivo conditions.", "original_sentence": "These results form a strong rationale for PCA prevention and therapeutic intervention studies with silibinin and silymarin in animal models, such as the MNU-testosterone rat PCA model, to establish their efficacy and to further define their mechanisms of action under in vivo conditions.", "pmid_article": 12386921, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1634743, "V1": 12141, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2643, "end_pos": 2652, "entity_type": "chemical_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634742, "V1": 12140, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2586, "end_pos": 2589, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1634745, "V1": 12143, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2718, "end_pos": 2721, "entity_type": "cancer_type_entity_p", "entity_pmid": 12386921, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }] }, { "pmid": "18701508", "peso_rules": "1.0", "peso_entities": "0.34", "peso_genes": "0.0", "peso_final": 26.5, "article": { "id": 76622, "title_article": "Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.", "abstract_article": "Herein, using transgenic adenocarcinoma of the mouse prostate (TRAMP) model, we assessed the stage-specific efficacy of silibinin feeding against prostate cancer (PCa) initiation, progression, angiogenesis and metastasis, and associated molecular events involved in silibinin effects during these stages. Male TRAMP mice starting at ages 4, 12, 20, and 30 weeks of age were fed with control or 1% silibinin-supplemented diet for 8 to 15 weeks in stage-specific manners. At the end of studies, silibinin-fed mice showed less severe prostatic lesions compared with positive controls. During early stages of prostate tumor development, silibinin mediated its efficacy mostly via antiproliferative mechanisms. Feeding of silibinin to animals burdened with higher stages of prostate tumor significantly decreased tumor grade via antiproliferative effect, and inhibition of angiogenesis as evidenced by decreased expressions of platelet endothelial cell adhesion molecule-1/CD-31, vascular endothelial growth factor, and associated receptor, vascular endothelial growth factor R2, hypoxia-inducible factor-1alpha, and inducible nitric oxide synthase. Metastasis to distant organs was decreased in silibinin-fed mice, which was associated with a decreased expression of matrix metalloproteinases, mesenchymal markers snail-1, and fibronectin in the prostatic tissue and retention of epithelial characteristics. Together, these findings are both novel and highly significant in establishing the dual efficacy of silibinin where it inhibits progression of primary prostatic tumor and also shows protective efficacy against angiogenesis and late stage metastasis. These effects of silibinin could have potential implications to improve the morbidity and survival in PCa patients.", "pmid": 18701508, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.829309, "FORESTS_PROB": 0.73333335, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 0.99470896, "med": 0.8893363 }, "rule": [{ "id": 289142, "sentence_id": "187015081", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "167", "sentence": "Stage-specific inhibitory effects and associated mechanisms of CH& n on D&S r progression and metastasis in transgenic D&S a of the mouse prostate model.", "original_sentence": "Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 15, "peso_genes": 1, "entitiesRules": [{ "id": 1745996, "V1": 1279, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 63, "end_pos": 72, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1745997, "V1": 1280, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 76, "end_pos": 81, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1745998, "V1": 1281, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 123, "end_pos": 137, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289143, "sentence_id": "18701508167", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "167", "end_pos": "471", "sentence": "Herein, using transgenic D&S of the mouse prostate (TRAMP) model, we assessed the stage-specific efficacy of CH& feeding against D&S (D&S) initiation, progression, angiogenesis and metastasis, and associated molecular events involved in CH& effects during these stages.", "original_sentence": "Herein, using transgenic adenocarcinoma of the mouse prostate (TRAMP) model, we assessed the stage-specific efficacy of silibinin feeding against prostate cancer (PCa) initiation, progression, angiogenesis and metastasis, and associated molecular events involved in silibinin effects during these stages.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1746000, "V1": 1283, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 289, "end_pos": 298, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746003, "V1": 1286, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 435, "end_pos": 444, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1745999, "V1": 1282, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 192, "end_pos": 206, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746001, "V1": 1284, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 315, "end_pos": 330, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746002, "V1": 1285, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 332, "end_pos": 335, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289144, "sentence_id": "18701508474", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "474", "end_pos": "638", "sentence": "Male G&N mice starting at ages 4, 12, 20, and 30 weeks of age were fed with control or 1% CH& -supplemented diet for 8 to 15 weeks in stage-specific manners.", "original_sentence": "Male TRAMP mice starting at ages 4, 12, 20, and 30 weeks of age were fed with control or 1% silibinin-supplemented diet for 8 to 15 weeks in stage-specific manners.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1746005, "V1": 1288, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 566, "end_pos": 575, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289145, "sentence_id": "18701508639", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "639", "end_pos": "750", "sentence": "At the end of studies, CH& -fed mice showed less severe prostatic lesions compared with positive controls.", "original_sentence": "At the end of studies, silibinin-fed mice showed less severe prostatic lesions compared with positive controls.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1746006, "V1": 1289, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 662, "end_pos": 671, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289146, "sentence_id": "18701508751", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "751", "end_pos": "874", "sentence": "During early stages of D&S development, CH& mediated its efficacy mostly via antiproliferative mechanisms.", "original_sentence": "During early stages of prostate tumor development, silibinin mediated its efficacy mostly via antiproliferative mechanisms.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1746008, "V1": 1291, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 802, "end_pos": 811, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746007, "V1": 1290, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 774, "end_pos": 788, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289147, "sentence_id": "18701508875", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "875", "end_pos": "1313", "sentence": "Feeding of CH& to animals burdened with higher stages of D&S significantly decreased D&S grade via antiproliferative effect, and inhibition of angiogenesis as evidenced by decreased expressions of platelet endothelial cell adhesion molecule-1/CD-31, vascular endothelial growth factor, and associated receptor, vascular endothelial growth factor R2, hypoxia-inducible factor-1alpha, and inducible nitric oxide synthase.", "original_sentence": "Feeding of silibinin to animals burdened with higher stages of prostate tumor significantly decreased tumor grade via antiproliferative effect, and inhibition of angiogenesis as evidenced by decreased expressions of platelet endothelial cell adhesion molecule-1/CD-31, vascular endothelial growth factor, and associated receptor, vascular endothelial growth factor R2, hypoxia-inducible factor-1alpha, and inducible nitric oxide synthase.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 9, "peso_genes": 3, "entitiesRules": [{ "id": 1746009, "V1": 1292, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 886, "end_pos": 895, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746010, "V1": 1293, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 938, "end_pos": 952, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746011, "V1": 1294, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 977, "end_pos": 982, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289148, "sentence_id": "187015081314", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1314", "end_pos": "1572", "sentence": "Metastasis to distant organs was decreased in CH& -fed mice, which was associated with a decreased expression of matrix metalloproteinases, mesenchymal markers snail-1, and G&N in the prostatic tissue and retention of epithelial characteristics.", "original_sentence": "Metastasis to distant organs was decreased in silibinin-fed mice, which was associated with a decreased expression of matrix metalloproteinases, mesenchymal markers snail-1, and fibronectin in the prostatic tissue and retention of epithelial characteristics.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1746012, "V1": 1295, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1360, "end_pos": 1369, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289149, "sentence_id": "187015081573", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1573", "end_pos": "1822", "sentence": "Together, these findings are both novel and highly significant in establishing the dual efficacy of CH& where it inhibits progression of primary D&S and also shows protective efficacy against angiogenesis and late stage metastasis.", "original_sentence": "Together, these findings are both novel and highly significant in establishing the dual efficacy of silibinin where it inhibits progression of primary prostatic tumor and also shows protective efficacy against angiogenesis and late stage metastasis.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "sim", "peso_frase": 8, "peso_genes": 3, "entitiesRules": [{ "id": 1746014, "V1": 1297, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1673, "end_pos": 1682, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746015, "V1": 1298, "pubtatot_term": "prostatic tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1724, "end_pos": 1739, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }, { "id": 289150, "sentence_id": "187015081823", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1823", "end_pos": "1938", "sentence": "These effects of CH& could have potential implications to improve the morbidity and survival in D&S patients.", "original_sentence": "These effects of silibinin could have potential implications to improve the morbidity and survival in PCa patients.", "pmid_article": 18701508, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1746016, "V1": 1299, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1840, "end_pos": 1849, "entity_type": "chemical_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }, { "id": 1746017, "V1": 1300, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1925, "end_pos": 1928, "entity_type": "cancer_type_entity_p", "entity_pmid": 18701508, "created_at": "2020-10-31T15:18:23.034Z", "updated_at": "2020-10-31T15:18:23.034Z" }] }] }, { "pmid": "18253818", "peso_rules": "0.45", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 26.3, "article": { "id": 76627, "title_article": "Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.", "abstract_article": "Epidermal growth factor (EGF) and transformation growth factor-alpha (TGFalpha) are potent mitogens that regulate proliferation of prostate cancer cells via autocrine and paracrine loops, and promote tumor metastasis. They exert their action through binding to the cell surface receptor, epidermal growth factor receptor (EGFR), and cause activation of Erk1/2 mediated mitogenic signaling in human prostate cancer (PCA) at both advanced and androgen-independent stages. Thus, we rationalized that inhibiting this mitogenic pathway could be useful in controlling advanced PCA growth. LNCaP and DU145 human PCA cells were treated with silibinin (100-200 microM) for different time points, and the levels of TGFalpha, activated signaling molecules (EGFR, Erk1/2 and Jnk1/2) and Erk1/2 kinase activity were analyzed employing ELISA, immunoprecipitation and/or immunoblotting techniques. The mRNA levels of TGFalpha were analyzed by RT-PCR. Treatment of cells (LNCaP and DU145) with silibinin resulted in a decrease in TGFalpha protein at both secreted and cellular levels together with a decrease in its mRNA level. Silibinin also caused an inhibition of EGFR activation followed by that of Erk1/2 without any change in their protein levels. The kinase activity of Erk1/2 to Elk1 was also inhibited by silibinin at least in DU145 cells. In other study, silibinin caused strong inhibition of Jnk1/2 activation in LNCaP cells while in DU145 cells, a strong induction in Jnk1/2 activation was observed. These results suggest that silibinin impairs TGFalpha-EGFR-Erk1/2 signaling in both androgen-dependent (LNCaP) and -independent (DU145) advanced human prostate carcinoma cells. This study, for the first time, identifies the inhibitory effect of silibinin on constitutively active TGFalpha-EGFR autocrine loop in advanced human PCA cells, which plausible contributes to the strong efficacy of silibinin in PCA prevention and intervention, as reported in recent studies.", "pmid": 18253818, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9983628, "FORESTS_PROB": 0.8333333, "LOGITBOOST_PROB": 0.9999546, "MAXENTROPY_PROB": 1, "med": 0.9579127 }, "rule": [{ "id": 264699, "sentence_id": "182538181", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "113", "sentence": "CH& impairs constitutively active G&N aG&N R autocrine loop in advanced human D&S a cells.", "original_sentence": "Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 10, "peso_genes": 1, "entitiesRules": [{ "id": 1629115, "V1": 6513, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629118, "V1": 6516, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 87, "end_pos": 105, "entity_type": "cancer_type_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264700, "sentence_id": "18253818705", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "705", "end_pos": "1013", "sentence": "METHODS: LNCaP and DU145 human D&S cells were treated with CH& (100-200 microM) for different time points, and the levels of G&N, activated signaling molecules (G&N, G&N and G&N ) and G&N kinase activity were analyzed employing ELISA, immunoprecipitation and/or immunoblotting techniques.", "original_sentence": "METHODS: LNCaP and DU145 human PCA cells were treated with silibinin (100-200 microM) for different time points, and the levels of TGFalpha, activated signaling molecules (EGFR, Erk1/2 and Jnk1/2) and Erk1/2 kinase activity were analyzed employing ELISA, immunoprecipitation and/or immunoblotting techniques.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1629129, "V1": 6527, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 764, "end_pos": 773, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629128, "V1": 6526, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 736, "end_pos": 739, "entity_type": "cancer_type_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264701, "sentence_id": "182538181067", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1067", "end_pos": "1251", "sentence": "RESULTS: Treatment of cells (LNCaP and DU145) with CH& resulted in a decrease in G&N protein at both secreted and cellular levels together with a decrease in its mRNA level.", "original_sentence": "RESULTS: Treatment of cells (LNCaP and DU145) with silibinin resulted in a decrease in TGFalpha protein at both secreted and cellular levels together with a decrease in its mRNA level.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 4, "peso_genes": 3, "entitiesRules": [{ "id": 1629136, "V1": 6534, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1118, "end_pos": 1127, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264702, "sentence_id": "182538181252", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1252", "end_pos": "1377", "sentence": "CH& also caused an inhibition of G&N activation followed by that of G&N without any change in their protein levels.", "original_sentence": "Silibinin also caused an inhibition of EGFR activation followed by that of Erk1/2 without any change in their protein levels.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1629138, "V1": 6536, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1252, "end_pos": 1261, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264703, "sentence_id": "182538181378", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1378", "end_pos": "1472", "sentence": "The kinase activity of G&N to G&N was also inhibited by CH& at least in DU145 cells.", "original_sentence": "The kinase activity of Erk1/2 to Elk1 was also inhibited by silibinin at least in DU145 cells.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1629143, "V1": 6541, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1438, "end_pos": 1447, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264704, "sentence_id": "182538181473", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1473", "end_pos": "1635", "sentence": "In other study, CH& caused strong inhibition of G&N /2 activation in LNCaP cells while in DU145 cells, a strong induction in G&N /2 activation was observed.", "original_sentence": "In other study, silibinin caused strong inhibition of Jnk1/2 activation in LNCaP cells while in DU145 cells, a strong induction in Jnk1/2 activation was observed.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1629144, "V1": 6542, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1489, "end_pos": 1498, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264705, "sentence_id": "182538181636", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1636", "end_pos": "1812", "sentence": "These results suggest that CH& impairs G&N -G&N - G&N signaling in both androgen-dependent (LNCaP) and -independent (DU145) advanced human D&S cells.", "original_sentence": "These results suggest that silibinin impairs TGFalpha-EGFR-Erk1/2 signaling in both androgen-dependent (LNCaP) and -independent (DU145) advanced human prostate carcinoma cells.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1629147, "V1": 6545, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1663, "end_pos": 1672, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629151, "V1": 6549, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1787, "end_pos": 1805, "entity_type": "cancer_type_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }, { "id": 264706, "sentence_id": "182538181813", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1813", "end_pos": "2117", "sentence": "CONCLUSIONS: This study, for the first time, identifies the inhibitory effect of CH& on constitutively active G&N -G&N autocrine loop in advanced human D&S cells, which plausible contributes to the strong efficacy of CH& in D&S prevention and intervention, as reported in recent studies.", "original_sentence": "CONCLUSIONS: This study, for the first time, identifies the inhibitory effect of silibinin on constitutively active TGFalpha-EGFR autocrine loop in advanced human PCA cells, which plausible contributes to the strong efficacy of silibinin in PCA prevention and intervention, as reported in recent studies.", "pmid_article": 18253818, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1629152, "V1": 6550, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1894, "end_pos": 1903, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629156, "V1": 6554, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2041, "end_pos": 2050, "entity_type": "chemical_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629155, "V1": 6553, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1976, "end_pos": 1979, "entity_type": "cancer_type_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }, { "id": 1629157, "V1": 6555, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2054, "end_pos": 2057, "entity_type": "cancer_type_entity_p", "entity_pmid": 18253818, "created_at": "2020-10-31T15:08:37.108Z", "updated_at": "2020-10-31T15:08:37.108Z" }] }] }, { "pmid": "10377442", "peso_rules": "0.54", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 26.1, "article": { "id": 62045, "title_article": "Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.", "abstract_article": "Reduction in serum prostate-specific antigen (PSA) levels has been proposed as an endpoint biomarker for hormone-refractory human prostate cancer intervention. We examined whether a flavonoid antioxidant silibinin (an active constituent of milk thistle) decreases PSA levels in hormone-refractory human prostate carcinoma LNCaP cells and whether this effect has biological relevance. Silibinin treatment of cells grown in serum resulted in a significant decrease in both intracellular and secreted forms of PSA concomitant with a highly significant to complete inhibition of cell growth via a G1 arrest in cell cycle progression. Treatment of cells grown in charcoal-stripped serum and 5alpha-dihydrotestosterone showed that the observed effects of silibinin are those involving androgen-stimulated PSA expression and cell growth. Silibinin-induced G1 arrest was associated with a marked decrease in the kinase activity of cyclin-dependent kinases (CDKs) and associated cyclins because of a highly significant decrease in cyclin D1, CDK4, and CDK6 levels and an induction of Cip1/p21 and Kip1/p27 followed by their increased binding with CDK2. Silibinin treatment of cells did not result in apoptosis and changes in p53 and bcl2, suggesting that the observed increase in Cip1/p21 is a p53-independent effect that does not lead to an apoptotic cell death pathway. Conversely, silibinin treatment resulted in a significant neuroendocrine differentiation of LNCaP cells as an alternative pathway after Cip1/p21 induction and G1 arrest. Together, these results suggest that silibinin could be a useful agent for the intervention of hormone-refractory human prostate cancer.", "pmid": 10377442, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9987303, "FORESTS_PROB": 0.85, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999998, "med": 0.9621825 }, "rule": [{ "id": 260383, "sentence_id": "103774421", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "192", "sentence": "CH& decreases G&N n with cell growth inhibition via G1 arrest, leading to differentiation of D&S a cells: implications for D&S r intervention.", "original_sentence": "Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 15, "peso_genes": 3, "entitiesRules": [{ "id": 1607480, "V1": 2609, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1607482, "V1": 2611, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 119, "end_pos": 137, "entity_type": "cancer_type_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1607483, "V1": 2612, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 162, "end_pos": 177, "entity_type": "cancer_type_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260384, "sentence_id": "10377442352", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "352", "end_pos": "575", "sentence": "We examined whether a CH& antioxidant CH& (an active constituent of milk thistle) decreases G&N levels in hormone-refractory human D&S LNCaP cells and whether this effect has biological relevance.", "original_sentence": "We examined whether a flavonoid antioxidant silibinin (an active constituent of milk thistle) decreases PSA levels in hormone-refractory human prostate carcinoma LNCaP cells and whether this effect has biological relevance.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1607487, "V1": 2616, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 396, "end_pos": 405, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1607489, "V1": 2618, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 495, "end_pos": 513, "entity_type": "cancer_type_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260385, "sentence_id": "10377442576", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "576", "end_pos": "821", "sentence": "CH& treatment of cells grown in serum resulted in a significant decrease in both intracellular and secreted forms of G&N concomitant with a highly significant to complete inhibition of cell growth via a G1 arrest in cell cycle progression.", "original_sentence": "Silibinin treatment of cells grown in serum resulted in a significant decrease in both intracellular and secreted forms of PSA concomitant with a highly significant to complete inhibition of cell growth via a G1 arrest in cell cycle progression.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1607490, "V1": 2619, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 576, "end_pos": 585, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260386, "sentence_id": "10377442822", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "822", "end_pos": "1022", "sentence": "Treatment of cells grown in charcoal-stripped serum and 5alpha-dihydrotestosterone showed that the observed effects of CH& are those involving androgen-stimulated G&N expression and cell growth.", "original_sentence": "Treatment of cells grown in charcoal-stripped serum and 5alpha-dihydrotestosterone showed that the observed effects of silibinin are those involving androgen-stimulated PSA expression and cell growth.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1607492, "V1": 2621, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 941, "end_pos": 950, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260387, "sentence_id": "103774421023", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1023", "end_pos": "1335", "sentence": "CH& -induced G1 arrest was associated with a marked decrease in the kinase activity of cyclin-dependent kinases (CDKs) and associated cyclins because of a highly significant decrease in G&N, G&N, and G&N levels and an induction of G&N /G&N and G&N /G&N followed by their increased binding with G&N .", "original_sentence": "Silibinin-induced G1 arrest was associated with a marked decrease in the kinase activity of cyclin-dependent kinases (CDKs) and associated cyclins because of a highly significant decrease in cyclin D1, CDK4, and CDK6 levels and an induction of Cip1/p21 and Kip1/p27 followed by their increased binding with CDK2.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1607494, "V1": 2623, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1023, "end_pos": 1032, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260388, "sentence_id": "103774421336", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1336", "end_pos": "1554", "sentence": "CH& treatment of cells did not result in apoptosis and changes in G&N and G&N, suggesting that the observed increase in G&N /G&N is a G&N-independent effect that does not lead to an apoptotic cell death pathway.", "original_sentence": "Silibinin treatment of cells did not result in apoptosis and changes in p53 and bcl2, suggesting that the observed increase in Cip1/p21 is a p53-independent effect that does not lead to an apoptotic cell death pathway.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1607503, "V1": 2632, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1336, "end_pos": 1345, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260389, "sentence_id": "103774421555", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1555", "end_pos": "1724", "sentence": "Conversely, CH& treatment resulted in a significant neuroendocrine differentiation of LNCaP cells as an alternative pathway after G&N /G&N induction and G1 arrest.", "original_sentence": "Conversely, silibinin treatment resulted in a significant neuroendocrine differentiation of LNCaP cells as an alternative pathway after Cip1/p21 induction and G1 arrest.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 2, "entitiesRules": [{ "id": 1607509, "V1": 2638, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1567, "end_pos": 1576, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260390, "sentence_id": "103774421725", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1725", "end_pos": "1861", "sentence": "Together, these results suggest that CH& could be a useful agent for the intervention of hormone-refractory human D&S.", "original_sentence": "Together, these results suggest that silibinin could be a useful agent for the intervention of hormone-refractory human prostate cancer.", "pmid_article": 10377442, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1607512, "V1": 2641, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1762, "end_pos": 1771, "entity_type": "chemical_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1607513, "V1": 2642, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1845, "end_pos": 1860, "entity_type": "cancer_type_entity_p", "entity_pmid": 10377442, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }] }, { "pmid": "25294820", "peso_rules": "1.0", "peso_entities": "0.47", "peso_genes": "0.0", "peso_final": 26.1, "article": { "id": 76542, "title_article": "Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.", "abstract_article": "Prostate cancer (PCA) kills thousands of men every year, demanding additional approaches to better understand and target this malignancy. Recently, critical role of aberrant lipogenesis is highlighted in prostate carcinogenesis, offering a unique opportunity to target it to reduce PCA. Here, we evaluated efficacy and associated mechanisms of silibinin in inhibiting lipid metabolism in PCA cells. At physiologically achievable levels in human, silibinin strongly reduced lipid and cholesterol accumulation specifically in human PCA cells but not in non-neoplastic prostate epithelial PWR-1E cells. Silibinin also decreased nuclear protein levels of sterol regulatory element binding protein 1 and 2 (SREBP1/2) and their target genes only in PCA cells. Mechanistically, silibinin activated AMPK, thereby increasing SREBP1 phosphorylation and inhibiting its nuclear translocation; AMPK inhibition reversed silibinin-mediated decrease in nuclear SREBP1 and lipid accumulation. Additionally, specific SREBP inhibitor fatostatin and stable overexpression of SREBP1 further confirmed the central role of SREBP1 in silibinin-mediated inhibition of PCA cell proliferation and lipid accumulation and cell cycle arrest. Importantly, silibinin also inhibited synthetic androgen R1881-induced lipid accumulation and completely abrogated the development of androgen-independent LNCaP cell clones via targeting SREBP1/2. Together, these mechanistic studies suggest that silibinin would be effective against PCA by targeting critical aberrant lipogenesis. ", "pmid": 25294820, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9982541, "FORESTS_PROB": 0.83666664, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999905, "med": 0.9587299 }, "rule": [{ "id": 263933, "sentence_id": "252948201", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "195", "sentence": "CH& inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in D&S r cells via primarily targeting the sterol response element binding protein 1.", "original_sentence": "Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1625393, "V1": 2791, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625394, "V1": 2792, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 102, "end_pos": 117, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263934, "sentence_id": "25294820482", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "482", "end_pos": "593", "sentence": "Here, we evaluated efficacy and associated mechanisms of CH& in inhibiting lipid metabolism in D&S cells.", "original_sentence": "Here, we evaluated efficacy and associated mechanisms of silibinin in inhibiting lipid metabolism in PCA cells.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1625399, "V1": 2797, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 539, "end_pos": 548, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625400, "V1": 2798, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 583, "end_pos": 586, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263935, "sentence_id": "25294820594", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "594", "end_pos": "794", "sentence": "At physiologically achievable levels in human, CH& strongly reduced lipid and cholesterol accumulation specifically in human D&S cells but not in non-neoplastic prostate epithelial PWR-1E cells.", "original_sentence": "At physiologically achievable levels in human, silibinin strongly reduced lipid and cholesterol accumulation specifically in human PCA cells but not in non-neoplastic prostate epithelial PWR-1E cells.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1625401, "V1": 2799, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 641, "end_pos": 650, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625402, "V1": 2800, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 725, "end_pos": 728, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263936, "sentence_id": "25294820795", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "795", "end_pos": "948", "sentence": "CH& also decreased nuclear protein levels of sterol regulatory element binding protein 1 and 2 (SREBP1/2) and their target genes only in D&S cells.", "original_sentence": "Silibinin also decreased nuclear protein levels of sterol regulatory element binding protein 1 and 2 (SREBP1/2) and their target genes only in PCA cells.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1625403, "V1": 2801, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 795, "end_pos": 804, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625404, "V1": 2802, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 938, "end_pos": 941, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263937, "sentence_id": "25294820949", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "949", "end_pos": "1170", "sentence": "Mechanistically, CH& activated G&N, thereby increasing G&N phosphorylation and inhibiting its nuclear translocation; G&N inhibition reversed CH& -mediated decrease in nuclear G&N and lipid accumulation.", "original_sentence": "Mechanistically, silibinin activated AMPK, thereby increasing SREBP1 phosphorylation and inhibiting its nuclear translocation; AMPK inhibition reversed silibinin-mediated decrease in nuclear SREBP1 and lipid accumulation.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1625405, "V1": 2803, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 966, "end_pos": 975, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625409, "V1": 2807, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1101, "end_pos": 1110, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263938, "sentence_id": "252948201171", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1171", "end_pos": "1406", "sentence": "Additionally, specific SREBP inhibitor fatostatin and stable overexpression of G&N further confirmed the central role of G&N in CH& -mediated inhibition of D&S cell proliferation and lipid accumulation and cell cycle arrest.", "original_sentence": "Additionally, specific SREBP inhibitor fatostatin and stable overexpression of SREBP1 further confirmed the central role of SREBP1 in silibinin-mediated inhibition of PCA cell proliferation and lipid accumulation and cell cycle arrest.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 7, "peso_genes": 3, "entitiesRules": [{ "id": 1625413, "V1": 2811, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1305, "end_pos": 1314, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625414, "V1": 2812, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1338, "end_pos": 1341, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263939, "sentence_id": "252948201407", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1407", "end_pos": "1603", "sentence": "Importantly, CH& also inhibited synthetic androgen R1881-induced lipid accumulation and completely abrogated the development of androgen-independent LNCaP cell clones via targeting SREBP1/2.", "original_sentence": "Importantly, silibinin also inhibited synthetic androgen R1881-induced lipid accumulation and completely abrogated the development of androgen-independent LNCaP cell clones via targeting SREBP1/2.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1625415, "V1": 2813, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1420, "end_pos": 1429, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263940, "sentence_id": "252948201604", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1604", "end_pos": "1737", "sentence": "Together, these mechanistic studies suggest that CH& would be effective against D&S by targeting critical aberrant lipogenesis.", "original_sentence": "Together, these mechanistic studies suggest that silibinin would be effective against PCA by targeting critical aberrant lipogenesis.", "pmid_article": 25294820, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1625416, "V1": 2814, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1653, "end_pos": 1662, "entity_type": "chemical_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1625417, "V1": 2815, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1690, "end_pos": 1693, "entity_type": "cancer_type_entity_p", "entity_pmid": 25294820, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }] }, { "pmid": "24692702", "peso_rules": "1.0", "peso_entities": "0.71", "peso_genes": "0.0", "peso_final": 25.9, "article": { "id": 57586, "title_article": "Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.", "abstract_article": "Silibinin, a naturally-occurring flavonoid produced by milk thistle, possesses antioxidant, anti-inflammatory and cancer-preventive activities. In the current study, we examined the effects of silibinin on the expression of secreted phospholipase A2 (sPLA2) enzymes, especially those of group IIA (hGIIA), which play a crucial role in inflammation and carcinogenesis. The effects of silibinin on sPLA2 expressions in human HepG2 hepatoma and PC-3 prostate cancer cells were analyzed using quantitative reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay technique. Silibinin inhibited the expression of hGIIA in unstimulated and cytokine-primed HepG2 and PC-3 cells. The mRNA levels of sPLA2 of groups IB, III and V were also significantly decreased by silibinin. Analyses of transcription factor activation suggest that nuclear factor-κB, but not specificity protein 1 (SP1) is implicated in the silibinin-mediated down-regulation of hGIIA. Silibinin exhibits inhibitory effects on basal and cytokine-induced expression of sPLA2s in cancer cells and therefore, may have the potential to protect against up-regulation of hGIIA and other sPLA2 isoforms during inflammation and cancer.", "pmid": 24692702, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.98781043, "FORESTS_PROB": 0.88, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.9999961, "med": 0.9669516 }, "rule": [{ "id": 254960, "sentence_id": "246927021", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "90", "sentence": "CH& down-regulates expression of G&N 2 enzymes in D&S r cells.", "original_sentence": "Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 3, "entitiesRules": [{ "id": 1580278, "V1": 32261, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580280, "V1": 32263, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 76, "end_pos": 82, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254961, "sentence_id": "2469270290", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "90", "end_pos": "245", "sentence": "BACKGROUND: CH&, a naturally-occurring CH& produced by milk thistle, possesses antioxidant, anti-inflammatory and D&S -preventive activities.", "original_sentence": "BACKGROUND: Silibinin, a naturally-occurring flavonoid produced by milk thistle, possesses antioxidant, anti-inflammatory and cancer-preventive activities.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1580281, "V1": 32264, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 102, "end_pos": 111, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580283, "V1": 32266, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 216, "end_pos": 222, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254962, "sentence_id": "24692702246", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "246", "end_pos": "469", "sentence": "In the current study, we examined the effects of CH& on the expression of G&N ( G&N ) enzymes, especially those of group IIA ( G&N ), which play a crucial role in inflammation and carcinogenesis.", "original_sentence": "In the current study, we examined the effects of silibinin on the expression of secreted phospholipase A2 (sPLA2) enzymes, especially those of group IIA (hGIIA), which play a crucial role in inflammation and carcinogenesis.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1580284, "V1": 32267, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 295, "end_pos": 304, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254963, "sentence_id": "24692702470", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "470", "end_pos": "723", "sentence": "MATERIALS AND METHODS: The effects of CH& on G&N expressions in human D&S D&S and D&S D&S cells were analyzed using quantitative reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay technique.", "original_sentence": "MATERIALS AND METHODS: The effects of silibinin on sPLA2 expressions in human HepG2 hepatoma and PC-3 prostate cancer cells were analyzed using quantitative reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay technique.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1580290, "V1": 32273, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 508, "end_pos": 517, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580292, "V1": 32275, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 548, "end_pos": 553, "entity_type": "cancer_type_entity_cell", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580293, "V1": 32276, "pubtatot_term": "hepatoma", "db_term": "Hepatocellular carcinoma", "db_equivalence": "Hepatocellular carcinoma", "mesh_id": "D006528", "term_id": "230098", "start_pos": 554, "end_pos": 562, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580294, "V1": 32277, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 567, "end_pos": 571, "entity_type": "cancer_type_entity_cell", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580295, "V1": 32278, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 572, "end_pos": 587, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254964, "sentence_id": "24692702724", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "724", "end_pos": "834", "sentence": "RESULTS: CH& inhibited the expression of G&N in unstimulated and cytokine-primed D&S and D&S cells.", "original_sentence": "RESULTS: Silibinin inhibited the expression of hGIIA in unstimulated and cytokine-primed HepG2 and PC-3 cells.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1580296, "V1": 32279, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 733, "end_pos": 742, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580298, "V1": 32281, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 813, "end_pos": 818, "entity_type": "cancer_type_entity_cell", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580299, "V1": 32282, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 823, "end_pos": 827, "entity_type": "cancer_type_entity_cell", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254965, "sentence_id": "24692702835", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "835", "end_pos": "931", "sentence": "The mRNA levels of G&N of groups IB, III and V were also significantly decreased by CH& .", "original_sentence": "The mRNA levels of sPLA2 of groups IB, III and V were also significantly decreased by silibinin.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1580301, "V1": 32284, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 921, "end_pos": 930, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254966, "sentence_id": "24692702932", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "932", "end_pos": "1110", "sentence": "Analyses of transcription factor activation suggest that nuclear factor-κB, but not G&N 1 (SP1) is implicated in the CH& n-mediated down-regulation of G&N A.", "original_sentence": "Analyses of transcription factor activation suggest that nuclear factor-κB, but not specificity protein 1 (SP1) is implicated in the silibinin-mediated down-regulation of hGIIA.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1580303, "V1": 32286, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1065, "end_pos": 1074, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254967, "sentence_id": "246927021111", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1111", "end_pos": "1364", "sentence": "CONCLUSION: CH& n exhibits inhibitory effects on basal and cytokine-induced expression of G&N s in D&S r cells and therefore, may have the potential to protect against up-regulation of G&N A and other G&N 2 isoforms during inflammation and D&S r.", "original_sentence": "CONCLUSION: Silibinin exhibits inhibitory effects on basal and cytokine-induced expression of sPLA2s in cancer cells and therefore, may have the potential to protect against up-regulation of hGIIA and other sPLA2 isoforms during inflammation and cancer.", "pmid_article": 24692702, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 11, "peso_genes": 3, "entitiesRules": [{ "id": 1580305, "V1": 32288, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1122, "end_pos": 1131, "entity_type": "chemical_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580307, "V1": 32290, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1214, "end_pos": 1220, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580311, "V1": 32294, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1356, "end_pos": 1362, "entity_type": "cancer_type_entity_p", "entity_pmid": 24692702, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "14504208", "peso_rules": "1.0", "peso_entities": "0.52", "peso_genes": "0.0", "peso_final": 25.9, "article": { "id": 76654, "title_article": "Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.", "abstract_article": "Recently, we observed that dietary feeding of silibinin strongly prevents and inhibits the growth of advanced human prostate tumor xenografts in athymic nude mice without any apparent signs of toxicity together with increased secretion of insulin-like growth factor-binding protein 3 from the tumor in to mouse plasma (R. P. Singh et al., Cancer Res., 62:3063-3069, 2002). In the present study, we investigated the effect of silibinin feeding [0.05% and 0.1% (w/w) in diet for 60 days] on the prognostic biomarkers (namely, proliferation, apoptosis, and angiogenesis) in the prostate tumor xenografts of the above-reported study. Immunohistochemical analysis of the tumors for proliferating cell nuclear antigen and Ki-67 showed that silibinin decreases proliferation index by 28-60% and 30-60% (P<0.001) as compared with their controls, respectively. In situ detection of apoptosis by terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling staining of tumors showed a 7.4-8.1-fold (P<0.001) increase in apoptotic cells in silibinin-fed groups over that of control group. Silibinin also increased activated caspase 3-positive cells by 2.3-3.6-fold (P<0.001). CD31 staining for tumor vasculature showed a significant decrease (21-38%; P<0.001) in tumor microvessel density in silibinin-fed groups of tumors as compared with control group of tumors. Tumor sections were also analyzed for vascular endothelial growth factor and insulin-like growth factor-binding protein 3 protein expression, and a slightly decreased and a moderately increased cytoplasmic immunostaining in silibinin-fed groups were observed as compared with the control group, respectively. Together, these results suggest that inhibition of advanced human prostate tumor xenograft growth in athymic nude mice by silibinin is associated with its in vivo antiproliferative, proapoptotic, and antiangiogenic efficacy in prostate tumor.", "pmid": 14504208, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.96781933, "FORESTS_PROB": 0.89666665, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9998938, "med": 0.966095 }, "rule": [{ "id": 255965, "sentence_id": "145042081", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "189", "sentence": "Suppression of advanced human D&S r growth in athymic mice by CH& n feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.", "original_sentence": "Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 17, "peso_genes": 3, "entitiesRules": [{ "id": 1585468, "V1": 37451, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 71, "end_pos": 80, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585467, "V1": 37450, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 30, "end_pos": 44, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255966, "sentence_id": "14504208189", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "189", "end_pos": "510", "sentence": "Recently, we observed that dietary feeding of CH& strongly prevents and inhibits the growth of advanced human D&S xenografts in athymic nude mice without any apparent signs of toxicity together with increased secretion of insulin-like growth factor-binding protein 3 from the D&S in to mouse plasma (R.", "original_sentence": "Recently, we observed that dietary feeding of silibinin strongly prevents and inhibits the growth of advanced human prostate tumor xenografts in athymic nude mice without any apparent signs of toxicity together with increased secretion of insulin-like growth factor-binding protein 3 from the tumor in to mouse plasma (R.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1585469, "V1": 37452, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 235, "end_pos": 244, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585470, "V1": 37453, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 305, "end_pos": 319, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585471, "V1": 37454, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 482, "end_pos": 487, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255967, "sentence_id": "14504208562", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "562", "end_pos": "645", "sentence": "In the present study, we investigated the effect of CH& feeding _0_05% and 0.", "original_sentence": "In the present study, we investigated the effect of silibinin feeding [0_05% and 0.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1585473, "V1": 37456, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 614, "end_pos": 623, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255968, "sentence_id": "14504208819", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "819", "end_pos": "1040", "sentence": "Immunohistochemical analysis of the D&S for proliferating cell nuclear antigen and Ki-67 showed that CH& decreases proliferation index by 28-60% and 30-60% (P<0_001) as compared with their controls, respectively.", "original_sentence": "Immunohistochemical analysis of the tumors for proliferating cell nuclear antigen and Ki-67 showed that silibinin decreases proliferation index by 28-60% and 30-60% (P<0_001) as compared with their controls, respectively.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1585476, "V1": 37459, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 923, "end_pos": 932, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585475, "V1": 37458, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 855, "end_pos": 861, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255969, "sentence_id": "145042081179", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1179", "end_pos": "1275", "sentence": "1-fold (P<0_001) increase in apoptotic cells in CH& -fed groups over that of control group.", "original_sentence": "1-fold (P<0_001) increase in apoptotic cells in silibinin-fed groups over that of control group.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1585478, "V1": 37461, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1227, "end_pos": 1236, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255970, "sentence_id": "145042081276", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1276", "end_pos": "1341", "sentence": "CH& also increased activated G&N -positive cells by 2.", "original_sentence": "Silibinin also increased activated caspase 3-positive cells by 2.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1585479, "V1": 37462, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1276, "end_pos": 1285, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255971, "sentence_id": "145042081363", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1363", "end_pos": "1551", "sentence": "G&N staining for D&S vasculature showed a significant decrease (21-38%; P<0_001) in D&S microvessel density in CH& -fed groups of D&S as compared with control group of D&S .", "original_sentence": "CD31 staining for tumor vasculature showed a significant decrease (21-38%; P<0_001) in tumor microvessel density in silibinin-fed groups of tumors as compared with control group of tumors.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1585484, "V1": 37467, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1479, "end_pos": 1488, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585482, "V1": 37465, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1381, "end_pos": 1386, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585483, "V1": 37466, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1450, "end_pos": 1455, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585485, "V1": 37468, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1503, "end_pos": 1509, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585486, "V1": 37469, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1544, "end_pos": 1550, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255972, "sentence_id": "145042081552", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1552", "end_pos": "1860", "sentence": "Tumor sections were also analyzed for vascular endothelial growth factor and insulin-like growth factor-binding protein 3 protein expression, and a slightly decreased and a moderately increased cytoplasmic immunostaining in CH& -fed groups were observed as compared with the control group, respectively.", "original_sentence": "Tumor sections were also analyzed for vascular endothelial growth factor and insulin-like growth factor-binding protein 3 protein expression, and a slightly decreased and a moderately increased cytoplasmic immunostaining in silibinin-fed groups were observed as compared with the control group, respectively.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1585487, "V1": 37470, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1776, "end_pos": 1785, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255973, "sentence_id": "145042081861", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1861", "end_pos": "2103", "sentence": "Together, these results suggest that inhibition of advanced human D&S xenograft growth in athymic nude mice by CH& is associated with its in vivo antiproliferative, proapoptotic, and antiangiogenic efficacy in D&S.", "original_sentence": "Together, these results suggest that inhibition of advanced human prostate tumor xenograft growth in athymic nude mice by silibinin is associated with its in vivo antiproliferative, proapoptotic, and antiangiogenic efficacy in prostate tumor.", "pmid_article": 14504208, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 11, "peso_genes": 1, "entitiesRules": [{ "id": 1585489, "V1": 37472, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1983, "end_pos": 1992, "entity_type": "chemical_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585488, "V1": 37471, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1927, "end_pos": 1941, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1585490, "V1": 37473, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2088, "end_pos": 2102, "entity_type": "cancer_type_entity_p", "entity_pmid": 14504208, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "11896607", "peso_rules": "0.59", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 25.4, "article": { "id": 76456, "title_article": "Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.", "abstract_article": "Prostate cancer (PCA) is one of the most common invasive malignancies of men in the US, however, there have been limited successes so far in its therapy. Even most potent agents (e.g. TNFalpha) are ineffective in killing human PCA cells possibly due to constitutive activation of NF-kappaB that subsequently activates a large number of anti-apoptotic genes. In such a scenario, strong apoptotic agent TNFalpha, further induces NF-kappaB activation rather than inducing apoptosis. In several recent studies, we have demonstrated both cancer preventive and anti-cancer efficacy of silymarin and its constituent silibinin in a variety of experimental tumor models and cell culture systems. Here we examined whether silibinin is effective in inhibiting constitutive NF-kappaB activation in human PCA cells, which would help in overcoming TNFalpha-insensitivity. Our studies reveal that silibinin effectively inhibits constitutive activation of NF-kappaB in advanced human prostate carcinoma DU145 cells. Consistent with this, nuclear levels of p65 and p50 sub-units of NF-kappaB were also reduced. In the studies assessing molecular mechanism of this effect, silibinin treatment resulted in a significant increase in the level of IkappaBalpha with a concomitant decrease in phospho-IkappaBalpha. Kinase assays revealed that silibinin dose-dependently decreases IKKalpha kinase activity. The effect of silibinin on IKKalpha seemed to be direct as evidenced by the in vitro kinase assay, where immunoprecipitated IKKalpha was incubated with silibinin. This shows that silibinin does not necessarily need an upstream event to bring about its inhibitory effect on IKKalpha and downstream effectors. Additional studies showed that silibinin also inhibits TNFalpha-induced activation of NF-kappaB via IkappaBalpha pathway and subsequently sensitizes DU145 cells to TNFalpha-induced apoptosis. These results indicate that silibinin could be used to enhance the effectiveness of TNFalpha-based chemotherapy in advanced PCA.", "pmid": 11896607, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9994773, "FORESTS_PROB": 0.89, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999994, "med": 0.9723693 }, "rule": [{ "id": 247342, "sentence_id": "118966071", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "160", "sentence": "CH& inhibits constitutive and G&N a-induced activation of NF-kappaB and sensitizes human D&S a DU145 cells to G&N a-induced apoptosis.", "original_sentence": "Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1540145, "V1": 12268, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540147, "V1": 12270, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 98, "end_pos": 116, "entity_type": "cancer_type_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247343, "sentence_id": "11896607640", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "640", "end_pos": "846", "sentence": "In several recent studies, we have demonstrated both D&S preventive and anti- D&S efficacy of silymarin and its constituent CH& in a variety of experimental D&S models and cell culture systems.", "original_sentence": "In several recent studies, we have demonstrated both cancer preventive and anti-cancer efficacy of silymarin and its constituent silibinin in a variety of experimental tumor models and cell culture systems.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1540155, "V1": 12278, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 769, "end_pos": 778, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540153, "V1": 12276, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 693, "end_pos": 699, "entity_type": "cancer_type_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540154, "V1": 12277, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 720, "end_pos": 726, "entity_type": "cancer_type_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540156, "V1": 12279, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 808, "end_pos": 813, "entity_type": "cancer_type_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247344, "sentence_id": "11896607847", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "847", "end_pos": "1017", "sentence": "Here we examined whether CH& is effective in inhibiting constitutive NF-kappaB activation in human PCA cells, which would help in overcoming G&N -insensitivity.", "original_sentence": "Here we examined whether silibinin is effective in inhibiting constitutive NF-kappaB activation in human PCA cells, which would help in overcoming TNFalpha-insensitivity.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1540157, "V1": 12280, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 872, "end_pos": 881, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247345, "sentence_id": "118966071018", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1018", "end_pos": "1159", "sentence": "Our studies reveal that CH& effectively inhibits constitutive activation of NF-kappaB in advanced human D&S DU145 cells.", "original_sentence": "Our studies reveal that silibinin effectively inhibits constitutive activation of NF-kappaB in advanced human prostate carcinoma DU145 cells.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1540159, "V1": 12282, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1042, "end_pos": 1051, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540160, "V1": 12283, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1128, "end_pos": 1146, "entity_type": "cancer_type_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247346, "sentence_id": "118966071254", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1254", "end_pos": "1451", "sentence": "In the studies assessing molecular mechanism of this effect, CH& treatment resulted in a significant increase in the level of G&N with a concomitant decrease in phospho- G&N .", "original_sentence": "In the studies assessing molecular mechanism of this effect, silibinin treatment resulted in a significant increase in the level of IkappaBalpha with a concomitant decrease in phospho-IkappaBalpha.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1540163, "V1": 12286, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1315, "end_pos": 1324, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247347, "sentence_id": "118966071452", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1452", "end_pos": "1542", "sentence": "Kinase assays revealed that CH& dose-dependently decreases G&N kinase activity.", "original_sentence": "Kinase assays revealed that silibinin dose-dependently decreases IKKalpha kinase activity.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1540166, "V1": 12289, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1480, "end_pos": 1489, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247348, "sentence_id": "118966071543", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1543", "end_pos": "1705", "sentence": "The effect of CH& on G&N seemed to be direct as evidenced by the in vitro kinase assay, where immunoprecipitated G&N was incubated with CH& .", "original_sentence": "The effect of silibinin on IKKalpha seemed to be direct as evidenced by the in vitro kinase assay, where immunoprecipitated IKKalpha was incubated with silibinin.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1540168, "V1": 12291, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1557, "end_pos": 1566, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }, { "id": 1540171, "V1": 12294, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1695, "end_pos": 1704, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247349, "sentence_id": "118966071706", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1706", "end_pos": "1850", "sentence": "This shows that CH& does not necessarily need an upstream event to bring about its inhibitory effect on G&N and downstream effectors.", "original_sentence": "This shows that silibinin does not necessarily need an upstream event to bring about its inhibitory effect on IKKalpha and downstream effectors.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1540172, "V1": 12295, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1722, "end_pos": 1731, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247350, "sentence_id": "118966071851", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1851", "end_pos": "2042", "sentence": "Additional studies showed that CH& also inhibits G&N -induced activation of NF-kappaB via G&N pathway and subsequently sensitizes DU145 cells to G&N -induced apoptosis.", "original_sentence": "Additional studies showed that silibinin also inhibits TNFalpha-induced activation of NF-kappaB via IkappaBalpha pathway and subsequently sensitizes DU145 cells to TNFalpha-induced apoptosis.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 4, "peso_genes": 3, "entitiesRules": [{ "id": 1540174, "V1": 12297, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1882, "end_pos": 1891, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }, { "id": 247351, "sentence_id": "118966072043", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2043", "end_pos": "2171", "sentence": "These results indicate that CH& could be used to enhance the effectiveness of G&N -based chemotherapy in advanced PCA.", "original_sentence": "These results indicate that silibinin could be used to enhance the effectiveness of TNFalpha-based chemotherapy in advanced PCA.", "pmid_article": 11896607, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1540178, "V1": 12301, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2071, "end_pos": 2080, "entity_type": "chemical_entity_p", "entity_pmid": 11896607, "created_at": "2020-10-31T15:00:35.215Z", "updated_at": "2020-10-31T15:00:35.215Z" }] }] }, { "pmid": "21546539", "peso_rules": "1.0", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 25.3, "article": { "id": 76589, "title_article": "Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.", "abstract_article": "The epithelial-to-mesenchymal transition (EMT) in prostate cancer (PCA) cells is considered prerequisite for acquiring migratory/invasive phenotype, and subsequent metastasis. We hypothesized that promoting the E-cadherin expression in PCA cells by using nontoxic phytochemicals, like silibinin, would prevent EMT and consequently invasiveness. Our results showed that silibinin treatment (5-90 μmol/L) significantly inhibits migratory and invasive potential of advance human PCA PC3, PC3MM2, and C4-2B cells in in vitro assays. Importantly, the antimigratory/antiinvasive efficacy of silibinin was not due to its cytotoxicity toward PCA cells. Molecular analyses showed that silibinin increases E-cadherin level that was localized mainly at cellular membrane as evidenced by subcellular fractional and confocal analyses in PC3 cells, which might be responsible for morphologically observed shift toward epithelial character. Silibinin also decreased the levels of Slug, Snail, phospho-Akt(ser(473)), nuclear β-catenin, phospho-Src(tyr(419)) and Hakai; together they play an important role in regulating E-cadherin expression/function and EMT. Similar silibinin effects on E-cadherin, β-catenin, phospho-Src(tyr(419)), and Hakai levels were also observed in PC3MM2 and C4-2B PCA cells. Selective Src inhibition by dasatinib also showed increased E-cadherin expression in PC3 cells suggesting a possible involvement of Src inhibition in silibinin-caused increase in E-cadherin level. Additional studies in PC3 cells with stable knock-down of E-cadherin expression revealed that antimigratory/antiinvasive efficacy of silibinin is in-part dependent on E-cadherin expression. Together, our results showing antimigratory/antiinvasive effects of silibinin and associated mechanisms suggest that silibinin should be tested further in clinically relevant animal models toward exploiting its potential benefits against metastatic PCA.", "pmid": 21546539, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99788207, "FORESTS_PROB": 0.8433333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999996, "med": 0.9603037 }, "rule": [{ "id": 262321, "sentence_id": "215465391", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "101", "sentence": "Role of G&N n in antimigratory and antiinvasive efficacy of CH& n in D&S r cells.", "original_sentence": "Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1617444, "V1": 12573, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 65, "end_pos": 74, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617445, "V1": 12574, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 78, "end_pos": 93, "entity_type": "cancer_type_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262322, "sentence_id": "21546539277", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "277", "end_pos": "445", "sentence": "We hypothesized that promoting the G&N expression in PCA cells by using nontoxic phytochemicals, like CH&, would prevent EMT and consequently invasiveness.", "original_sentence": "We hypothesized that promoting the E-cadherin expression in PCA cells by using nontoxic phytochemicals, like silibinin, would prevent EMT and consequently invasiveness.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1617448, "V1": 12577, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 386, "end_pos": 395, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262323, "sentence_id": "21546539446", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "446", "end_pos": "630", "sentence": "Our results showed that CH& treatment (5-90 μmol/L) significantly inhibits migratory and invasive potential of advance human PCAD&S3, PC3MM2, and C4-2B cells in in vitro assays.", "original_sentence": "Our results showed that silibinin treatment (5-90 μmol/L) significantly inhibits migratory and invasive potential of advance human PCA PC3, PC3MM2, and C4-2B cells in in vitro assays.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1617449, "V1": 12578, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 470, "end_pos": 479, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617450, "V1": 12579, "pubtatot_term": "PC3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 581, "end_pos": 584, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262324, "sentence_id": "21546539631", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "631", "end_pos": "746", "sentence": "Importantly, the antimigratory/antiinvasive efficacy of CH& n was not due to its cytotoxicity toward PCA cells.", "original_sentence": "Importantly, the antimigratory/antiinvasive efficacy of silibinin was not due to its cytotoxicity toward PCA cells.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1617451, "V1": 12580, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 686, "end_pos": 695, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262325, "sentence_id": "21546539747", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "747", "end_pos": "1027", "sentence": "Molecular analyses showed that CH& n increases G&N n level that was localized mainly at cellular membrane as evidenced by subcellular fractional and confocal analyses inD&S3 cells, which might be responsible for morphologically observed shift toward epithelial character.", "original_sentence": "Molecular analyses showed that silibinin increases E-cadherin level that was localized mainly at cellular membrane as evidenced by subcellular fractional and confocal analyses in PC3 cells, which might be responsible for morphologically observed shift toward epithelial character.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1617452, "V1": 12581, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 777, "end_pos": 786, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617454, "V1": 12583, "pubtatot_term": "PC3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 925, "end_pos": 928, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262326, "sentence_id": "215465391247", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1247", "end_pos": "1389", "sentence": "Simila CH& in effects o G&N in G&N nin, phospG&NSrc(tyr(419)), and Hakai levels were also observed in PC3MM2 and C4-2B PCA cells.", "original_sentence": "Similar silibinin effects on E-cadherin, β-catenin, phospho-Src(tyr(419)), and Hakai levels were also observed in PC3MM2 and C4-2B PCA cells.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1617461, "V1": 12590, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1253, "end_pos": 1262, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262327, "sentence_id": "215465391390", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1390", "end_pos": "1586", "sentence": "SelectiG&NSrc inhibition by dasatinib also showed increas G&N rin expression D&SPC3 cells suggesting a possible involvement G&NSrc inhibition CH& nin-caused increase G&N rin level.", "original_sentence": "Selective Src inhibition by dasatinib also showed increased E-cadherin expression in PC3 cells suggesting a possible involvement of Src inhibition in silibinin-caused increase in E-cadherin level.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1617469, "V1": 12598, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1537, "end_pos": 1546, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617467, "V1": 12596, "pubtatot_term": "PC3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1472, "end_pos": 1475, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262328, "sentence_id": "215465391587", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1587", "end_pos": "1776", "sentence": "Additional studies D&SPC3 cells with stable knock-down G&N rin expression revealed that antimigratory/antiinvasive efficacy CH& nin is in-part dependent G&N rin expression.", "original_sentence": "Additional studies in PC3 cells with stable knock-down of E-cadherin expression revealed that antimigratory/antiinvasive efficacy of silibinin is in-part dependent on E-cadherin expression.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1617473, "V1": 12602, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1717, "end_pos": 1726, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617471, "V1": 12600, "pubtatot_term": "PC3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1606, "end_pos": 1609, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 262329, "sentence_id": "215465391777", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1777", "end_pos": "2030", "sentence": "Together, our results showing antimigratory/antiinvasive effects CH& nin and associated mechanisms suggest th CH& nin should be tested further in clinically relevant animal models toward exploiting its potential benefits against metastatic PCA.", "original_sentence": "Together, our results showing antimigratory/antiinvasive effects of silibinin and associated mechanisms suggest that silibinin should be tested further in clinically relevant animal models toward exploiting its potential benefits against metastatic PCA.", "pmid_article": 21546539, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1617475, "V1": 12604, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1842, "end_pos": 1851, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1617476, "V1": 12605, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1891, "end_pos": 1900, "entity_type": "chemical_entity_p", "entity_pmid": 21546539, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }] }, { "pmid": "19047104", "peso_rules": "1.0", "peso_entities": "0.74", "peso_genes": "0.0", "peso_final": 25.3, "article": { "id": 76617, "title_article": "Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.", "abstract_article": "The chronic nature of prostate cancer growth and progression leading to metastasis provides a large window for intervention. Herein, for the first time, we investigated the effect and associated mechanisms of silibinin phosphatidylcholine (silybin-phytosome) on established prostate tumors in transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Twenty-week-old TRAMP male mice having palpable prostate tumor were fed with control or 0.5% and 1%, w/w, silybin-phytosome diets for 11 weeks and then sacrificed. Dietary silibinin inhibited the growth of prostate tumors (up to 60%, P < 0.001) and suppressed tumor progression from prostatic intraepithelial neoplasia to differentiated adenocarcinoma and poorly differentiated adenocarcinoma, with a complete absence of poorly differentiated adenocarcinoma at higher doses. It also inhibited the incidence of tumor invasion of seminal vesicle (up to 81%, P < 0.001) with complete absence of distant metastasis. Silibinin moderately inhibited tumor cell proliferation and induced apoptosis, but strongly suppressed tumor microvessel density (up to 60%, P < 0.001), vascular endothelial growth factor, and vascular endothelial growth factor receptor-2 expression. Antibody array analysis of plasma showed a decrease in the circulatory levels of vascular endothelial growth factor and basic fibroblast growth factor. Decreased levels of matrix metalloproteinases (MMP), snail-1, and vimentin, and an increased level of E-cadherin were also observed, indicating the anti-epithelial-mesenchymal transition effect of silibinin in tumors. Overall, silibinin treatment of TRAMP mice bearing prostate tumor inhibited tumor growth, progression, local invasion, and distant metastasis involving suppression of tumor angiogenesis and epithelial-mesenchymal transition. These findings would have greater relevance for the ongoing phase II clinical trial with silibinin-phytosome in prostate cancer patients.", "pmid": 19047104, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.96817654, "FORESTS_PROB": 0.78333336, "LOGITBOOST_PROB": 0.9999546, "MAXENTROPY_PROB": 1, "med": 0.9378661 }, "rule": [{ "id": 277060, "sentence_id": "190471041", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "227", "sentence": "CH& inhibits established D&S r growth, progression, invasion, and D&S s and suppresses D&S r angiogenesis and epithelial-mesenchymal transition in transgenic D&S a of the mouse prostate model mice.", "original_sentence": "Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1691166, "V1": 17843, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691167, "V1": 17844, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 31, "end_pos": 45, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691168, "V1": 17845, "pubtatot_term": "metastasis", "db_term": "Neoplasm Metastasis", "db_equivalence": "Neoplasm Metastasis", "mesh_id": "D009362", "term_id": "10000", "start_pos": 81, "end_pos": 91, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691169, "V1": 17846, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 107, "end_pos": 112, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691170, "V1": 17847, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 178, "end_pos": 192, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277061, "sentence_id": "19047104361", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "361", "end_pos": "591", "sentence": "Herein, for the first time, we investigated the effect and associated mechanisms of CH& ( CH& -phytosome) on established D&S in transgenic D&S of the mouse prostate (TRAMP) model.", "original_sentence": "Herein, for the first time, we investigated the effect and associated mechanisms of silibinin phosphatidylcholine (silybin-phytosome) on established prostate tumors in transgenic adenocarcinoma of the mouse prostate (TRAMP) model.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1691172, "V1": 17849, "pubtatot_term": "silibinin phosphatidylcholine", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 445, "end_pos": 474, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691173, "V1": 17850, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 476, "end_pos": 483, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691174, "V1": 17851, "pubtatot_term": "prostate tumors", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 510, "end_pos": 525, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691175, "V1": 17852, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 540, "end_pos": 554, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277062, "sentence_id": "19047104703", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "703", "end_pos": "776", "sentence": "5% and 1%, w/w, CH& -phytosome diets for 11 weeks and then sacrificed.", "original_sentence": "5% and 1%, w/w, silybin-phytosome diets for 11 weeks and then sacrificed.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1691178, "V1": 17855, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 719, "end_pos": 726, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277063, "sentence_id": "19047104777", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "777", "end_pos": "1096", "sentence": "RESULTS: Dietary CH& inhibited the growth of D&S (up to 60%, P < 0_001) and suppressed D&S progression from prostatic intraepithelial neoplasia to differentiated D&S and poorly differentiated D&S, with a complete absence of poorly differentiated D&S at higher doses.", "original_sentence": "RESULTS: Dietary silibinin inhibited the growth of prostate tumors (up to 60%, P < 0_001) and suppressed tumor progression from prostatic intraepithelial neoplasia to differentiated adenocarcinoma and poorly differentiated adenocarcinoma, with a complete absence of poorly differentiated adenocarcinoma at higher doses.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1691179, "V1": 17856, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 794, "end_pos": 803, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691180, "V1": 17857, "pubtatot_term": "prostate tumors", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 828, "end_pos": 843, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691181, "V1": 17858, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 882, "end_pos": 887, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691182, "V1": 17859, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 959, "end_pos": 973, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691183, "V1": 17860, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 1000, "end_pos": 1014, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691184, "V1": 17861, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 1065, "end_pos": 1079, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277064, "sentence_id": "190471041234", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1234", "end_pos": "1484", "sentence": "CH& moderately inhibited D&S cell proliferation and induced apoptosis, but strongly suppressed D&S microvessel density (up to 60%, P < 0_001), vascular endothelial growth factor, and vascular endothelial growth factor receptor-2 expression.", "original_sentence": "Silibinin moderately inhibited tumor cell proliferation and induced apoptosis, but strongly suppressed tumor microvessel density (up to 60%, P < 0_001), vascular endothelial growth factor, and vascular endothelial growth factor receptor-2 expression.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 7, "peso_genes": 3, "entitiesRules": [{ "id": 1691186, "V1": 17863, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1234, "end_pos": 1243, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691187, "V1": 17864, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1265, "end_pos": 1270, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691188, "V1": 17865, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1337, "end_pos": 1342, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277065, "sentence_id": "190471041637", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1637", "end_pos": "1854", "sentence": "Decreased levels of matrix metalloproteinases (MMP), snail-1, and G&N, and an increased level of G&N were also observed, indicating the anti-epithelial-mesenchymal transition effect of CH& in D&S .", "original_sentence": "Decreased levels of matrix metalloproteinases (MMP), snail-1, and vimentin, and an increased level of E-cadherin were also observed, indicating the anti-epithelial-mesenchymal transition effect of silibinin in tumors.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1691191, "V1": 17868, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1834, "end_pos": 1843, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691192, "V1": 17869, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1847, "end_pos": 1853, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277066, "sentence_id": "190471041855", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1855", "end_pos": "2092", "sentence": "CONCLUSIONS: Overall, CH& treatment of TRAMP mice bearing D&S inhibited D&S growth, progression, local invasion, and distant metastasis involving suppression of D&S angiogenesis and epithelial-mesenchymal transition.", "original_sentence": "CONCLUSIONS: Overall, silibinin treatment of TRAMP mice bearing prostate tumor inhibited tumor growth, progression, local invasion, and distant metastasis involving suppression of tumor angiogenesis and epithelial-mesenchymal transition.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 7, "peso_genes": 3, "entitiesRules": [{ "id": 1691193, "V1": 17870, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1877, "end_pos": 1886, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691194, "V1": 17871, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1919, "end_pos": 1933, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691195, "V1": 17872, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1944, "end_pos": 1949, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691196, "V1": 17873, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 2035, "end_pos": 2040, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277067, "sentence_id": "190471042093", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2093", "end_pos": "2230", "sentence": "These findings would have greater relevance for the ongoing phase II clinical trial with CH& -phytosome in D&S patients.", "original_sentence": "These findings would have greater relevance for the ongoing phase II clinical trial with silibinin-phytosome in prostate cancer patients.", "pmid_article": 19047104, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1691197, "V1": 17874, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2182, "end_pos": 2191, "entity_type": "chemical_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1691198, "V1": 17875, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2205, "end_pos": 2220, "entity_type": "cancer_type_entity_p", "entity_pmid": 19047104, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }] }, { "pmid": "25285031", "peso_rules": "0.10", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 24.6, "article": { "id": 57235, "title_article": "Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.", "abstract_article": "Prostate cancer (PCA) is the 2nd leading cause of cancer-related deaths among men in the United States. Preventing or inhibiting metastasis-related events through non-toxic agents could be a useful approach for lowering high mortality among PCA patients. We have earlier reported that natural flavonoid silibinin possesses strong anti-metastatic efficacy against PCA however, mechanism/s of its action still remains largely unknown. One of the major events during metastasis is the replacement of cell-cell interaction with integrins-based cell-matrix interaction that controls motility, invasiveness and survival of cancer cells. Accordingly, here we examined silibinin effect on advanced human PCA PC3 cells' interaction with extracellular matrix component fibronectin. Silibinin (50-200 μM) treatment significantly decreased the fibronectin (5 μg/ml)-induced motile morphology via targeting actin cytoskeleton organization in PC3 cells. Silibinin also decreased the fibronectin-induced cell proliferation and motility but significantly increased cell death in PC3 cells. Silibinin also inhibited the PC3 cells invasiveness in Transwell invasion assays with fibronectin or cancer associated fibroblasts (CAFs) serving as chemoattractant. Importantly, PC3-luc cells cultured on fibronectin showed rapid dissemination and localized in lungs following tail vein injection in athymic male nude mice; however, in silibinin-treated PC3-luc cells, dissemination and lung localization was largely compromised. Molecular analyses revealed that silibinin treatment modulated the fibronectin-induced expression of integrins (α5, αV, β1 and β3), actin-remodeling (FAK, Src, GTPases, ARP2 and cortactin), apoptosis (cPARP and cleaved caspase 3), EMT (E-cadherin and β-catenin), and cell survival (survivin and Akt) related signaling molecules in PC3 cells. Furthermore, PC3-xenograft tissue analyses confirmed the inhibitory effect of silibinin on fibronectin and integrins expression. Together, these results showed that silibinin targets PCA cells' interaction with fibronectin and inhibits their motility, invasiveness and survival; thus further supporting silibinin use in PCA intervention including its metastatic progression.", "pmid": 25285031, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9998051, "FORESTS_PROB": 0.8666667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.96661794 }, "rule": [{ "id": 304219, "sentence_id": "252850311", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "113", "sentence": "CH& inhibits G&N n induced motility, D&S s and survival in human D&S aG&N3 cells via targeting integrin signaling.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1581880, "V1": 33863, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815650, "V1": 33463, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581882, "V1": 33865, "pubtatot_term": "invasiveness", "db_term": "Neoplasm Invasiveness", "db_equivalence": "Neoplasm Invasiveness", "mesh_id": "D009361", "term_id": "9999", "start_pos": 49, "end_pos": 61, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581883, "V1": 33866, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 84, "end_pos": 102, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815652, "V1": 33465, "pubtatot_term": "invasiveness", "db_term": "Neoplasm Invasiveness", "db_equivalence": "Neoplasm Invasiveness", "mesh_id": "D009361", "term_id": "9999", "start_pos": 49, "end_pos": 61, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815653, "V1": 33466, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 84, "end_pos": 102, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304220, "sentence_id": "25285031402", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "402", "end_pos": "566", "sentence": "We have earlier reported that natural CH& CH& possesses strong anti-metastatic efficacy against D&S however, mechanism/s of its action still remains largely unknown.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581890, "V1": 33873, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 450, "end_pos": 459, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815660, "V1": 33473, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 450, "end_pos": 459, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581891, "V1": 33874, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 510, "end_pos": 513, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815661, "V1": 33474, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 510, "end_pos": 513, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304221, "sentence_id": "25285031775", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "775", "end_pos": "901", "sentence": "Accordingly, here we examined CH& effect on advanced human D&S G&N cells' interaction with extracellular matrix component G&N .", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581893, "V1": 33876, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 808, "end_pos": 817, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815663, "V1": 33476, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 808, "end_pos": 817, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581894, "V1": 33877, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 843, "end_pos": 846, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815664, "V1": 33477, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 843, "end_pos": 846, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304222, "sentence_id": "25285031902", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "902", "end_pos": "1337", "sentence": "CH& (50-200 μM) treatment significantly decreased the G&N n (5 μg/ml)-induced motile morphology via targeting actin cytoskeleton organization iG&NC3 cells CH& in also decreased th G&N in-induced cell proliferation and motility but significantly increased cell death iG&NC3 cells CH& in also inhibited thG&NC3 cells invasiveness in Transwell invasion assays wit G&N in o D&S er associated fibroblastsD&S Fs) serving as chemoattractant.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581897, "V1": 33880, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 919, "end_pos": 928, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581900, "V1": 33883, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1087, "end_pos": 1096, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581903, "V1": 33886, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1221, "end_pos": 1230, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815667, "V1": 33480, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 919, "end_pos": 928, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815670, "V1": 33483, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1087, "end_pos": 1096, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815673, "V1": 33486, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1221, "end_pos": 1230, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581906, "V1": 33889, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1322, "end_pos": 1328, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815676, "V1": 33489, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1322, "end_pos": 1328, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304223, "sentence_id": "252850311338", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1338", "end_pos": "1590", "sentence": "ImportantlyG&NC3-luc cells cultured o G&N in showed rapid dissemination and localized in lungs following tail vein injection in athymic male nude mice; however, i CH& in-treateG&NC3-luc cells, dissemination and lung localization was largely compromised.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581910, "V1": 33893, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1557, "end_pos": 1566, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815680, "V1": 33493, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1557, "end_pos": 1566, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581907, "V1": 33890, "pubtatot_term": "CAFs", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1353, "end_pos": 1357, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815677, "V1": 33490, "pubtatot_term": "CAFs", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1353, "end_pos": 1357, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304224, "sentence_id": "252850311591", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1591", "end_pos": "1912", "sentence": "Molecular analyses revealed tha CH& in treatment modulated th G&N in-induced expression of integrins (α5, αV, β1 and β3), actin-remodeG&Ng G&NK, Src, GTPG&N, ARP G&N tactin), apoptosis (cPARP and cleaved caspasG&N), G&N dheri G&N catenin), and cell survival (survivG&Nand Akt) related signaling molecuG&N in PC3 cells.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581912, "V1": 33895, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1684, "end_pos": 1693, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815682, "V1": 33495, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1684, "end_pos": 1693, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304225, "sentence_id": "252850312000", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2000", "end_pos": "2118", "sentence": "FurtheG&Nre, PC3-xenograft tissue analyses confirmed the inhibitory eff CH& libi G&N onectin and integrins expression.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581924, "V1": 33907, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2071, "end_pos": 2080, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815694, "V1": 33507, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2071, "end_pos": 2080, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }, { "id": 304226, "sentence_id": "252850312119", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "2119", "end_pos": "2342", "sentence": "Together, these results showe CH& libinin tD&Sets PCA cells' interactio G&N onectin and inhibits their mot D&S iveness and survival; thus further supp CH& libinin D&S in PCA intervention including its metastatic progression.", "original_sentence": "NA", "pmid_article": 25285031, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581930, "V1": 33913, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2296, "end_pos": 2305, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581926, "V1": 33909, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2158, "end_pos": 2167, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815696, "V1": 33509, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2158, "end_pos": 2167, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815700, "V1": 33513, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2296, "end_pos": 2305, "entity_type": "chemical_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1581929, "V1": 33912, "pubtatot_term": "invasiveness", "db_term": "Neoplasm Invasiveness", "db_equivalence": "Neoplasm Invasiveness", "mesh_id": "D009361", "term_id": "9999", "start_pos": 2245, "end_pos": 2257, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581931, "V1": 33914, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2313, "end_pos": 2316, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581927, "V1": 33910, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2176, "end_pos": 2179, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1815697, "V1": 33510, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2176, "end_pos": 2179, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815699, "V1": 33512, "pubtatot_term": "invasiveness", "db_term": "Neoplasm Invasiveness", "db_equivalence": "Neoplasm Invasiveness", "mesh_id": "D009361", "term_id": "9999", "start_pos": 2245, "end_pos": 2257, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }, { "id": 1815701, "V1": 33514, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2313, "end_pos": 2316, "entity_type": "cancer_type_entity_p", "entity_pmid": 25285031, "created_at": "2020-10-31T15:23:45.430Z", "updated_at": "2020-10-31T15:23:45.430Z" }] }] }, { "pmid": "26522224", "peso_rules": "1.0", "peso_entities": "0.37", "peso_genes": "0.0", "peso_final": 24.5, "article": { "id": 76341, "title_article": "Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.", "abstract_article": "Silibinin is a major bioactive component of silymarin and has anticancer effects on cancer cell line and has been used as a supportive therapy for chronic inflammatory liver condition. These anticancer effects of silibinin have been demonstrated both in vitro and in vivo cancer models. Although various evidences showed apoptosis signaling pathways by silibinin, there is no report to address the clearly mechanism of silibinin-induced autophagy in prostate cancer PC-3 cells. Our study showed that silibinin triggered autophagy through up-regulation of microtubule-associated protein 1 light chain 3 (LC3)-II, formation of acidic vesicular organelles (AVO) and punctuate of GFP-LC3, which was inhibited by 3-methyladenine (3-MA), an inhibitor of specific autophagy. In addition, silibinin induced autophagy through production of reactive oxygen species (ROS). Inhibition of ROS with diphenyleneiodonium (DPI), a ROS inhibitor, attenuated silibinin-triggered autophagy. Inhibition of autophagy with 3-MA enhanced the silibinin-induced apoptosis through the regulation of caspase-3 and PARP. These results suggested that silibinin induced autophagy by regulating ROS and its mechanism played a protective role against apoptosis in PC-3 cells.  ", "pmid": 26522224, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99982196, "FORESTS_PROB": 0.9533333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9882888 }, "rule": [{ "id": 218385, "sentence_id": "265222241", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "sim", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "144", "sentence": "Autophagy inhibition enhances CH& n-induced apoptosis by regulating reactive oxygen species production in human D&S rD&S 3 cells.", "original_sentence": "Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 19, "peso_genes": 1, "entitiesRules": [{ "id": 1382535, "V1": 29291, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 30, "end_pos": 39, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382536, "V1": 29292, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 116, "end_pos": 131, "entity_type": "cancer_type_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382537, "V1": 29293, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 132, "end_pos": 136, "entity_type": "cancer_type_entity_cell", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218386, "sentence_id": "26522224144", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "144", "end_pos": "328", "sentence": "CH& is a major bioactive component of silymarin and has anticancer effects on D&S cell line and has been used as a supportive therapy for chronic inflammatory liver condition.", "original_sentence": "Silibinin is a major bioactive component of silymarin and has anticancer effects on cancer cell line and has been used as a supportive therapy for chronic inflammatory liver condition.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1382538, "V1": 29294, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 144, "end_pos": 153, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382539, "V1": 29295, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 228, "end_pos": 234, "entity_type": "cancer_type_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218387, "sentence_id": "26522224329", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "329", "end_pos": "432", "sentence": "These anticancer effects of CH& have been demonstrated both in� vitro and in� viv D&S er models.", "original_sentence": "These anticancer effects of silibinin have been demonstrated both in� vitro and in� vivo cancer models.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1382540, "V1": 29296, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 357, "end_pos": 366, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382541, "V1": 29297, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 416, "end_pos": 422, "entity_type": "cancer_type_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218388, "sentence_id": "26522224433", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "433", "end_pos": "623", "sentence": "Although various evidences showed apoptosis signaling pathways b CH& in, there is no report to address the clearly mechanism o CH& in-induced autophagy i D&S eD&S -3 cells.", "original_sentence": "Although various evidences showed apoptosis signaling pathways by silibinin, there is no report to address the clearly mechanism of silibinin-induced autophagy in prostate cancer PC-3 cells.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1382542, "V1": 29298, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 497, "end_pos": 506, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382543, "V1": 29299, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 563, "end_pos": 572, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382544, "V1": 29300, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 594, "end_pos": 609, "entity_type": "cancer_type_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382545, "V1": 29301, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 610, "end_pos": 614, "entity_type": "cancer_type_entity_cell", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218389, "sentence_id": "26522224624", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "624", "end_pos": "913", "sentence": "Our study showed tha CH& in triggered autophagy through up-regulation of microtubule-associated protein 1 light chain 3 (LC3)-II, formation of acidic vesicular organelles (AVO) and punctuate of GFP-LC3, which was inhibited by 3-methyladenine (3-MA), an inhibitor of specific autophagy.", "original_sentence": "Our study showed that silibinin triggered autophagy through up-regulation of microtubule-associated protein 1 light chain 3 (LC3)-II, formation of acidic vesicular organelles (AVO) and punctuate of GFP-LC3, which was inhibited by 3-methyladenine (3-MA), an inhibitor of specific autophagy.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 3, "peso_genes": 2, "entitiesRules": [{ "id": 1382546, "V1": 29302, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 644, "end_pos": 653, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218390, "sentence_id": "26522224914", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "914", "end_pos": "1007", "sentence": "In addition CH& in induced autophagy through production of reactive oxygen species (ROS).", "original_sentence": "In addition, silibinin induced autophagy through production of reactive oxygen species (ROS).", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1382547, "V1": 29303, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 925, "end_pos": 934, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218391, "sentence_id": "265222241008", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1008", "end_pos": "1116", "sentence": "Inhibition of ROS with diphenyleneiodonium (DPI), a ROS inhibitor, attenuate CH& in-triggered autophagy.", "original_sentence": "Inhibition of ROS with diphenyleneiodonium (DPI), a ROS inhibitor, attenuated silibinin-triggered autophagy.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1382548, "V1": 29304, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1084, "end_pos": 1093, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218392, "sentence_id": "265222241117", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1117", "end_pos": "1237", "sentence": "Inhibition of autophagy with 3-MA enhanced th CH& in-induced apoptosis through the regulation o G&N -3 anG&N RP.", "original_sentence": "Inhibition of autophagy with 3-MA enhanced the silibinin-induced apoptosis through the regulation of caspase-3 and PARP.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1382549, "V1": 29305, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1162, "end_pos": 1171, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }, { "id": 218393, "sentence_id": "265222241238", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1238", "end_pos": "1388", "sentence": "These results suggested tha CH& in induced autophagy by regulating ROS and its mechanism played a protective role against apoptosis iD&S -3 cells.", "original_sentence": "These results suggested that silibinin induced autophagy by regulating ROS and its mechanism played a protective role against apoptosis in PC-3 cells.", "pmid_article": 26522224, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1382552, "V1": 29308, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1265, "end_pos": 1274, "entity_type": "chemical_entity_p", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }, { "id": 1382553, "V1": 29309, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1375, "end_pos": 1379, "entity_type": "cancer_type_entity_cell", "entity_pmid": 26522224, "created_at": "2020-10-31T14:45:52.585Z", "updated_at": "2020-10-31T14:45:52.585Z" }] }] }, { "pmid": "17916909", "peso_rules": "0.56", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 24.4, "article": { "id": 76631, "title_article": "Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.", "abstract_article": "Chemoprevention is an upcoming approach to control cancer including prostate cancer (PCa). Here, we studied the efficacy and associated mechanisms of a chemopreventive agent silibinin against ectopically growing and established advanced human prostate carcinoma PC-3 tumor xenografts in athymic nude mice. Dietary silibinin (0.5%, w/w) did not show any adverse health effect in mice. In first protocol, silibinin started 1 week prior to xenograft implantation and continued for 60 additional days, whereas in the second protocol, silibinin treatment was started after 25 days of established tumors for 4, 8 and 16 days. Silibinin inhibited tumor growth rate in both protocols showing up to 35% (P = 0.010) and 18-56% (P = 0.002 to <0.001) decrease in tumor volume per mouse and 27% (P < 0.01) and 44% (P = 0.014) decrease in tumor weight per mouse, respectively. In first protocol, silibinin decreased (P < 0.001) tumor cell proliferation and microvessel density but increased (P < 0.001) apoptosis. An increase in insulin-like growth factor-binding protein-3 (IGFBP-3) expression with a concomitant decrease in vascular endothelial growth factor (VEGF) expression was noted. Silibinin strongly increased phospho-extracellular signal-regulated kinase 1/2 (ERK1/2), Cip1/p21 and Kip1/p27 (cyclin-dependent kinase inhibitors) levels but moderately decreased Bcl-2 and survivin levels. In established tumors, similar biomarkers and molecular changes were observed due to silibinin corresponding to its antitumor efficacy. These findings identified in vivo antitumor efficacy of silibinin against PC-3 human PCa in both intervention protocols accompanied with its anti-proliferative, pro-apoptotic and anti-angiogenic activities. At molecular level, silibinin increased IGFBP-3, Cip1/p21, Kip1/p27 levels and ERK1/2 activation and decreased Bcl-2, survivin and VEGF levels in tumors.", "pmid": 17916909, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.95960885, "FORESTS_PROB": 0.91, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999994, "med": 0.9674022 }, "rule": [{ "id": 254399, "sentence_id": "179169091", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "86", "sentence": "CH& suppresses in vivo growth of human D&S r xenograft.", "original_sentence": "Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1577281, "V1": 29264, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577282, "V1": 29265, "pubtatot_term": "prostate carcinoma PC-3 tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 45, "end_pos": 74, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254400, "sentence_id": "17916909177", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "177", "end_pos": "391", "sentence": "Here, we studied the efficacy and associated mechanisms of a chemopreventive agent CH& against ectopically growing and established advanced human D&S xenografts in athymic nude mice.", "original_sentence": "Here, we studied the efficacy and associated mechanisms of a chemopreventive agent silibinin against ectopically growing and established advanced human prostate carcinoma PC-3 tumor xenografts in athymic nude mice.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 6, "peso_genes": 0, "entitiesRules": [{ "id": 1577285, "V1": 29268, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 260, "end_pos": 269, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577286, "V1": 29269, "pubtatot_term": "prostate carcinoma PC-3 tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 329, "end_pos": 358, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254401, "sentence_id": "17916909470", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "470", "end_pos": "705", "sentence": "In first protocol, CH& started 1 week prior to xenograft implantation and continued for 60 additional days, whereas in the second protocol, CH& treatment was started after 25 days of established D&S for 4, 8 and 16 days.", "original_sentence": "In first protocol, silibinin started 1 week prior to xenograft implantation and continued for 60 additional days, whereas in the second protocol, silibinin treatment was started after 25 days of established tumors for 4, 8 and 16 days.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1577288, "V1": 29271, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 489, "end_pos": 498, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577289, "V1": 29272, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 616, "end_pos": 625, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577290, "V1": 29273, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 677, "end_pos": 683, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254402, "sentence_id": "17916909706", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "706", "end_pos": "810", "sentence": "CH& inhibited D&S growth rate in both protocols showing up to 35% (P = 0_010) and 18-56% (P = 0.", "original_sentence": "Silibinin inhibited tumor growth rate in both protocols showing up to 35% (P = 0_010) and 18-56% (P = 0.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1577291, "V1": 29274, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 706, "end_pos": 715, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577292, "V1": 29275, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 726, "end_pos": 731, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254403, "sentence_id": "17916909949", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "949", "end_pos": "1085", "sentence": "In first protocol, CH& decreased (P < 0_001) D&S cell proliferation and microvessel density but increased (P < 0_001) apoptosis.", "original_sentence": "In first protocol, silibinin decreased (P < 0_001) tumor cell proliferation and microvessel density but increased (P < 0_001) apoptosis.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1577295, "V1": 29278, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 968, "end_pos": 977, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577296, "V1": 29279, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1000, "end_pos": 1005, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254404, "sentence_id": "179169091262", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1262", "end_pos": "1468", "sentence": "CH& strongly increased phospho-extracellular signal-regulated kinase 1/2 ( G&N ), G&N /G&N and G&N /G&N (cyclin-dependent kinase inhibitors) levels but moderately decreased G&N and survivin levels.", "original_sentence": "Silibinin strongly increased phospho-extracellular signal-regulated kinase 1/2 (ERK1/2), Cip1/p21 and Kip1/p27 (cyclin-dependent kinase inhibitors) levels but moderately decreased Bcl-2 and survivin levels.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1577301, "V1": 29284, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1262, "end_pos": 1271, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254405, "sentence_id": "179169091469", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1469", "end_pos": "1604", "sentence": "In established D&S, similar biomarkers and molecular changes were observed due to CH& corresponding to its antitumor efficacy.", "original_sentence": "In established tumors, similar biomarkers and molecular changes were observed due to silibinin corresponding to its antitumor efficacy.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1577309, "V1": 29292, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1554, "end_pos": 1563, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577308, "V1": 29291, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1484, "end_pos": 1490, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254406, "sentence_id": "179169091605", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1605", "end_pos": "1811", "sentence": "These findings identified in vivo antitumor efficacy of CH& against D&S human PCa in both intervention protocols accompanied with its anti-proliferative, pro-apoptotic and anti-angiogenic activities.", "original_sentence": "These findings identified in vivo antitumor efficacy of silibinin against PC-3 human PCa in both intervention protocols accompanied with its anti-proliferative, pro-apoptotic and anti-angiogenic activities.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1577310, "V1": 29293, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1661, "end_pos": 1670, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577311, "V1": 29294, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1679, "end_pos": 1683, "entity_type": "cancer_type_entity_cell", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254407, "sentence_id": "179169091812", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1812", "end_pos": "1965", "sentence": "At molecular level, CH& increased G&N, G&N /G&N, G&N /G&N levels and G&N activation and decreased G&N, survivin and G&N levels in D&S.", "original_sentence": "At molecular level, silibinin increased IGFBP-3, Cip1/p21, Kip1/p27 levels and ERK1/2 activation and decreased Bcl-2, survivin and VEGF levels in tumors.", "pmid_article": 17916909, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1577312, "V1": 29295, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1832, "end_pos": 1841, "entity_type": "chemical_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1577321, "V1": 29304, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1958, "end_pos": 1964, "entity_type": "cancer_type_entity_p", "entity_pmid": 17916909, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "15076315", "peso_rules": "1.0", "peso_entities": "0.75", "peso_genes": "0.0", "peso_final": 24.2, "article": { "id": 76650, "title_article": "Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.", "abstract_article": "The androgen sensitive prostate cancer cell line LNCaP is strongly positive for dihydrotestosterone (DHT) dependent telomerase activity, which is an important factor in cellular immortality and carcinogenesis. In this study we determined the potential of silibinin as an anticancer drug that down-regulates telomerase activity and prostate specific antigen (PSA) together with the co-activator of the androgen receptor prostate epithelium specific Ets transcription factor. LNCaP cells were treated with various concentrations of silibinin in the presence or absence of 5alpha-DHT. We used real-time reverse transcriptase-polymerase chain reaction to quantify mRNA expression of PSA, prostate epithelium specific Ets transcription factor and the catalytic subunit of telomerase vs the housekeeping gene porphobilinogen deaminase with gene specific, dual labeled fluorescence probes. PSA secretion from LNCaP cells in conditioned medium was measured with an Elecsys System 2010 (Roche Diagnostics, Mannheim, Germany) and telomerase activity in extracts from LNCaP cells was measured with a TRAP (telomeric repeat amplification protocol) assay. Silibinin down-regulated PSA mRNA expression and PSA secretion in conditioned medium. Simultaneous stimulation with silibinin and 10(-8) M DHT also resulted in PSA down-regulation, whereas DHT alone increased PSA secretion. Telomerase catalytic subunit mRNA decreased significantly after silibinin stimulation. Telomerase activity was down-regulated by silibinin and stimulated by DHT. The 2 agents in combination resulted in telomerase down-regulation. The down-regulation of PSA by silibinin and its counteraction on DHT effects indicate that this compound can interact with the expression of genes that are regulated through the androgen receptor. Silibinin can also inhibit the telomerase activity that mediates cell immortality and carcinogenesis. The 2 effects underline the possible therapeutic use of silibinin as an antiproliferative agent in intervention for prostate cancer.", "pmid": 15076315, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99946374, "FORESTS_PROB": 0.8833333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.97069925 }, "rule": [{ "id": 249796, "sentence_id": "150763151", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "sim", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "116", "sentence": "Inhibition of telomerase activity and secretion of G&N n by CH& n in D&S r cells.", "original_sentence": "Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 19, "peso_genes": 3, "entitiesRules": [{ "id": 1553559, "V1": 5542, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 80, "end_pos": 89, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553560, "V1": 5543, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 93, "end_pos": 108, "entity_type": "cancer_type_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249797, "sentence_id": "15076315335", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "sim", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "335", "end_pos": "598", "sentence": "In this study we determined the potential of CH& as an anticancer drug that down-regulates telomerase activity and G&N (G&N) together with the co-activator of the G&N prostate epithelium specific Ets transcription factor.", "original_sentence": "In this study we determined the potential of silibinin as an anticancer drug that down-regulates telomerase activity and prostate specific antigen (PSA) together with the co-activator of the androgen receptor prostate epithelium specific Ets transcription factor.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1553563, "V1": 5546, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 380, "end_pos": 389, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249798, "sentence_id": "15076315599", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "599", "end_pos": "729", "sentence": "MATERIALS AND METHODS: LNCaP cells were treated with various concentrations of CH& in the presence or absence of 5alpha-DHT.", "original_sentence": "MATERIALS AND METHODS: LNCaP cells were treated with various concentrations of silibinin in the presence or absence of 5alpha-DHT.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1553567, "V1": 5550, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 678, "end_pos": 687, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249799, "sentence_id": "150763151291", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1291", "end_pos": "1385", "sentence": "RESULTS: CH& down-regulated G&N mRNA expression and G&N secretion in conditioned medium.", "original_sentence": "RESULTS: Silibinin down-regulated PSA mRNA expression and PSA secretion in conditioned medium.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1553570, "V1": 5553, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1300, "end_pos": 1309, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249800, "sentence_id": "150763151386", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1386", "end_pos": "1523", "sentence": "Simultaneous stimulation with CH& and 10(-8) M DHT also resulted in G&N down-regulation, whereas DHT alone increased G&N secretion.", "original_sentence": "Simultaneous stimulation with silibinin and 10(-8) M DHT also resulted in PSA down-regulation, whereas DHT alone increased PSA secretion.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1553573, "V1": 5556, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1416, "end_pos": 1425, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249801, "sentence_id": "150763151524", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "sim", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1524", "end_pos": "1610", "sentence": "Telomerase catalytic subunit mRNA decreased significantly after CH& stimulation.", "original_sentence": "Telomerase catalytic subunit mRNA decreased significantly after silibinin stimulation.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1553576, "V1": 5559, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1588, "end_pos": 1597, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249802, "sentence_id": "150763151611", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "sim", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1611", "end_pos": "1685", "sentence": "Telomerase activity was down-regulated by CH& and stimulated by DHT.", "original_sentence": "Telomerase activity was down-regulated by silibinin and stimulated by DHT.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1553577, "V1": 5560, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1653, "end_pos": 1662, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249803, "sentence_id": "150763151754", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1754", "end_pos": "1963", "sentence": "CONCLUSIONS: The down-regulation of G&N by CH& and its counteraction on DHT effects indicate that this compound can interact with the expression of genes that are regulated through the G&N .", "original_sentence": "CONCLUSIONS: The down-regulation of PSA by silibinin and its counteraction on DHT effects indicate that this compound can interact with the expression of genes that are regulated through the androgen receptor.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1553579, "V1": 5562, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1797, "end_pos": 1806, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249804, "sentence_id": "150763151964", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "sim", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1964", "end_pos": "2065", "sentence": "CH& can also inhibit the telomerase activity that mediates cell immortality and carcinogenesis.", "original_sentence": "Silibinin can also inhibit the telomerase activity that mediates cell immortality and carcinogenesis.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 2, "entitiesRules": [{ "id": 1553581, "V1": 5564, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1964, "end_pos": 1973, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249805, "sentence_id": "150763152066", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2066", "end_pos": "2198", "sentence": "The 2 effects underline the possible therapeutic use of CH& as an antiproliferative agent in intervention for D&S.", "original_sentence": "The 2 effects underline the possible therapeutic use of silibinin as an antiproliferative agent in intervention for prostate cancer.", "pmid_article": 15076315, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1553583, "V1": 5566, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2122, "end_pos": 2131, "entity_type": "chemical_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553584, "V1": 5567, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2182, "end_pos": 2197, "entity_type": "cancer_type_entity_p", "entity_pmid": 15076315, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }] }, { "pmid": "19778521", "peso_rules": "1.0", "peso_entities": "0.0", "peso_genes": "0.0", "peso_final": 23.5, "article": { "id": 59818, "title_article": "Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.", "abstract_article": "Silibinin is a polyphenolic flavonoid isolated from the milk thistle (Silybum marianum) and is reported to exhibit anticancer properties. Recently, it has been reported that silibinin inhibits hypoxia-inducible factor-1alpha (HIF-1alpha) expression in cancer cells. However, the precise mechanism by which silibinin decreases HIF-1 expression is not fully understood. In this study, silibinin inhibited basal and hypoxia induced expression levels of HIF-1alpha protein in LNCaP and PC-3 prostate cancer cells, while the rate of HIF-1alpha protein degradation and mRNA levels were not affected. We found that the decrease in HIF-1 protein by silibinin correlated with suppression of de novo synthesis of HIF-1alpha protein. Silibinin inhibited global protein synthesis coincided with reduction of eIF4F complex formation and induction of phosphorylation of the translation initiation factor 2alpha (eIF-2alpha) which can cause inhibition of general protein synthesis. These results suggest that silibinin's activity to inhibit HIF-1alpha protein expression is associated with the suppression of global protein translation.", "pmid": 19778521, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99463326, "FORESTS_PROB": 0.9266667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.980325 }, "rule": [{ "id": 233942, "sentence_id": "197785211", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "113", "sentence": "CH& inhibits expression of G&N a through suppression of protein translation in prostate D&S r cells.", "original_sentence": "Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 15, "peso_genes": 3, "entitiesRules": [{ "id": 1468325, "V1": 46563, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }, { "id": 1468327, "V1": 46565, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 99, "end_pos": 105, "entity_type": "cancer_type_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233943, "sentence_id": "19778521113", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "113", "end_pos": "250", "sentence": "CH& is a CH& isolated from the milk thistle (Silybum marianum) and is reported to exhibit anticancer properties.", "original_sentence": "Silibinin is a polyphenolic flavonoid isolated from the milk thistle (Silybum marianum) and is reported to exhibit anticancer properties.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1468328, "V1": 46566, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 113, "end_pos": 122, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233944, "sentence_id": "19778521251", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "251", "end_pos": "378", "sentence": "Recently, it has been reported that CH& inhibits hypoxia-inducible factor-1alpha ( G&N ) expression in D&S cells.", "original_sentence": "Recently, it has been reported that silibinin inhibits hypoxia-inducible factor-1alpha (HIF-1alpha) expression in cancer cells.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1468330, "V1": 46568, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 287, "end_pos": 296, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }, { "id": 1468332, "V1": 46570, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 365, "end_pos": 371, "entity_type": "cancer_type_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233945, "sentence_id": "19778521379", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "379", "end_pos": "480", "sentence": "However, the precise mechanism by which CH& decreases G&N expression is not fully understood.", "original_sentence": "However, the precise mechanism by which silibinin decreases HIF-1 expression is not fully understood.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1468333, "V1": 46571, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 419, "end_pos": 428, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233946, "sentence_id": "19778521481", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "481", "end_pos": "706", "sentence": "In this study, CH& inhibited basal and hypoxia induced expression levels of G&N protein in LNCaP and D&S D&S cells, while the rate of G&N protein degradation and mRNA levels were not affected.", "original_sentence": "In this study, silibinin inhibited basal and hypoxia induced expression levels of HIF-1alpha protein in LNCaP and PC-3 prostate cancer cells, while the rate of HIF-1alpha protein degradation and mRNA levels were not affected.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1468335, "V1": 46573, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 496, "end_pos": 505, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }, { "id": 1468337, "V1": 46575, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 595, "end_pos": 599, "entity_type": "cancer_type_entity_cell", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }, { "id": 1468338, "V1": 46576, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 600, "end_pos": 615, "entity_type": "cancer_type_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233947, "sentence_id": "19778521707", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "707", "end_pos": "835", "sentence": "We found that the decrease in G&N protein by CH& correlated with suppression of de novo synthesis of G&N protein.", "original_sentence": "We found that the decrease in HIF-1 protein by silibinin correlated with suppression of de novo synthesis of HIF-1alpha protein.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1468341, "V1": 46579, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 754, "end_pos": 763, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233948, "sentence_id": "19778521836", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "836", "end_pos": "1079", "sentence": "CH& inhibited global protein synthesis coincided with reduction of eIF4F complex formation and induction of phosphorylation of the translation initiation factor 2alpha ( G&N ) which can cause inhibition of general protein synthesis.", "original_sentence": "Silibinin inhibited global protein synthesis coincided with reduction of eIF4F complex formation and induction of phosphorylation of the translation initiation factor 2alpha (eIF-2alpha) which can cause inhibition of general protein synthesis.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1468343, "V1": 46581, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 836, "end_pos": 845, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }, { "id": 233949, "sentence_id": "197785211080", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1080", "end_pos": "1234", "sentence": "These results suggest that CH& 's activity to inhibit G&N protein expression is associated with the suppression of global protein translation.", "original_sentence": "These results suggest that silibinin's activity to inhibit HIF-1alpha protein expression is associated with the suppression of global protein translation.", "pmid_article": 19778521, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1468345, "V1": 46583, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1107, "end_pos": 1116, "entity_type": "chemical_entity_p", "entity_pmid": 19778521, "created_at": "2020-10-31T14:53:50.797Z", "updated_at": "2020-10-31T14:53:50.797Z" }] }] }, { "pmid": "27207648", "peso_rules": "0.74", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 23.1, "article": { "id": 55919, "title_article": "Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.", "abstract_article": "Tumor microenvironment plays an essential role in prostate carcinogenesis and offers novel opportunities to prevent and treat prostate cancer (PCA). Here, we investigated the ability of cancer-associated fibroblasts (CAFs) to promote PCA progression, and silibinin efficacy to target this response. We collected conditioned media from CAFs treated with vehicle or silibinin, and labeled as control conditioned media (CCM) or silibinin-treatment conditioned media (SBCM), respectively. Next, we characterized the effect of CCM and SBCM treatment in several PCA cell lines (RWPE-1, WPE-1 NA-22, WPE-1 NB-14 and PC3). Result showed that compared with SBCM, CCM significantly reduces E-cadherin expression and increases invasiveness and clonogenicity in PCA cells. Further molecular studies identified monocyte chemotactic protein-1 (MCP-1) as the key component of CCM that promotes PCA invasiveness, whereas silibinin treatment strongly reduced MCP-1 expression in CAFs by inhibiting the DNA-binding activity of MCP-1 transcriptional regulators-nuclear factor-kappaB and AP-1. In vivo, silibinin feeding (200mg/kg body weight) strongly reduced TRAMPC1 allografts growth (by 68%) in syngeneic C57Bl/6 mice. TRAMPC1 tumor analysis showed that silibinin reduced MCP-1 and CAFs' biomarkers (fibroblast activation protein, α-smooth muscle actin, transforming growth factor beta 2, vimentin etc.) and significantly modulated the recruitment of immune cells in the tumor microenvironment. Similar inhibitory effects of silibinin on MCP-1 and immune cells recruitment were also observed in TRAMP PCA tissues with reported silibinin efficacy. Overall, our data suggest that silibinin can target CAF-mediated invasiveness in PCA by inhibiting MCP-1 secretion. This, in turn, was associated with a reduction in immune cell recruitment in vivo along with a marked reduction in tumor growth. ", "pmid": 27207648, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9984085, "FORESTS_PROB": 0.89666665, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999994, "med": 0.9737688 }, "rule": [{ "id": 245274, "sentence_id": "272076481", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "sim", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "175", "sentence": "Beneficial effects of the naturally occurring CH& d CH& n on the D&S r microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.", "original_sentence": "Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1528890, "V1": 1013, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 56, "end_pos": 65, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528891, "V1": 1014, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 73, "end_pos": 88, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245275, "sentence_id": "27207648324", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "324", "end_pos": "473", "sentence": "Here, we investigated the ability of D&S -associated fibroblasts (D&S ) to promote D&S progression, and CH& efficacy to target this response.", "original_sentence": "Here, we investigated the ability of cancer-associated fibroblasts (CAFs) to promote PCA progression, and silibinin efficacy to target this response.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1528898, "V1": 1021, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 430, "end_pos": 439, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528895, "V1": 1018, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 361, "end_pos": 367, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528896, "V1": 1019, "pubtatot_term": "CAFs", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 392, "end_pos": 396, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528897, "V1": 1020, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 409, "end_pos": 412, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245276, "sentence_id": "27207648474", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "474", "end_pos": "659", "sentence": "We collected conditioned media from CAFs treated with vehicle or CH&, and labeled as control conditioned media (CCM) or CH& -treatment conditioned media (SBCM), respectively.", "original_sentence": "We collected conditioned media from CAFs treated with vehicle or silibinin, and labeled as control conditioned media (CCM) or silibinin-treatment conditioned media (SBCM), respectively.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1528899, "V1": 1022, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 539, "end_pos": 548, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528900, "V1": 1023, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 600, "end_pos": 609, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245277, "sentence_id": "27207648936", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "936", "end_pos": "1248", "sentence": "Further molecular studies identified monocyte chemotactic protein-1 ( G&N ) as the key component of CCM that promotes D&S invasiveness, whereas CH& treatment strongly reduced G&N expression in CAFs by inhibiting the DNA-binding activity of G&N transcriptional regulators-nuclear factor-kappaB and AP-1.", "original_sentence": "Further molecular studies identified monocyte chemotactic protein-1 (MCP-1) as the key component of CCM that promotes PCA invasiveness, whereas silibinin treatment strongly reduced MCP-1 expression in CAFs by inhibiting the DNA-binding activity of MCP-1 transcriptional regulators-nuclear factor-kappaB and AP-1.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1528907, "V1": 1030, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1080, "end_pos": 1089, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528906, "V1": 1029, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1054, "end_pos": 1057, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245278, "sentence_id": "272076481249", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1249", "end_pos": "1377", "sentence": "In vivo, CH& feeding (200mg/kg body weight) strongly reduced TRAMPC1 allografts growth (by 68%) in syngeneic C57Bl/6 mice.", "original_sentence": "In vivo, silibinin feeding (200mg/kg body weight) strongly reduced TRAMPC1 allografts growth (by 68%) in syngeneic C57Bl/6 mice.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 2, "entitiesRules": [{ "id": 1528910, "V1": 1033, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1258, "end_pos": 1267, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245279, "sentence_id": "272076481378", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1378", "end_pos": "1562", "sentence": "TRAMPC1 D&S analysis showed that CH& reduced G&N and CAFs' biomarkers (fibroblast activation protein, α-smooth muscle actin, transforming growth factor beta 2, G&N n etc.", "original_sentence": "TRAMPC1 tumor analysis showed that silibinin reduced MCP-1 and CAFs' biomarkers (fibroblast activation protein, α-smooth muscle actin, transforming growth factor beta 2, vimentin etc.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1528912, "V1": 1035, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1413, "end_pos": 1422, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528911, "V1": 1034, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1386, "end_pos": 1391, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245280, "sentence_id": "272076481655", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "sim", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1655", "end_pos": "1806", "sentence": "Similar inhibitory effects of CH& n on G&N 1 and immune cells recruitment were also observed in TRAMPD&SA tissues with reported CH& n efficacy.", "original_sentence": "Similar inhibitory effects of silibinin on MCP-1 and immune cells recruitment were also observed in TRAMP PCA tissues with reported silibinin efficacy.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1528916, "V1": 1039, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1684, "end_pos": 1693, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528919, "V1": 1042, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1786, "end_pos": 1795, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528918, "V1": 1041, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1760, "end_pos": 1763, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245281, "sentence_id": "272076481807", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1807", "end_pos": "1922", "sentence": "Overall, our data suggest that CH& n can targetG&NF-mediated invasiveness inD&SA by inhibiting G&N 1 secretion.", "original_sentence": "Overall, our data suggest that silibinin can target CAF-mediated invasiveness in PCA by inhibiting MCP-1 secretion.", "pmid_article": 27207648, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1528920, "V1": 1043, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1837, "end_pos": 1846, "entity_type": "chemical_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1528922, "V1": 1045, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1887, "end_pos": 1890, "entity_type": "cancer_type_entity_p", "entity_pmid": 27207648, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }] }, { "pmid": "23115104", "peso_rules": "0.11", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 23, "article": { "id": 76568, "title_article": "Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.", "abstract_article": "Currently, there are limited therapeutic options against bone metastatic prostate cancer (PCA), which is primarily responsible for high mortality and morbidity in PCA patients. Enhanced osteoclastogenesis is an essential feature associated with metastatic PCA in the bone microenvironment. Silibinin, an effective chemopreventive agent, is in phase II clinical trials in PCA patients but its efficacy against PCA cells-induced osteoclastogenesis is largely unknown. Accordingly, here we examined silibinin effect on PCA cells-induced osteoclastogenesis employing human PCA (PC3MM2, PC3, and C4-2B) and murine macrophage RAW264.7 cells. We also assessed silibinin effect on receptor activator of nuclear factor κB ligand (RANKL)-induced signaling associated with osteoclast differentiation in RAW264.7 cells. Further, we analyzed silibinin effect on osteomimicry biomarkers in PCA cells. Results revealed that silibinin (30-90 μM) inhibits PCA cells-induced osteoclast activity and differentiation in RAW264.7 cells via modulating expression of several cytokines (IGF-1, TGF-β, TNF-α, I-TAC, M-CSF, G-CSF, GM-CSF, etc.) that are important in osteoclastogenesis. Additionally, in RAW264.7 cells, silibinin decreased the RANKL-induced expression and nuclear localization of NFATc1, which is considered the master regulator of osteoclastogenesis. Furthermore, silibinin decreased the RANKL-induced DNA binding activity of NFATc1 and its regulators NF-κB and AP1, and the protein expression of osteoclast specific markers (TRAP, OSCAR, and cathepsin K). Importantly, silibinin also decreased the expression of osteomimicry biomarkers (RANKL, Runx2, osteocalcin, and PTHrP) in cell culture (PC3 and C4-2B cells) and/or in PC3 tumors. Together, our findings showing that silibinin inhibits PCA cells-induced osteoclastogenesis, suggest that silibinin could be useful clinically against bone metastatic PCA. ", "pmid": 23115104, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99995935, "FORESTS_PROB": 0.8466667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9616565 }, "rule": [{ "id": 304741, "sentence_id": "231151041", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "117", "sentence": "CH& inhibits D&S r cells- and G&N L-induced osteoclastogenesis by targeting G&N 1, NF-κB, and AP-1 activation i D&S .", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1610224, "V1": 5353, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818728, "V1": 36541, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610225, "V1": 5354, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 19, "end_pos": 34, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818729, "V1": 36542, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 19, "end_pos": 34, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304742, "sentence_id": "23115104608", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "608", "end_pos": "769", "sentence": "Accordingly, here we examined CH& n effect onD&SA cells-induced osteoclastogenesis employing humanD&SA (PC3MM2,G&N3, and C4-2B) and murine macrophage D&S 7 cells.", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610236, "V1": 5365, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 642, "end_pos": 651, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818740, "V1": 36553, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 642, "end_pos": 651, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610237, "V1": 5366, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 662, "end_pos": 665, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1610238, "V1": 5367, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 715, "end_pos": 718, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818741, "V1": 36554, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 662, "end_pos": 665, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1818742, "V1": 36555, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 715, "end_pos": 718, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304743, "sentence_id": "23115104927", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "927", "end_pos": "1000", "sentence": "Further, we analyze CH& in effect on osteomimicry biomarkers iD&SCA cells.", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610244, "V1": 5373, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 975, "end_pos": 984, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818748, "V1": 36561, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 975, "end_pos": 984, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610243, "V1": 5372, "pubtatot_term": "RAW264.7", "db_term": "Acute Monocytic Leukemia", "db_equivalence": "raw264.7", "mesh_id": "D007948", "term_id": "568", "start_pos": 938, "end_pos": 946, "entity_type": "cancer_type_entity_cell", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818747, "V1": 36560, "pubtatot_term": "RAW264.7", "db_term": "Acute Monocytic Leukemia", "db_equivalence": "raw264.7", "mesh_id": "D007948", "term_id": "568", "start_pos": 938, "end_pos": 946, "entity_type": "cancer_type_entity_cell", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304744, "sentence_id": "231151041001", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1001", "end_pos": "1116", "sentence": "Results revealed tha CH& in (30-90 μM) inhiD&Ss PCA cells-induced osteoclast activity and differentiatio D&S 264.", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610246, "V1": 5375, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1055, "end_pos": 1064, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818750, "V1": 36563, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1055, "end_pos": 1064, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610245, "V1": 5374, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1022, "end_pos": 1025, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1610247, "V1": 5376, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1085, "end_pos": 1088, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818749, "V1": 36562, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1022, "end_pos": 1025, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1818751, "V1": 36564, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1085, "end_pos": 1088, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304745, "sentence_id": "231151041262", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1262", "end_pos": "1411", "sentence": "7 CH& libinin decreas G&N e RANKL-induced expression and nuclear localizat G&N NFATc1, which is considered the master regulator of osteoclastogenesis.", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610256, "V1": 5385, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1340, "end_pos": 1349, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818760, "V1": 36573, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1340, "end_pos": 1349, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610255, "V1": 5384, "pubtatot_term": "RAW264.7", "db_term": "Acute Monocytic Leukemia", "db_equivalence": "raw264.7", "mesh_id": "D007948", "term_id": "568", "start_pos": 1324, "end_pos": 1332, "entity_type": "cancer_type_entity_cell", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818759, "V1": 36572, "pubtatot_term": "RAW264.7", "db_term": "Acute Monocytic Leukemia", "db_equivalence": "raw264.7", "mesh_id": "D007948", "term_id": "568", "start_pos": 1324, "end_pos": 1332, "entity_type": "cancer_type_entity_cell", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304746, "sentence_id": "231151041412", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1412", "end_pos": "1611", "sentence": "Furthe CH& libinin decreas G&N e RANKL-induced DNA binding activ G&N NFATc1 and its regulators NF-κB and AP1, and the protein expression of osteoclast specific markers (TRAP, OSCAR, and cathepsin K).", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610259, "V1": 5388, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1502, "end_pos": 1511, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818763, "V1": 36576, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1502, "end_pos": 1511, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }, { "id": 304747, "sentence_id": "231151041778", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1778", "end_pos": "1925", "sentence": "Together, our findings showi CH& ilibinin iD&Sbits PCA cells-induced osteoclastogenesis, sugge CH& ilibinin could be useful clinically D&S atic PCA.", "original_sentence": "NA", "pmid_article": 23115104, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1610270, "V1": 5399, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1910, "end_pos": 1919, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818774, "V1": 36587, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1910, "end_pos": 1919, "entity_type": "chemical_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1610269, "V1": 5398, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1866, "end_pos": 1872, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1818773, "V1": 36586, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1866, "end_pos": 1872, "entity_type": "cancer_type_entity_p", "entity_pmid": 23115104, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }] }] }, { "pmid": "12429642", "peso_rules": "1.0", "peso_entities": "0.72", "peso_genes": "0.0", "peso_final": 22.7, "article": { "id": 76658, "title_article": "Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.", "abstract_article": "We recently demonstrated the strong anticancer efficacy of silibinin,an active constituent of a widely consumed dietary supplement milk thistle extract, against human prostate cancer cells in culture and nude mice xenografts. We also observed that pharmacologically achievable concentrations of silibinin in animal studies were in the range of 25-100 microM, depending on the dose regimen, which did not show any apparent toxicity to the animals. In this study, we assessed whether silibinin synergizes the therapeutic potential of the chemotherapeutic drug doxorubicin against prostate cancer, the effectiveness of which is limited because of high systemic toxicity. Prostate cancer cells were treated with silibinin and doxorubicin, either alone or in combination, and cell growth was determined by manual cell counting. Cell cycle progression was assessed by saponin/propidium iodide staining and fluorescence-activated cell sorter analysis. Protein levels of cell cycle regulators were determined by Western blotting, and cdc2/p34 kinase activity was analyzed by in-beads kinase assay. Apoptosis was quantified by annexin V/propidium iodide staining and fluorescence-activated cell sorter analysis. Silibinin strongly synergized the growth-inhibitory effect of doxorubicin in prostate carcinoma DU145 cells (combination index, 0.235-0.587), which was associated with a strong G(2)-M arrest in cell cycle progression, showing 88% cells in G2-M phase by this combination compared with 19 and 41% of cells in silibinin and doxorubicin treatment alone, respectively. The underlying mechanism of G2-M arrest showed a strong inhibitory effect of combination on cdc25C, cdc2/p34, and cyclin B1 protein expression and cdc2/p34 kinase activity. More importantly, this combination caused 41% apoptotic cell death compared with 15% by either agent alone. Silibinin and doxorubicin alone as well as in combination were also effective in inhibiting the growth of androgen-dependent prostate carcinoma LNCaP cells. These findings suggest a need for in vivo studies with this combination in preclinical prostate cancer models. Positive outcomes might be relevant for a clinical application in prostate cancer patients.", "pmid": 12429642, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99978983, "FORESTS_PROB": 0.8666667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9666141 }, "rule": [{ "id": 255302, "sentence_id": "124296421", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "137", "sentence": "CH& strongly synergizes human D&S a DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.", "original_sentence": "Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1581988, "V1": 33971, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581989, "V1": 33972, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 36, "end_pos": 54, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255303, "sentence_id": "12429642137", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "137", "end_pos": "371", "sentence": "PURPOSE: We recently demonstrated the strong anticancer efficacy of CH&,an active constituent of a widely consumed dietary supplement milk thistle extract, against human D&S cells in culture and nude mice xenografts.", "original_sentence": "PURPOSE: We recently demonstrated the strong anticancer efficacy of silibinin,an active constituent of a widely consumed dietary supplement milk thistle extract, against human prostate cancer cells in culture and nude mice xenografts.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1581990, "V1": 33973, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 205, "end_pos": 214, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581991, "V1": 33974, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 313, "end_pos": 328, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255304, "sentence_id": "12429642372", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "372", "end_pos": "592", "sentence": "We also observed that pharmacologically achievable concentrations of CH& in animal studies were in the range of 25-100 microM, depending on the dose regimen, which did not show any apparent toxicity to the animals.", "original_sentence": "We also observed that pharmacologically achievable concentrations of silibinin in animal studies were in the range of 25-100 microM, depending on the dose regimen, which did not show any apparent toxicity to the animals.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1581992, "V1": 33975, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 441, "end_pos": 450, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255305, "sentence_id": "12429642593", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "593", "end_pos": "813", "sentence": "In this study, we assessed whether CH& synergizes the therapeutic potential of the chemotherapeutic drug doxorubicin against D&S, the effectiveness of which is limited because of high systemic toxicity.", "original_sentence": "In this study, we assessed whether silibinin synergizes the therapeutic potential of the chemotherapeutic drug doxorubicin against prostate cancer, the effectiveness of which is limited because of high systemic toxicity.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1581993, "V1": 33976, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 628, "end_pos": 637, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581994, "V1": 33977, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 724, "end_pos": 739, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255306, "sentence_id": "12429642814", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "814", "end_pos": "989", "sentence": "EXPERIMENTAL DESIGN: D&S cells were treated with CH& and doxorubicin, either alone or in combination, and cell growth was determined by manual cell counting.", "original_sentence": "EXPERIMENTAL DESIGN: Prostate cancer cells were treated with silibinin and doxorubicin, either alone or in combination, and cell growth was determined by manual cell counting.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1581996, "V1": 33979, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 875, "end_pos": 884, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1581995, "V1": 33978, "pubtatot_term": "Prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 835, "end_pos": 850, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255307, "sentence_id": "124296421370", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1370", "end_pos": "1509", "sentence": "RESULTS: CH& strongly synergized the growth-inhibitory effect of doxorubicin in D&S DU145 cells (combination index, 0.", "original_sentence": "RESULTS: Silibinin strongly synergized the growth-inhibitory effect of doxorubicin in prostate carcinoma DU145 cells (combination index, 0.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1582000, "V1": 33983, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1379, "end_pos": 1388, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1582001, "V1": 33984, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1456, "end_pos": 1474, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255308, "sentence_id": "124296421515", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1515", "end_pos": "1742", "sentence": "587), which was associated with a strong G(2)-M arrest in cell cycle progression, showing 88% cells in G2-M phase by this combination compared with 19 and 41% of cells in CH& and doxorubicin treatment alone, respectively.", "original_sentence": "587), which was associated with a strong G(2)-M arrest in cell cycle progression, showing 88% cells in G2-M phase by this combination compared with 19 and 41% of cells in silibinin and doxorubicin treatment alone, respectively.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1582002, "V1": 33985, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1686, "end_pos": 1695, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 255309, "sentence_id": "124296422024", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2024", "end_pos": "2180", "sentence": "CH& and doxorubicin alone as well as in combination were also effective in inhibiting the growth of androgen-dependent D&S LNCaP cells.", "original_sentence": "Silibinin and doxorubicin alone as well as in combination were also effective in inhibiting the growth of androgen-dependent prostate carcinoma LNCaP cells.", "pmid_article": 12429642, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1582009, "V1": 33992, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2024, "end_pos": 2033, "entity_type": "chemical_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1582010, "V1": 33993, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2149, "end_pos": 2167, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429642, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "12036915", "peso_rules": "1.0", "peso_entities": "0.77", "peso_genes": "0.0", "peso_final": 22, "article": { "id": 61664, "title_article": "Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.", "abstract_article": "We have reported recently the anticancer effect of flavonoid antioxidant silymarin, the major part of milk thistle extract, against advanced human prostate carcinoma DU145 cells (X. Zi et al., Cancer Res., 58: 1920-1929, 1998) and later identified that silibinin is the main active component in silymarin responsible for its effect in cell culture studies. On the basis of these observations, here we assessed in vivo growth inhibitory potential of silibinin against advanced human prostate cancer (PCA). Dietary feeding of silibinin at 0.05 and 0.1% doses (w/w) for 60 days, 24 h after s.c. DU145 tumor xenograft implantation in athymic male nude mice, significantly inhibited tumor volume by 35 and 58% (P < 0.05), and wet weight of tumor by 29 and 40% (P < 0.05), respectively. In a second experiment where mice were fed with these test diets for 3 weeks before tumor xenograft implantation and continued on these diets for a total of 63 days, tumor volume and wet weight of tumor were reduced by 53-64% (P < 0.001-0.05) and 31-52% (P < 0.05), respectively. In both studies, animals did not show weight loss or reduced food consumption. These in vivo anticancer effects of silibinin were associated with an increased accumulation (up to 5.8 fold; P < 0.05) of human insulin-like growth factor-binding protein-3 in mouse plasma. In additional studies assessing biological availability of silibinin in nude mice and its antiproliferative activity at such doses in DU145 cells in culture, silibinin levels in plasma and prostate were found to be in the range of 7-13 microg/ml and 3.7-4.6 microg/g, respectively. At these biologically achievable silibinin concentrations, increased IGFBP-3 level in DU145 cell culture medium and a strong DU145 cell growth inhibition were observed that were irreversible in the absence of silibinin in culture medium. These findings extend and translate our observations on in vitro anticancer effect of silibinin/silymarin to an in vivo preclinical PCA model, which may form the basis for a Phase I clinical trial in PCA patients.", "pmid": 12036915, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.996293, "FORESTS_PROB": 0.75333333, "LOGITBOOST_PROB": 0.99999917, "MAXENTROPY_PROB": 0.9999999, "med": 0.93740636 }, "rule": [{ "id": 277311, "sentence_id": "120369151", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "173", "sentence": "Dietary feeding of CH& n inhibits advance human D&S a growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.", "original_sentence": "Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1692143, "V1": 18820, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 19, "end_pos": 28, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692144, "V1": 18821, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 52, "end_pos": 70, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277312, "sentence_id": "12036915173", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "173", "end_pos": "354", "sentence": "We have reported recently the anticancer effect of CH& antioxidant silymarin, the major part of milk thistle extract, against advanced human D&S DU145 cells (X.", "original_sentence": "We have reported recently the anticancer effect of flavonoid antioxidant silymarin, the major part of milk thistle extract, against advanced human prostate carcinoma DU145 cells (X.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1692146, "V1": 18823, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 320, "end_pos": 338, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277313, "sentence_id": "12036915377", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "377", "end_pos": "529", "sentence": ", 58: 1920-1929, 1998) and later identified that CH& is the main active component in silymarin responsible for its effect in cell culture studies.", "original_sentence": ", 58: 1920-1929, 1998) and later identified that silibinin is the main active component in silymarin responsible for its effect in cell culture studies.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1692148, "V1": 18825, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 426, "end_pos": 435, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277314, "sentence_id": "12036915530", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "530", "end_pos": "677", "sentence": "On the basis of these observations, here we assessed in vivo growth inhibitory potential of CH& against advanced human D&S (D&S).", "original_sentence": "On the basis of these observations, here we assessed in vivo growth inhibitory potential of silibinin against advanced human prostate cancer (PCA).", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 8, "peso_genes": 1, "entitiesRules": [{ "id": 1692149, "V1": 18826, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 622, "end_pos": 631, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692150, "V1": 18827, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 655, "end_pos": 670, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692151, "V1": 18828, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 672, "end_pos": 675, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277315, "sentence_id": "12036915678", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "678", "end_pos": "721", "sentence": "Dietary feeding of CH& at 0_05 and 0.", "original_sentence": "Dietary feeding of silibinin at 0_05 and 0.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1692152, "V1": 18829, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 697, "end_pos": 706, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277316, "sentence_id": "120369151313", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1313", "end_pos": "1415", "sentence": "These in vivo anticancer effects of CH& were associated with an increased accumulation (up to 5.", "original_sentence": "These in vivo anticancer effects of silibinin were associated with an increased accumulation (up to 5.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1692159, "V1": 18836, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1349, "end_pos": 1358, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277317, "sentence_id": "120369151504", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1504", "end_pos": "1756", "sentence": "In additional studies assessing biological availability of CH& in nude mice and its antiproliferative activity at such doses in DU145 cells in culture, CH& levels in plasma and prostate were found to be in the range of 7-13 microg/ml and 3.", "original_sentence": "In additional studies assessing biological availability of silibinin in nude mice and its antiproliferative activity at such doses in DU145 cells in culture, silibinin levels in plasma and prostate were found to be in the range of 7-13 microg/ml and 3.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1692161, "V1": 18838, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1563, "end_pos": 1572, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692162, "V1": 18839, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1662, "end_pos": 1671, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277318, "sentence_id": "120369151786", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1786", "end_pos": "2023", "sentence": "At these biologically achievable CH& concentrations, increased G&N level in DU145 cell culture medium and a strong DU145 cell growth inhibition were observed that were irreversible in the absence of CH& in culture medium.", "original_sentence": "At these biologically achievable silibinin concentrations, increased IGFBP-3 level in DU145 cell culture medium and a strong DU145 cell growth inhibition were observed that were irreversible in the absence of silibinin in culture medium.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1692163, "V1": 18840, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1819, "end_pos": 1828, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692165, "V1": 18842, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1995, "end_pos": 2004, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277319, "sentence_id": "120369152024", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "2024", "end_pos": "2237", "sentence": "These findings extend and translate our observations on in vitro anticancer effect of CH& /silymarin to an in vivo preclinical D&S model, which may form the basis for a Phase I clinical trial in D&S patients.", "original_sentence": "These findings extend and translate our observations on in vitro anticancer effect of silibinin/silymarin to an in vivo preclinical PCA model, which may form the basis for a Phase I clinical trial in PCA patients.", "pmid_article": 12036915, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1692166, "V1": 18843, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2110, "end_pos": 2119, "entity_type": "chemical_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692167, "V1": 18844, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2156, "end_pos": 2159, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1692168, "V1": 18845, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2224, "end_pos": 2227, "entity_type": "cancer_type_entity_p", "entity_pmid": 12036915, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }] }, { "pmid": "12429923", "peso_rules": "0.77", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 21.9, "article": { "id": 61596, "title_article": "The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.", "abstract_article": "Phosphorylation status of retinoblastoma (Rb) and related proteins is important to drive cell cycle progression. In hyperphosphorylated state, they are growth stimulatory, but their hypophosphorylation is growth inhibitory. Here we assessed whether silibinin causes hypophosphorylation of Rb-related proteins as its growth inhibitory response in human prostate cancer (PCA) DU145 cells. Silibinin treatment of cells resulted in a strong increase (up to 2.3-and 5.4-fold) in the levels of hypophosphorylated Rb/p107 and Rb2/p130, respectively, but a strong decrease (91, 78 and 45%) in protein levels of transcription factors E2F3, E2F4 and E2F5, respectively. In the studies analyzing whether this effect of silibinin is via modulation of cell cycle regulators, silibinin-treated cells showed a strong increase (up to 13- and 6-fold) in Cip1/p21 and Kip1/p27 levels, respectively. Silibinin treatment also resulted in 90 and 70% decrease in CDK4 and CDK2 levels, respectively, but did not alter the protein levels of cyclin D1 and cyclin E. Consistent with its effect on G1 cell cycle regulators, silibinin treated cells exhibited a strong G1 arrest, almost complete growth inhibition, and morphological changes suggestive of differentiation. Together, these results suggest that silibinin caused hypophosphorylation of Rb-related proteins may in part be responsible for its cancer preventive and anti-carcinogenic efficacy in different cancer models including PCA.", "pmid": 12429923, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99476767, "FORESTS_PROB": 0.82666665, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 0.9999908, "med": 0.95535475 }, "rule": [{ "id": 266830, "sentence_id": "124299231", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "174", "sentence": "The D&S r preventive CH& d CH& n causes hypophosphorylation ofD&SG&N 7 andG&N2G&N 0 via modulation of cell cycle regulators in human D&S a DU145 cells.", "original_sentence": "The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 11, "peso_genes": 0, "entitiesRules": [{ "id": 1640451, "V1": 191, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 32, "end_pos": 41, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640449, "V1": 189, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 4, "end_pos": 10, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640452, "V1": 192, "pubtatot_term": "Rb", "db_term": "Retinoblastoma", "db_equivalence": "Retinoblastoma", "mesh_id": "D012175", "term_id": "522", "start_pos": 72, "end_pos": 74, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640456, "V1": 196, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 142, "end_pos": 160, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266831, "sentence_id": "12429923398", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "398", "end_pos": "560", "sentence": "Here we assessed whether CH& causes hypophosphorylation of D&Srelated proteins as its growth inhibitory response in human D&S (D&S) DU145 cells.", "original_sentence": "Here we assessed whether silibinin causes hypophosphorylation of Rb-related proteins as its growth inhibitory response in human prostate cancer (PCA) DU145 cells.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1640459, "V1": 199, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 423, "end_pos": 432, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640460, "V1": 200, "pubtatot_term": "Rb", "db_term": "Retinoblastoma", "db_equivalence": "Retinoblastoma", "mesh_id": "D012175", "term_id": "522", "start_pos": 463, "end_pos": 465, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640461, "V1": 201, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 526, "end_pos": 541, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640462, "V1": 202, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 543, "end_pos": 546, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266832, "sentence_id": "12429923561", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "561", "end_pos": "629", "sentence": "CH& treatment of cells resulted in a strong increase (up to 2.", "original_sentence": "Silibinin treatment of cells resulted in a strong increase (up to 2.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1640463, "V1": 203, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 561, "end_pos": 570, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266833, "sentence_id": "12429923834", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "834", "end_pos": "1054", "sentence": "In the studies analyzing whether this effect of CH& is via modulation of cell cycle regulators, CH& -treated cells showed a strong increase (up to 13- and 6-fold) in G&N /G&N and G&N /G&N levels, respectively.", "original_sentence": "In the studies analyzing whether this effect of silibinin is via modulation of cell cycle regulators, silibinin-treated cells showed a strong increase (up to 13- and 6-fold) in Cip1/p21 and Kip1/p27 levels, respectively.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 4, "peso_genes": 3, "entitiesRules": [{ "id": 1640471, "V1": 211, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 882, "end_pos": 891, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640472, "V1": 212, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 936, "end_pos": 945, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266834, "sentence_id": "124299231055", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1055", "end_pos": "1214", "sentence": "CH& treatment also resulted in 90 and 70% decrease in G&N and G&N levels, respectively, but did not alter the protein levels of G&N and cyclin E.", "original_sentence": "Silibinin treatment also resulted in 90 and 70% decrease in CDK4 and CDK2 levels, respectively, but did not alter the protein levels of cyclin D1 and cyclin E.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1640477, "V1": 217, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1055, "end_pos": 1064, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266835, "sentence_id": "124299231215", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1215", "end_pos": "1416", "sentence": "Consistent with its effect on G1 cell cycle regulators, CH& treated cells exhibited a strong G1 arrest, almost complete growth inhibition, and morphological changes suggestive of differentiation.", "original_sentence": "Consistent with its effect on G1 cell cycle regulators, silibinin treated cells exhibited a strong G1 arrest, almost complete growth inhibition, and morphological changes suggestive of differentiation.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1640481, "V1": 221, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1271, "end_pos": 1280, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266836, "sentence_id": "124299231417", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1417", "end_pos": "1639", "sentence": "Together, these results suggest that CH& caused hypophosphorylation of D&Srelated proteins may in part be responsible for its D&S preventive and anti-carcinogenic efficacy in different D&S models including D&S.", "original_sentence": "Together, these results suggest that silibinin caused hypophosphorylation of Rb-related proteins may in part be responsible for its cancer preventive and anti-carcinogenic efficacy in different cancer models including PCA.", "pmid_article": 12429923, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1640482, "V1": 222, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1454, "end_pos": 1463, "entity_type": "chemical_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640483, "V1": 223, "pubtatot_term": "Rb", "db_term": "Retinoblastoma", "db_equivalence": "Retinoblastoma", "mesh_id": "D012175", "term_id": "522", "start_pos": 1494, "end_pos": 1496, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640484, "V1": 224, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1549, "end_pos": 1555, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640485, "V1": 225, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1611, "end_pos": 1617, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1640486, "V1": 226, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1635, "end_pos": 1638, "entity_type": "cancer_type_entity_p", "entity_pmid": 12429923, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }] }, { "pmid": "18006855", "peso_rules": "1.0", "peso_entities": "0.80", "peso_genes": "0.0", "peso_final": 21.6, "article": { "id": 76629, "title_article": "Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.", "abstract_article": "Herein, for the first time, we evaluated the chemopreventive efficacy of dietary silibinin against prostate cancer (PCa) growth and progression in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice from two different genetic backgrounds [C57BL/6 (TRAMP) x FVB; C57BL/6 (TRAMP) x C57BL/6]. At 4 weeks of age, mice were fed control or 0.1% to 1% silibinin-supplemented diets until 23 to 24 weeks of age. Silibinin-fed groups had a lower tumor grade and higher incidence of prostatic intraepithelial neoplasia (PIN) at the expense of a strong decrease in adenocarcinoma incidence. Prostate tissue showed a 47% (P < 0.001) decrease in proliferating cell nuclear antigen (PCNA)-positive cells and an approximately 7-fold (P < 0.001) increase in apoptotic cells at the highest silibinin dose. As potential mechanisms of silibinin efficacy, an approximately 50% (P < 0.05) decrease in insulin-like growth factor (IGF) receptor type I beta and an approximately 13-fold (P < 0.001) increase in IGF-binding protein 3 (IGFBP-3) protein levels were also observed. These changes were specific to tumors as they were not reflected in circulating IGF-IGFBP-3 system. Additionally, silibinin decreased protein expression of cyclin-dependent kinases (Cdk) by more than 90% (P < 0.001) with a concomitant increase in Cdk inhibitors, Cip1/p21 and Kip1/p27 (P < 0.05, for both). A dose-dependent decrease was also observed in cyclin B1, cyclin E, and cyclin A protein levels by silibinin. Together, these findings suggest that oral silibinin blocks PCa growth and progression at PIN stage in TRAMP mice via modulation of tumor IGF-IGFBP-3 axis and cell cycle regulation, and therefore it has practical and translational potential in suppressing growth and neoplastic conversion of PIN to PCa in humans.", "pmid": 18006855, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.98018706, "FORESTS_PROB": 0.8333333, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.9999987, "med": 0.95337975 }, "rule": [{ "id": 268224, "sentence_id": "180068551", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "134", "sentence": "Dietary feeding of CH& n inhibits D&S r growth and progression in transgenic D&S a of the mouse prostate model.", "original_sentence": "Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1647472, "V1": 7212, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 19, "end_pos": 28, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647473, "V1": 7213, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 38, "end_pos": 52, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647474, "V1": 7214, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 90, "end_pos": 104, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268225, "sentence_id": "18006855134", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "134", "end_pos": "432", "sentence": "Herein, for the first time, we evaluated the chemopreventive efficacy of dietary CH& against D&S (PCa) growth and progression in transgenic D&S of the mouse prostate (TRAMP) mice from two different genetic backgrounds _C57BL/6 (TRAMP) x FVB; C57BL/6 (TRAMP) x C57BL/6].", "original_sentence": "Herein, for the first time, we evaluated the chemopreventive efficacy of dietary silibinin against prostate cancer (PCa) growth and progression in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice from two different genetic backgrounds [C57BL/6 (TRAMP) x FVB; C57BL/6 (TRAMP) x C57BL/6].", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1647475, "V1": 7215, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 215, "end_pos": 224, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647476, "V1": 7216, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 233, "end_pos": 248, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647477, "V1": 7217, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 292, "end_pos": 306, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268226, "sentence_id": "18006855479", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "479", "end_pos": "545", "sentence": "1% to 1% CH& -supplemented diets until 23 to 24 weeks of age.", "original_sentence": "1% to 1% silibinin-supplemented diets until 23 to 24 weeks of age.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1647478, "V1": 7218, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 488, "end_pos": 497, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268227, "sentence_id": "18006855546", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "546", "end_pos": "721", "sentence": "CH& -fed groups had a lower D&S grade and higher incidence of prostatic intraepithelial neoplasia (PIN) at the expense of a strong decrease in D&S incidence.", "original_sentence": "Silibinin-fed groups had a lower tumor grade and higher incidence of prostatic intraepithelial neoplasia (PIN) at the expense of a strong decrease in adenocarcinoma incidence.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1647479, "V1": 7219, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 546, "end_pos": 555, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647480, "V1": 7220, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 579, "end_pos": 584, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647481, "V1": 7221, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 696, "end_pos": 710, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268228, "sentence_id": "18006855722", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "722", "end_pos": "930", "sentence": "Prostate tissue showed a 47% (P < 0_001) decrease in G&N (G&N )-positive cells and an approximately 7-fold (P < 0_001) increase in apoptotic cells at the highest CH& dose.", "original_sentence": "Prostate tissue showed a 47% (P < 0_001) decrease in proliferating cell nuclear antigen (PCNA)-positive cells and an approximately 7-fold (P < 0_001) increase in apoptotic cells at the highest silibinin dose.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1647484, "V1": 7224, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 915, "end_pos": 924, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268229, "sentence_id": "18006855931", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "931", "end_pos": "1195", "sentence": "As potential mechanisms of CH& efficacy, an approximately 50% (P < 0_05) decrease in insulin-like growth factor (IGF) receptor type I beta and an approximately 13-fold (P < 0_001) increase in G&N (IGFBP-3) protein levels were also observed.", "original_sentence": "As potential mechanisms of silibinin efficacy, an approximately 50% (P < 0_05) decrease in insulin-like growth factor (IGF) receptor type I beta and an approximately 13-fold (P < 0_001) increase in IGF-binding protein 3 (IGFBP-3) protein levels were also observed.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1647485, "V1": 7225, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 958, "end_pos": 967, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268230, "sentence_id": "180068551296", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1296", "end_pos": "1502", "sentence": "Additionally, CH& decreased protein expression of cyclin-dependent kinases (Cdk) by more than 90% (P < 0_001) with a concomitant increase in Cdk inhibitors, G&N /G&N and G&N /G&N (P < 0_05, for both).", "original_sentence": "Additionally, silibinin decreased protein expression of cyclin-dependent kinases (Cdk) by more than 90% (P < 0_001) with a concomitant increase in Cdk inhibitors, Cip1/p21 and Kip1/p27 (P < 0_05, for both).", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1647488, "V1": 7228, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1310, "end_pos": 1319, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268231, "sentence_id": "180068551503", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1503", "end_pos": "1612", "sentence": "A dose-dependent decrease was also observed in G&N, cyclin E, and G&N protein levels by CH& .", "original_sentence": "A dose-dependent decrease was also observed in cyclin B1, cyclin E, and cyclin A protein levels by silibinin.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1647495, "V1": 7235, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1602, "end_pos": 1611, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }, { "id": 268232, "sentence_id": "180068551613", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1613", "end_pos": "1926", "sentence": "Together, these findings suggest that oral CH& blocks PCa growth and progression at PIN stage in TRAMP mice via modulation of D&S IGF-IGFBP-3 axis and cell cycle regulation, and therefore it has practical and translational potential in suppressing growth and neoplastic conversion of PIN to PCa in humans.", "original_sentence": "Together, these findings suggest that oral silibinin blocks PCa growth and progression at PIN stage in TRAMP mice via modulation of tumor IGF-IGFBP-3 axis and cell cycle regulation, and therefore it has practical and translational potential in suppressing growth and neoplastic conversion of PIN to PCa in humans.", "pmid_article": 18006855, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 6, "peso_genes": 3, "entitiesRules": [{ "id": 1647496, "V1": 7236, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1656, "end_pos": 1665, "entity_type": "chemical_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }, { "id": 1647497, "V1": 7237, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1745, "end_pos": 1750, "entity_type": "cancer_type_entity_p", "entity_pmid": 18006855, "created_at": "2020-10-31T15:10:01.623Z", "updated_at": "2020-10-31T15:10:01.623Z" }] }] }, { "pmid": "19966941", "peso_rules": "0.68", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 21.3, "article": { "id": 76604, "title_article": "Silibinin suppresses CD44 expression in prostate cancer cells.", "abstract_article": "Prostate cancer (PCa), like most human cancers, features dysregulated CD44 expression. Expression of CD44 standard (CD44s), present in benign epithelium, is lost in PCa while pro-invasive splice variant isoform CD44v7-10 is overexpressed. The role of CD44 in silibinin's anti-growth effects was uncertain. To assess silibinin's effects on CD44 promoter activity, PC-3M PCa cells were transfected with luciferase-CD44 promoter construct 24 h prior to 25-200 muM silibinin treatment for 48 h. Also, cells' expression of CD44 RNA (by qRT-PCR) and protein (Western blot analysis) was studied. Silibinin was further tested preoperatively on a pilot cohort of 6 men with PCa compared with 7 matched placebo-treated men, with immunostaining for CD44v7-10 in their prostates. In PC-3M cells, silibinin dose-dependently inhibited CD44 promoter activity up to 87%, caused a 90% inhibition of total CD44 and 70% decrease in CD44v7-10 RNA, and at the protein level, decreased total CD44 at 100-200 muM dose and decreased CD44v7-10 after 3 days. Silibinin decreased adhesion to hyaluronan and fibronectin. Silibinin at 100-200 muM inhibited Egr-1, a regulator of CD44 promoter activity. Men treated with silibinin did not differ in tissue CD44v7-10 expression. In conclusion, CD44 inhibition is one mechanism by which silibinin reduces PCa tumorigenicity.", "pmid": 19966941, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9977732, "FORESTS_PROB": 0.8833333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9702766 }, "rule": [{ "id": 250401, "sentence_id": "199669411", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "63", "sentence": "CH& suppressesG&N 4 expression in D&S r cells.", "original_sentence": "Silibinin suppresses CD44 expression in prostate cancer cells.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1556827, "V1": 8810, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1556829, "V1": 8812, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 40, "end_pos": 55, "entity_type": "cancer_type_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250402, "sentence_id": "19966941302", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "302", "end_pos": "368", "sentence": "The role of G&N in CH& 's anti-growth effects was uncertain.", "original_sentence": "The role of CD44 in silibinin's anti-growth effects was uncertain.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1556837, "V1": 8820, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 322, "end_pos": 331, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250403, "sentence_id": "19966941369", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "369", "end_pos": "553", "sentence": "To assess CH& 's effects on G&N promoter activity, PC-3M PCa cells were transfected with luciferase-G&N promoter construct 24 h prior to 25-200 muM CH& treatment for 48 h.", "original_sentence": "To assess silibinin's effects on CD44 promoter activity, PC-3M PCa cells were transfected with luciferase-CD44 promoter construct 24 h prior to 25-200 muM silibinin treatment for 48 h.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1556838, "V1": 8821, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 379, "end_pos": 388, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1556841, "V1": 8824, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 524, "end_pos": 533, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250404, "sentence_id": "19966941652", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "652", "end_pos": "830", "sentence": "CH& was further tested preoperatively on a pilot cohort of 6 men with D&S compared with 7 matched placebo-treated men, with immunostaining for CD44v7-10 in their prostates.", "original_sentence": "Silibinin was further tested preoperatively on a pilot cohort of 6 men with PCa compared with 7 matched placebo-treated men, with immunostaining for CD44v7-10 in their prostates.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1556843, "V1": 8826, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 652, "end_pos": 661, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1556844, "V1": 8827, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 728, "end_pos": 731, "entity_type": "cancer_type_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250405, "sentence_id": "19966941831", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "831", "end_pos": "1095", "sentence": "In PC-3M cells, CH& dose-dependently inhibited G&N promoter activity up to 87%, caused a 90% inhibition of total G&N and 70% decrease in CD44v7-10 RNA, and at the protein level, decreased total G&N at 100-200 muM dose and decreased CD44v7-10 after 3 days.", "original_sentence": "In PC-3M cells, silibinin dose-dependently inhibited CD44 promoter activity up to 87%, caused a 90% inhibition of total CD44 and 70% decrease in CD44v7-10 RNA, and at the protein level, decreased total CD44 at 100-200 muM dose and decreased CD44v7-10 after 3 days.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1556845, "V1": 8828, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 847, "end_pos": 856, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250406, "sentence_id": "199669411096", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1096", "end_pos": "1155", "sentence": "CH& decreased adhesion to hyaluronan and G&N .", "original_sentence": "Silibinin decreased adhesion to hyaluronan and fibronectin.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1556849, "V1": 8832, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1096, "end_pos": 1105, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250407, "sentence_id": "199669411156", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1156", "end_pos": "1236", "sentence": "CH& at 100-200 muM inhibited Egr-1, a regulator of G&N promoter activity.", "original_sentence": "Silibinin at 100-200 muM inhibited Egr-1, a regulator of CD44 promoter activity.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1556851, "V1": 8834, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1156, "end_pos": 1165, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250408, "sentence_id": "199669411237", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1237", "end_pos": "1310", "sentence": "Men treated with CH& did not differ in tissue CD44v7-10 expression.", "original_sentence": "Men treated with silibinin did not differ in tissue CD44v7-10 expression.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1556853, "V1": 8836, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1254, "end_pos": 1263, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250409, "sentence_id": "199669411311", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1311", "end_pos": "1405", "sentence": "In conclusion, G&N inhibition is one mechanism by which CH& reduces D&S tumorigenicity.", "original_sentence": "In conclusion, CD44 inhibition is one mechanism by which silibinin reduces PCa tumorigenicity.", "pmid_article": 19966941, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1556855, "V1": 8838, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1368, "end_pos": 1377, "entity_type": "chemical_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1556856, "V1": 8839, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1386, "end_pos": 1389, "entity_type": "cancer_type_entity_p", "entity_pmid": 19966941, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }] }, { "pmid": "17938263", "peso_rules": "0.62", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 21.2, "article": { "id": 76630, "title_article": "p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.", "abstract_article": "Recent studies have shown that silibinin induces p21/Cip1 and p27/Kip1 and G1 arrest in different prostate cancer cells irrespective of p53 status; however, biological significance and mechanism of such induction have not been studied. Here, using two different prostate cancer cell lines DU145 and 22Rv1, representing androgen-independent and androgen-dependent stages of malignancy, first we investigated the importance of p21 and p27 induction in silibinin-mediated G1 arrest. Silencing p21 and p27 individually by RNA interference showed marked reversal in G1 arrest; however, their simultaneous ablation showed additional reversal of G1 arrest in 22Rv1 but not DU145 cells. These results suggest that whereas relative importance of these molecules might be cell line specific, their induction by silibinin is essential for its G1 arrest effect. Next, studies were done to examine mechanisms of their induction where cycloheximide-chase experiments showed that silibinin increases p21 and p27 protein half-life. This effect was accompanied by strong reduction in Skp2 level and its binding with p21 and p27 together with strong decrease in phosphorylated Thr(187) p27 without considerable change in proteasomal activity, suggesting a posttranslational mechanism. Skp2 role was further elucidated using Skp2-small interfering RNA-transfected cells, where decreased G1 arrest and attenuated Cip/Kip induction were observed with silibinin treatment. Further, silibinin caused a marked increase in p21 and p27 mRNA levels together with an increase in their promoter activity, also indicating a transcriptional mechanism. Together, our results for the first time identify a central role of p21 and p27 induction and their regulatory mechanism in silibinin-mediated cell cycle arrest.", "pmid": 17938263, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9939786, "FORESTS_PROB": 0.87666667, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 0.9998205, "med": 0.9676149 }, "rule": [{ "id": 254048, "sentence_id": "179382631", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "110", "sentence": "G&N andG&N7 induction by CH& n is essential for its cell cycle arrest effect in D&S a cells.", "original_sentence": "p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1575603, "V1": 27586, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 25, "end_pos": 34, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1575604, "V1": 27587, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 84, "end_pos": 102, "entity_type": "cancer_type_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254049, "sentence_id": "17938263110", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "110", "end_pos": "345", "sentence": "Recent studies have shown that CH& induces G&N/G&N and G&N/G&N and G1 arrest in different D&S cells irrespective of G&N status; however, biological significance and mechanism of such induction have not been studied.", "original_sentence": "Recent studies have shown that silibinin induces p21/Cip1 and p27/Kip1 and G1 arrest in different prostate cancer cells irrespective of p53 status; however, biological significance and mechanism of such induction have not been studied.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 4, "peso_genes": 1, "entitiesRules": [{ "id": 1575605, "V1": 27588, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 141, "end_pos": 150, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1575610, "V1": 27593, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 208, "end_pos": 223, "entity_type": "cancer_type_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254050, "sentence_id": "17938263346", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "346", "end_pos": "589", "sentence": "Here, using two different D&S cell lines DU145 and 22Rv1, representing androgen-independent and androgen-dependent stages of malignancy, first we investigated the importance of G&N and G&N induction in CH& -mediated G1 arrest.", "original_sentence": "Here, using two different prostate cancer cell lines DU145 and 22Rv1, representing androgen-independent and androgen-dependent stages of malignancy, first we investigated the importance of p21 and p27 induction in silibinin-mediated G1 arrest.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1575615, "V1": 27598, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 560, "end_pos": 569, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1575612, "V1": 27595, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 372, "end_pos": 387, "entity_type": "cancer_type_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254051, "sentence_id": "17938263789", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "789", "end_pos": "959", "sentence": "These results suggest that whereas relative importance of these molecules might be cell line specific, their induction by CH& is essential for its G1 arrest effect.", "original_sentence": "These results suggest that whereas relative importance of these molecules might be cell line specific, their induction by silibinin is essential for its G1 arrest effect.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1575618, "V1": 27601, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 911, "end_pos": 920, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254052, "sentence_id": "17938263960", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "960", "end_pos": "1125", "sentence": "Next, studies were done to examine mechanisms of their induction where cycloheximide-chase experiments showed that CH& increases G&N and G&N protein half-life.", "original_sentence": "Next, studies were done to examine mechanisms of their induction where cycloheximide-chase experiments showed that silibinin increases p21 and p27 protein half-life.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1575619, "V1": 27602, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1075, "end_pos": 1084, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254053, "sentence_id": "179382631377", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1377", "end_pos": "1560", "sentence": "G&N role was further elucidated using G&N -small interfering RNA-transfected cells, where decreased G1 arrest and attenuated Cip/Kip induction were observed with CH& treatment.", "original_sentence": "Skp2 role was further elucidated using Skp2-small interfering RNA-transfected cells, where decreased G1 arrest and attenuated Cip/Kip induction were observed with silibinin treatment.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1575628, "V1": 27611, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1540, "end_pos": 1549, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254054, "sentence_id": "179382631561", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1561", "end_pos": "1730", "sentence": "Further, CH& caused a marked increase in G&N and G&N mRNA levels together with an increase in their promoter activity, also indicating a transcriptional mechanism.", "original_sentence": "Further, silibinin caused a marked increase in p21 and p27 mRNA levels together with an increase in their promoter activity, also indicating a transcriptional mechanism.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1575629, "V1": 27612, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1570, "end_pos": 1579, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 254055, "sentence_id": "179382631731", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1731", "end_pos": "1892", "sentence": "Together, our results for the first time identify a central role of G&N and G&N induction and their regulatory mechanism in CH& -mediated cell cycle arrest.", "original_sentence": "Together, our results for the first time identify a central role of p21 and p27 induction and their regulatory mechanism in silibinin-mediated cell cycle arrest.", "pmid_article": 17938263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1575634, "V1": 27617, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1855, "end_pos": 1864, "entity_type": "chemical_entity_p", "entity_pmid": 17938263, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }] }, { "pmid": "15476849", "peso_rules": "1.0", "peso_entities": "0.59", "peso_genes": "0.0", "peso_final": 20.6, "article": { "id": 74721, "title_article": "A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.", "abstract_article": "There are many epigenetic variables that affect the biological responses of autocrine, paracrine and endocrine regulatory molecules, which determine the growth and development of different cancers including prostate cancer (PCA). One of the focuses of the current cancer chemoprevention studies is the search for non-toxic chemopreventive agents that inhibit mitogenic and cell survival signaling in cancer cells. In general, advanced stage cancer cells harbor many constitutively active mitogenic signaling and anti-apoptotic mechanisms, which make them less dependent on external growth factors as well as resistant to chemotherapeutic agents. In this regard, silibinin (a naturally occurring flavanone) has shown the pleiotropic anticancer effects in different cancer cells. Our extensive studies with PCA have shown that inhibition of mitogenic and cell survival signaling, such as epidermal growth factor receptor, insulin-like growth factor receptor type I and nuclear factor kappa B signaling are the most likely molecular targets of silibinin's efficacy in PCA. We have observed that silibinin inhibits prostate tumor growth in animal models without any apparent signs of toxicity. At the same time, silibinin is also physiologically available in different organs of the body including plasma and prostate, which is generally required for the pharmacological dosing and translational mechanistic studies of the compound. There are substantial amount of data to support the inhibitory effect of silibinin on mitogenic and cell survival signaling in PCA, which are reviewed in the present communication.", "pmid": 15476849, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9950845, "FORESTS_PROB": 0.87666667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999994, "med": 0.96793765 }, "rule": [{ "id": 253723, "sentence_id": "154768491", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "103", "sentence": "A D&S r chemopreventive agent CH& n, targets mitogenic and survival signaling in D&S r.", "original_sentence": "A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 13, "peso_genes": 0, "entitiesRules": [{ "id": 1574033, "V1": 26016, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 31, "end_pos": 40, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574032, "V1": 26015, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 2, "end_pos": 8, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574034, "V1": 26017, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 86, "end_pos": 101, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253724, "sentence_id": "15476849749", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "749", "end_pos": "880", "sentence": "In this regard, CH& (a naturally occurring CH& ) has shown the pleiotropic anticancer effects in different D&S cells.", "original_sentence": "In this regard, silibinin (a naturally occurring flavanone) has shown the pleiotropic anticancer effects in different cancer cells.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1574041, "V1": 26024, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 765, "end_pos": 774, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574043, "V1": 26026, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 867, "end_pos": 873, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253725, "sentence_id": "15476849881", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "881", "end_pos": "1172", "sentence": "Our extensive studies with D&S have shown that inhibition of mitogenic and cell survival signaling, such as G&N, insulin-like growth factor receptor type I and nuclear factor kappa B signaling are the most likely molecular targets of CH& 's efficacy in D&S.", "original_sentence": "Our extensive studies with PCA have shown that inhibition of mitogenic and cell survival signaling, such as epidermal growth factor receptor, insulin-like growth factor receptor type I and nuclear factor kappa B signaling are the most likely molecular targets of silibinin's efficacy in PCA.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 7, "peso_genes": 3, "entitiesRules": [{ "id": 1574046, "V1": 26029, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1144, "end_pos": 1153, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574044, "V1": 26027, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 908, "end_pos": 911, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574047, "V1": 26030, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1168, "end_pos": 1171, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253726, "sentence_id": "154768491173", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1173", "end_pos": "1292", "sentence": "We have observed that CH& inhibits D&S growth in animal models without any apparent signs of toxicity.", "original_sentence": "We have observed that silibinin inhibits prostate tumor growth in animal models without any apparent signs of toxicity.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1574048, "V1": 26031, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1195, "end_pos": 1204, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574049, "V1": 26032, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1214, "end_pos": 1228, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253727, "sentence_id": "154768491293", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1293", "end_pos": "1531", "sentence": "At the same time, CH& is also physiologically available in different organs of the body including plasma and prostate, which is generally required for the pharmacological dosing and translational mechanistic studies of the compound.", "original_sentence": "At the same time, silibinin is also physiologically available in different organs of the body including plasma and prostate, which is generally required for the pharmacological dosing and translational mechanistic studies of the compound.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1574050, "V1": 26033, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1311, "end_pos": 1320, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 253728, "sentence_id": "154768491532", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1532", "end_pos": "1712", "sentence": "There are substantial amount of data to support the inhibitory effect of CH& on mitogenic and cell survival signaling in D&S, which are reviewed in the present communication.", "original_sentence": "There are substantial amount of data to support the inhibitory effect of silibinin on mitogenic and cell survival signaling in PCA, which are reviewed in the present communication.", "pmid_article": 15476849, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1574051, "V1": 26034, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1605, "end_pos": 1614, "entity_type": "chemical_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1574052, "V1": 26035, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1659, "end_pos": 1662, "entity_type": "cancer_type_entity_p", "entity_pmid": 15476849, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }] }, { "pmid": "11059749", "peso_rules": "1.0", "peso_entities": "0.69", "peso_genes": "0.0", "peso_final": 20.3, "article": { "id": 61861, "title_article": "Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.", "abstract_article": "Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effects against various malignant cell lines, but the underlying mechanism of action remains to be elucidated. We investigated the effect of silibinin on androgen-independent prostate cancer PC-3 cells. At pharmacologically achievable silibinin concentrations (0.02-20 microM), we observed increased insulin-like growth factor-binding protein 3 (IGFBP-3) accumulation in PC-3 cell conditioned medium and a dose-dependent increase of IGFBP-3 mRNA abundance with a 9-fold increase over baseline at 20 microM silibinin. An IGFBP-3 antisense oligodeoxynucleotide that attenuated silibinin-induced IGFBP-3 gene expression and protein accumulation reduced the antiproliferative action of silibinin. We also observed that silibinin reduced insulin receptor substrate 1 tyrosine phosphorylation, indicating an inhibitory effect on the insulin-like growth factor I receptor-mediated signaling pathway. These results suggest a novel mechanism by which silibinin acts as an antiproliferative agent and justify further work to investigate potential use of this compound or its derivatives in prostate cancer treatment and prevention.", "pmid": 11059749, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9929756, "FORESTS_PROB": 0.95, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999225, "med": 0.985742 }, "rule": [{ "id": 223493, "sentence_id": "110597491", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "153", "sentence": "CH& up-regulates G&N 3 expression and inhibits proliferation of androgen-independent D&S r cells.", "original_sentence": "Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 13, "peso_genes": 3, "entitiesRules": [{ "id": 1410180, "V1": 56936, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410182, "V1": 56938, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 130, "end_pos": 145, "entity_type": "cancer_type_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223494, "sentence_id": "11059749153", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "153", "end_pos": "402", "sentence": "CH&, a naturally occurring CH& antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effects against various malignant cell lines, but the underlying mechanism of action remains to be elucidated.", "original_sentence": "Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effects against various malignant cell lines, but the underlying mechanism of action remains to be elucidated.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1410183, "V1": 56939, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 153, "end_pos": 162, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223495, "sentence_id": "11059749403", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "403", "end_pos": "494", "sentence": "We investigated the effect of CH& on androgen-independent D&S D&S cells.", "original_sentence": "We investigated the effect of silibinin on androgen-independent prostate cancer PC-3 cells.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1410185, "V1": 56941, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 433, "end_pos": 442, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410186, "V1": 56942, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 467, "end_pos": 482, "entity_type": "cancer_type_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410187, "V1": 56943, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 483, "end_pos": 487, "entity_type": "cancer_type_entity_cell", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223496, "sentence_id": "11059749555", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "555", "end_pos": "808", "sentence": "02-20 microM), we observed increased G&N ( G&N ) accumulation in D&S cell conditioned medium and a dose-dependent increase of G&N mRNA abundance with a 9-fold increase over baseline at 20 microM CH& .", "original_sentence": "02-20 microM), we observed increased insulin-like growth factor-binding protein 3 (IGFBP-3) accumulation in PC-3 cell conditioned medium and a dose-dependent increase of IGFBP-3 mRNA abundance with a 9-fold increase over baseline at 20 microM silibinin.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1410193, "V1": 56949, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 798, "end_pos": 807, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410191, "V1": 56947, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 663, "end_pos": 667, "entity_type": "cancer_type_entity_cell", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223497, "sentence_id": "11059749809", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "809", "end_pos": "984", "sentence": "An G&N antisense oligodeoxynucleotide that attenuated CH& -induced G&N gene expression and protein accumulation reduced the antiproliferative action of CH& .", "original_sentence": "An IGFBP-3 antisense oligodeoxynucleotide that attenuated silibinin-induced IGFBP-3 gene expression and protein accumulation reduced the antiproliferative action of silibinin.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1410195, "V1": 56951, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 867, "end_pos": 876, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410197, "V1": 56953, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 974, "end_pos": 983, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223498, "sentence_id": "11059749985", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "985", "end_pos": "1184", "sentence": "We also observed that CH& reduced G&N tyrosine phosphorylation, indicating an inhibitory effect on the insulin-like growth factor I receptor-mediated signaling pathway.", "original_sentence": "We also observed that silibinin reduced insulin receptor substrate 1 tyrosine phosphorylation, indicating an inhibitory effect on the insulin-like growth factor I receptor-mediated signaling pathway.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1410198, "V1": 56954, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1007, "end_pos": 1016, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223499, "sentence_id": "110597491185", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "sim", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1185", "end_pos": "1413", "sentence": "These results suggest a novel mechanism by which CH& acts as an antiproliferative agent and justify further work to investigate potential use of this compound or its derivatives in D&S treatment and prevention.", "original_sentence": "These results suggest a novel mechanism by which silibinin acts as an antiproliferative agent and justify further work to investigate potential use of this compound or its derivatives in prostate cancer treatment and prevention.", "pmid_article": 11059749, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 8, "peso_genes": 0, "entitiesRules": [{ "id": 1410200, "V1": 56956, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1234, "end_pos": 1243, "entity_type": "chemical_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410201, "V1": 56957, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1372, "end_pos": 1387, "entity_type": "cancer_type_entity_p", "entity_pmid": 11059749, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }] }, { "pmid": "14965263", "peso_rules": "1.0", "peso_entities": "0.68", "peso_genes": "0.0", "peso_final": 20, "article": { "id": 76451, "title_article": "Prostate cancer prevention by silibinin.", "abstract_article": "Several epigenetic alterations leading to constitutively active mitogenic and cell-survival signaling, and loss of apoptotic response are causally involved in self-sufficiency of prostate cancer (PCA) cells toward uncontrolled growth, and increased secretion of pro-angiogenic factors. Therefore, one targeted approach for PCA prevention, growth control and/or treatment could be inhibition of epigenetic molecular events involved in PCA growth, progression and angiogenesis. In this regard, silibinin/silymarin (silibinin is the major active compound in silymarin) has shown promising efficacy. Our extensive studies with silibinin/silymarin and PCA cells have shown the pleiotropic anticancer effects leading to cell growth inhibition in culture and nude mice. The underlying mechanisms of silibinin/silymarin efficacy against PCA involve alteration in cell cycle progression, and inhibition of mitogenic and cell survival signaling, such as epidermal growth factor receptor, insulin-like growth factor receptor type I and nuclear factor kappa B signaling. Silibinin also synergizes the therapeutic effects of doxorubicin in PCA cells, making it a strong candidate for combination chemotherapy. Silibinin/ silymarin also inhibits the secretion of proangiogenic factors from tumor cells, and causes growth inhibition and apoptotic death of endothelial cells accompanied by disruption of capillary tube formation on Matrigel. More importantly, silibinin inhibits the growth of in vivo advanced human prostate tumor xenograft in nude mice. Recently, due to its non-toxic and mechanism-based strong preventive/therapeutic efficacy, silibinin has entered in phase I clinical trial in prostate cancer patients.", "pmid": 14965263, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9998486, "FORESTS_PROB": 0.88, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9699622 }, "rule": [{ "id": 250750, "sentence_id": "14965263517", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "517", "end_pos": "636", "sentence": "In this regard, CH& /silymarin ( CH& is the major active compound in silymarin) has shown promising efficacy.", "original_sentence": "In this regard, silibinin/silymarin (silibinin is the major active compound in silymarin) has shown promising efficacy.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1558890, "V1": 10873, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 533, "end_pos": 542, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558891, "V1": 10874, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 554, "end_pos": 563, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250751, "sentence_id": "14965263637", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "637", "end_pos": "803", "sentence": "Our extensive studies with CH& /silymarin and D&S cells have shown the pleiotropic anticancer effects leading to cell growth inhibition in culture and nude mice.", "original_sentence": "Our extensive studies with silibinin/silymarin and PCA cells have shown the pleiotropic anticancer effects leading to cell growth inhibition in culture and nude mice.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 8, "peso_genes": 1, "entitiesRules": [{ "id": 1558892, "V1": 10875, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 664, "end_pos": 673, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558893, "V1": 10876, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 688, "end_pos": 691, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250752, "sentence_id": "14965263804", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "804", "end_pos": "1099", "sentence": "The underlying mechanisms of CH& /silymarin efficacy against D&S involve alteration in cell cycle progression, and inhibition of mitogenic and cell survival signaling, such as G&N, insulin-like growth factor receptor type I and nuclear factor kappa B signaling.", "original_sentence": "The underlying mechanisms of silibinin/silymarin efficacy against PCA involve alteration in cell cycle progression, and inhibition of mitogenic and cell survival signaling, such as epidermal growth factor receptor, insulin-like growth factor receptor type I and nuclear factor kappa B signaling.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 3, "entitiesRules": [{ "id": 1558894, "V1": 10877, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 833, "end_pos": 842, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558895, "V1": 10878, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 870, "end_pos": 873, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250753, "sentence_id": "149652631100", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1100", "end_pos": "1237", "sentence": "CH& also synergizes the therapeutic effects of doxorubicin in D&S cells, making it a strong candidate for combination chemotherapy.", "original_sentence": "Silibinin also synergizes the therapeutic effects of doxorubicin in PCA cells, making it a strong candidate for combination chemotherapy.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1558897, "V1": 10880, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1100, "end_pos": 1109, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558898, "V1": 10881, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1168, "end_pos": 1171, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250754, "sentence_id": "149652631238", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "sim", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1238", "end_pos": "1466", "sentence": "CH& / CH& also inhibits the secretion of proangiogenic factors from D&S cells, and causes growth inhibition and apoptotic death of endothelial cells accompanied by disruption of capillary tube formation on Matrigel.", "original_sentence": "Silibinin/ silymarin also inhibits the secretion of proangiogenic factors from tumor cells, and causes growth inhibition and apoptotic death of endothelial cells accompanied by disruption of capillary tube formation on Matrigel.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 9, "peso_genes": 1, "entitiesRules": [{ "id": 1558899, "V1": 10882, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1238, "end_pos": 1247, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558901, "V1": 10884, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1317, "end_pos": 1322, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250755, "sentence_id": "149652631467", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1467", "end_pos": "1579", "sentence": "More importantly, CH& inhibits the growth of in vivo advanced human D&S xenograft in nude mice.", "original_sentence": "More importantly, silibinin inhibits the growth of in vivo advanced human prostate tumor xenograft in nude mice.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1558902, "V1": 10885, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1485, "end_pos": 1494, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558903, "V1": 10886, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1541, "end_pos": 1555, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250756, "sentence_id": "149652631580", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1580", "end_pos": "1747", "sentence": "Recently, due to its non-toxic and mechanism-based strong preventive/therapeutic efficacy, CH& has entered in phase I clinical trial in D&S patients.", "original_sentence": "Recently, due to its non-toxic and mechanism-based strong preventive/therapeutic efficacy, silibinin has entered in phase I clinical trial in prostate cancer patients.", "pmid_article": 14965263, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1558904, "V1": 10887, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1671, "end_pos": 1680, "entity_type": "chemical_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1558905, "V1": 10888, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1722, "end_pos": 1737, "entity_type": "cancer_type_entity_p", "entity_pmid": 14965263, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }] }, { "pmid": "15486995", "peso_rules": "1.0", "peso_entities": "0.55", "peso_genes": "0.0", "peso_final": 18.7, "article": { "id": 76647, "title_article": "Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.", "abstract_article": "Phytoestrogens may reduce tumorigenesis in prostate cancer. We screened five phytoestrogens for their effect on cell growth and apoptosis in PWR-1E, LNCaP, PC-3, and DU145 prostate epithelial cells in vitro. We assessed cell number, proliferation, and apoptosis using crystal violet assays, flow cytometric analysis, and TUNEL. Focusing specifically on apigenin we assessed the ability of calpain, serine protease, caspase, estrogen receptor, and ceramide synthase inhibitors to block apigenin induced apoptosis. We also analyzed caspase 3, 7, 8, 9, Bcl-2, Bax, Bid, and cytochrome C by Western analysis, and mitochondrial permeability and reactive oxygen species production by flow cytometry using mitosensor(TM) and DCFH-DA, respectively. Apigenin and silybinin significantly reduced cell number, with apigenin inducing apoptosis in PWR-1E, LNCaP, PC-3, and DU145 cells. The PC-3 and DU145 cells were less susceptible to apigenin induced apoptosis then LNCaP and PWR-1E cells. The induction of apoptosis by apigenin was caspase dependent. Apigenin generated reactive oxygen species, a loss of mitochondrial Bcl-2 expression, mitochondrial permeability, cytochrome C release, and the cleavage of caspase 3, 7, 8, and 9 and the concomitant cleavage of the inhibitor of apoptosis protein, cIAP-2. The overexpression of Bcl-2 in LNCaP B10 cells reduced the apoptotic effects of apigenin. Apigenin induces cell death in prostate epithelial cells using a mitochondrial mediated cell death pathway. Bcl-2 has a role in inhibiting apigenin induced cell death in prostate epithelial cells. ", "pmid": 15486995, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99990124, "FORESTS_PROB": 0.97333336, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.99330866 }, "rule": [{ "id": 209271, "sentence_id": "154869951", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "nao", "start_pos": "1", "end_pos": "146", "sentence": "CH& drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.", "original_sentence": "Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 11, "peso_genes": 0, "entitiesRules": [] }, { "id": 209272, "sentence_id": "15486995495", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "495", "end_pos": "679", "sentence": "Focusing specifically on CH& we assessed the ability of calpain, G&N, caspase, G&N, and ceramide synthase inhibitors to block CH& induced apoptosis.", "original_sentence": "Focusing specifically on apigenin we assessed the ability of calpain, serine protease, caspase, estrogen receptor, and ceramide synthase inhibitors to block apigenin induced apoptosis.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 209273, "sentence_id": "15486995908", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "908", "end_pos": "1048", "sentence": "RESULTS: CH& and CH& significantly reduced cell number, with CH& inducing apoptosis in PWR-1E, D&S, PC-3, and DU145 cells.", "original_sentence": "RESULTS: Apigenin and silybinin significantly reduced cell number, with apigenin inducing apoptosis in PWR-1E, LNCaP, PC-3, and DU145 cells.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1332967, "V1": 26996, "pubtatot_term": "silybinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 930, "end_pos": 939, "entity_type": "chemical_entity_p", "entity_pmid": 15486995, "created_at": "2020-10-31T14:42:02.226Z", "updated_at": "2020-10-31T14:42:02.226Z" }, { "id": 1332969, "V1": 26998, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 1019, "end_pos": 1024, "entity_type": "cancer_type_entity_cell", "entity_pmid": 15486995, "created_at": "2020-10-31T14:42:02.226Z", "updated_at": "2020-10-31T14:42:02.226Z" }] }, { "id": 209274, "sentence_id": "154869951049", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1049", "end_pos": "1154", "sentence": "The PC-3 and DU145 cells were less susceptible to CH& induced apoptosis then D&S and PWR-1E cells.", "original_sentence": "The PC-3 and DU145 cells were less susceptible to apigenin induced apoptosis then LNCaP and PWR-1E cells.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1332971, "V1": 27000, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 1131, "end_pos": 1136, "entity_type": "cancer_type_entity_cell", "entity_pmid": 15486995, "created_at": "2020-10-31T14:42:02.226Z", "updated_at": "2020-10-31T14:42:02.226Z" }] }, { "id": 209275, "sentence_id": "154869951155", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1155", "end_pos": "1216", "sentence": "The induction of apoptosis by CH& was caspase dependent.", "original_sentence": "The induction of apoptosis by apigenin was caspase dependent.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 209276, "sentence_id": "154869951217", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1217", "end_pos": "1471", "sentence": "CH& generated reactive oxygen species, a loss of mitochondrial G&N expression, mitochondrial permeability, G&N release, and the cleavage of caspase 3, 7, 8, and 9 and the concomitant cleavage of the inhibitor of apoptosis protein, G&N .", "original_sentence": "Apigenin generated reactive oxygen species, a loss of mitochondrial Bcl-2 expression, mitochondrial permeability, cytochrome C release, and the cleavage of caspase 3, 7, 8, and 9 and the concomitant cleavage of the inhibitor of apoptosis protein, cIAP-2.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 209277, "sentence_id": "154869951472", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1472", "end_pos": "1561", "sentence": "The overexpression of G&N in LNCaP B10 cells reduced the apoptotic effects of CH& .", "original_sentence": "The overexpression of Bcl-2 in LNCaP B10 cells reduced the apoptotic effects of apigenin.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }, { "id": 209278, "sentence_id": "154869951562", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1562", "end_pos": "1682", "sentence": "CONCLUSIONS: CH& induces cell death in prostate epithelial cells using a mitochondrial mediated cell death pathway.", "original_sentence": "CONCLUSIONS: Apigenin induces cell death in prostate epithelial cells using a mitochondrial mediated cell death pathway.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 6, "peso_genes": 0, "entitiesRules": [] }, { "id": 209279, "sentence_id": "154869951683", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1683", "end_pos": "1771", "sentence": "G&N has a role in inhibiting CH& induced cell death in prostate epithelial cells.", "original_sentence": "Bcl-2 has a role in inhibiting apigenin induced cell death in prostate epithelial cells.", "pmid_article": 15486995, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }] }, { "pmid": "29755557", "peso_rules": "1.0", "peso_entities": "0.37", "peso_genes": "0.0", "peso_final": 18.5, "article": { "id": 76475, "title_article": "Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.", "abstract_article": "Human hepatocellular carcinoma is one of the most common recurrent malignancies since there is no effective therapy for it. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anti-cancer effects on human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon cancer cells. Considering the anti-hepatotoxic activity of silibinin and its strong preventive and anti-cancer efficacy against various epithelial cancers, we investigated the efficacy of silibinin against human HCC and HUVEC cell lines. Silibinin effects on the growth and mode of cell death of these two cell lines are presented in this paper. HepG2 and HUVEC cells were incubated with different doses of silibinin (12.5, 25, 50, 100, 150 and 200 μg/mL) at 24, 48, and 72 h. Cytotoxicity was assessed using MTT and Trypan blue assays. Mode of cell death induced by silibinin was investigated using LDH assay and acridine orange/PI double dye staining. The results showed that silibinin has dose-dependent inhibitory effect on the viability of HepG2 and HUVEC cells. However, Silibinin causes a more continuous dose-dependent cytotoxicity in HepG2 cells compared to the HUVEC cells in which some degrees of resistance is apparent at the beginning. The mode of cell death looks also different in these two cell lines with HepG2 cells being more in favor of apoptosis while necrosis is more evident for the HUVEC cells.", "pmid": 29755557, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99973375, "FORESTS_PROB": 0.95, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.98743343 }, "rule": [{ "id": 220133, "sentence_id": "297555571", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "154", "sentence": "Evaluation of CH& n Effects on the Viability of D&S 2 (Human D&S a) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.", "original_sentence": "Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1392146, "V1": 38902, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 14, "end_pos": 23, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392147, "V1": 38903, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 52, "end_pos": 57, "entity_type": "cancer_type_entity_cell", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392148, "V1": 38904, "pubtatot_term": "hepatocellular liver carcinoma", "db_term": "Hepatocellular carcinoma", "db_equivalence": "Hepatocellular carcinoma", "mesh_id": "D006528", "term_id": "230098", "start_pos": 65, "end_pos": 95, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220134, "sentence_id": "29755557278", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "278", "end_pos": "552", "sentence": "CH&, a widely used drug and supplement for various liver disorders, demonstrated anti- D&S effects on human D&S, human D&S cells, human D&S cells, human ectocervical D&S cells, and human D&S cells.", "original_sentence": "Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anti-cancer effects on human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon cancer cells.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1392150, "V1": 38906, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 278, "end_pos": 287, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392151, "V1": 38907, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 370, "end_pos": 376, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392152, "V1": 38908, "pubtatot_term": "hepatocellular carcinoma", "db_term": "Hepatocellular carcinoma", "db_equivalence": "Hepatocellular carcinoma", "mesh_id": "D006528", "term_id": "230098", "start_pos": 394, "end_pos": 418, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392153, "V1": 38909, "pubtatot_term": "prostate adenocarcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 426, "end_pos": 449, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392154, "V1": 38910, "pubtatot_term": "breast carcinoma", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 463, "end_pos": 479, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392155, "V1": 38911, "pubtatot_term": "carcinoma", "db_term": "Carcinoma", "db_equivalence": "Carcinoma", "mesh_id": "D002277", "term_id": "3224", "start_pos": 506, "end_pos": 515, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392156, "V1": 38912, "pubtatot_term": "colon cancer", "db_term": "Colorectal Cancer", "db_equivalence": "Colorectal Cancer", "mesh_id": "D015179", "term_id": "15585", "start_pos": 533, "end_pos": 545, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220135, "sentence_id": "29755557553", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "553", "end_pos": "776", "sentence": "Considering the anti-hepatotoxic activity of CH& and its strong preventive and anti- D&S efficacy against various epithelial D&S, we investigated the efficacy of CH& against human HCC and HUVEC cell lines.", "original_sentence": "Considering the anti-hepatotoxic activity of silibinin and its strong preventive and anti-cancer efficacy against various epithelial cancers, we investigated the efficacy of silibinin against human HCC and HUVEC cell lines.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 6, "peso_genes": 0, "entitiesRules": [{ "id": 1392157, "V1": 38913, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 598, "end_pos": 607, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392160, "V1": 38916, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 727, "end_pos": 736, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392158, "V1": 38914, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 643, "end_pos": 649, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392159, "V1": 38915, "pubtatot_term": "cancers", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 686, "end_pos": 693, "entity_type": "cancer_type_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220136, "sentence_id": "29755557777", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "777", "end_pos": "884", "sentence": "CH& effects on the growth and mode of cell death of these two cell lines are presented in this paper.", "original_sentence": "Silibinin effects on the growth and mode of cell death of these two cell lines are presented in this paper.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1392161, "V1": 38917, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 777, "end_pos": 786, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220137, "sentence_id": "29755557885", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "885", "end_pos": "960", "sentence": "D&S and HUVEC cells were incubated with different doses of CH& (12.", "original_sentence": "HepG2 and HUVEC cells were incubated with different doses of silibinin (12.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1392163, "V1": 38919, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 946, "end_pos": 955, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392162, "V1": 38918, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 885, "end_pos": 890, "entity_type": "cancer_type_entity_cell", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220138, "sentence_id": "297555571077", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "sim", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1077", "end_pos": "1193", "sentence": "Mode of cell death induced by CH& was investigated using LDH assay and acridine orange/PI double dye staining.", "original_sentence": "Mode of cell death induced by silibinin was investigated using LDH assay and acridine orange/PI double dye staining.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1392164, "V1": 38920, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1107, "end_pos": 1116, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220139, "sentence_id": "297555571194", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1194", "end_pos": "1307", "sentence": "The results showed that CH& has dose-dependent inhibitory effect on the viability of D&S and HUVEC cells.", "original_sentence": "The results showed that silibinin has dose-dependent inhibitory effect on the viability of HepG2 and HUVEC cells.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 8, "peso_genes": 3, "entitiesRules": [{ "id": 1392165, "V1": 38921, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1218, "end_pos": 1227, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392166, "V1": 38922, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 1285, "end_pos": 1290, "entity_type": "cancer_type_entity_cell", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }, { "id": 220140, "sentence_id": "297555571308", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1308", "end_pos": "1488", "sentence": "However, CH& causes a more continuous dose-dependent cytotoxicity in D&S cells compared to the HUVEC cells in which some degrees of resistance is apparent at the beginning.", "original_sentence": "However, Silibinin causes a more continuous dose-dependent cytotoxicity in HepG2 cells compared to the HUVEC cells in which some degrees of resistance is apparent at the beginning.", "pmid_article": 29755557, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1392167, "V1": 38923, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1317, "end_pos": 1326, "entity_type": "chemical_entity_p", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }, { "id": 1392168, "V1": 38924, "pubtatot_term": "HepG2", "db_term": "Liver Cancer", "db_equivalence": "hepg-2", "mesh_id": "D008113", "term_id": "506", "start_pos": 1383, "end_pos": 1388, "entity_type": "cancer_type_entity_cell", "entity_pmid": 29755557, "created_at": "2020-10-31T14:46:37.190Z", "updated_at": "2020-10-31T14:46:37.190Z" }] }] }, { "pmid": "27405931", "peso_rules": "1.0", "peso_entities": "0.70", "peso_genes": "0.0", "peso_final": 18.4, "article": { "id": 76509, "title_article": "Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis.", "abstract_article": "Silibinin, a biologically active compound of milk thistle, has chemopreventive effects on cancer cell lines. Recently it was reported that silibinin inhibited tumor growth through activation of the apoptotic signaling pathway. Although various evidences showed multiple signaling pathways of silibinin in apoptosis, there were no reports to address the clear mechanism of ROS-mediated pathway in prostate cancer PC-3 cells. Several studies suggested that reactive oxygen species (ROS) play an important role in various signaling cascades, but the primary source of ROS was currently unclear. The effect of silibinin was investigated on cell growth of prostate cell lines by MTT assay. We examined whether silibinin induced apoptosis through production of ROS using flow cytometry. Expression of apoptosis-, endoplasmic reticulum (ER)-related protein and gene were determined by western blotting and RT-PCR, respectively. Results showed that silibinin triggered mitochondrial ROS production through NOX4 expression and finally led to induce apoptosis. In addition, mitochondrial ROS caused ER stress through disruption of Ca(2+) homeostasis. Co-treatment of ROS inhibitor reduced the silibinin-induced apoptosis through the inhibition of NOX4 expression, resulting in reduction of both Ca(2+) level and ER stress response. Taken together, silibinin induced mitochondrial ROS-dependent apoptosis through NOX4, which is associated with disruption of Ca(2+) homeostasis and ER stress response. Therefore, the regulation of NOX4, mitochondrial ROS producer, could be a potential target for the treatment of prostate cancer.", "pmid": 27405931, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99974567, "FORESTS_PROB": 0.9633333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.99076974 }, "rule": [{ "id": 213561, "sentence_id": "274059311", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "114", "sentence": "CH& induces mitochondrialG&N 4-mediated endoplasmic reticulum stress response and its subsequent apoptosis.", "original_sentence": "Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 7, "peso_genes": 1, "entitiesRules": [{ "id": 1356187, "V1": 2943, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213562, "sentence_id": "27405931114", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "114", "end_pos": "234", "sentence": "BACKGROUND: CH&, a biologically active compound of milk thistle, has chemopreventive effects on D&S cell lines.", "original_sentence": "BACKGROUND: Silibinin, a biologically active compound of milk thistle, has chemopreventive effects on cancer cell lines.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 4, "peso_genes": 1, "entitiesRules": [{ "id": 1356189, "V1": 2945, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 126, "end_pos": 135, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1356190, "V1": 2946, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 216, "end_pos": 222, "entity_type": "cancer_type_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213563, "sentence_id": "27405931235", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "235", "end_pos": "352", "sentence": "Recently it was reported that CH& inhibited D&S growth through activation of the apoptotic signaling pathway.", "original_sentence": "Recently it was reported that silibinin inhibited tumor growth through activation of the apoptotic signaling pathway.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1356191, "V1": 2947, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 265, "end_pos": 274, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1356192, "V1": 2948, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 285, "end_pos": 290, "entity_type": "cancer_type_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213564, "sentence_id": "27405931353", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "353", "end_pos": "549", "sentence": "Although various evidences showed multiple signaling pathways of CH& in apoptosis, there were no reports to address the clear mechanism of ROS-mediated pathway in D&S D&S cells.", "original_sentence": "Although various evidences showed multiple signaling pathways of silibinin in apoptosis, there were no reports to address the clear mechanism of ROS-mediated pathway in prostate cancer PC-3 cells.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1356193, "V1": 2949, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 418, "end_pos": 427, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1356194, "V1": 2950, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 522, "end_pos": 537, "entity_type": "cancer_type_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1356195, "V1": 2951, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 538, "end_pos": 542, "entity_type": "cancer_type_entity_cell", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213565, "sentence_id": "27405931718", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "718", "end_pos": "819", "sentence": "METHODS: The effect of CH& was investigated on cell growth of prostate cell lines by MTT assay.", "original_sentence": "METHODS: The effect of silibinin was investigated on cell growth of prostate cell lines by MTT assay.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1356196, "V1": 2952, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 741, "end_pos": 750, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213566, "sentence_id": "27405931820", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "820", "end_pos": "915", "sentence": "We examined whether CH& induced apoptosis through production of ROS using flow cytometry.", "original_sentence": "We examined whether silibinin induced apoptosis through production of ROS using flow cytometry.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1356197, "V1": 2953, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 840, "end_pos": 849, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213567, "sentence_id": "274059311056", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1056", "end_pos": "1194", "sentence": "RESULTS: Results showed that CH& triggered mitochondrial ROS production through G&N expression and finally led to induce apoptosis.", "original_sentence": "RESULTS: Results showed that silibinin triggered mitochondrial ROS production through NOX4 expression and finally led to induce apoptosis.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1356198, "V1": 2954, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1085, "end_pos": 1094, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213568, "sentence_id": "274059311285", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1285", "end_pos": "1465", "sentence": "Co-treatment of ROS inhibitor reduced the CH& -induced apoptosis through the inhibition of G&N expression, resulting in reduction of both Ca(2_) level and ER stress response.", "original_sentence": "Co-treatment of ROS inhibitor reduced the silibinin-induced apoptosis through the inhibition of NOX4 expression, resulting in reduction of both Ca(2+) level and ER stress response.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1356200, "V1": 2956, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1327, "end_pos": 1336, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 213569, "sentence_id": "274059311466", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1466", "end_pos": "1646", "sentence": "CONCLUSIONS: Taken together, CH& induced mitochondrial ROS-dependent apoptosis through G&N, which is associated with disruption of Ca(2_) homeostasis and ER stress response.", "original_sentence": "CONCLUSIONS: Taken together, silibinin induced mitochondrial ROS-dependent apoptosis through NOX4, which is associated with disruption of Ca(2+) homeostasis and ER stress response.", "pmid_article": 27405931, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1356202, "V1": 2958, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1495, "end_pos": 1504, "entity_type": "chemical_entity_p", "entity_pmid": 27405931, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }] }, { "pmid": "27533043", "peso_rules": "0.15", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 18.2, "article": { "id": 55760, "title_article": "Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.", "abstract_article": "Hypoxia is associated with aggressive phenotype and poor prognosis in prostate cancer (PCa) patients suggesting that PCa growth and progression could be controlled via targeting hypoxia-induced signaling and biological effects. Here, we analyzed silibinin (a natural flavonoid) efficacy to target cell growth, angiogenesis, and metabolic changes in human PCa, LNCaP, and 22Rv1 cells under hypoxic condition. Silibinin treatment inhibited the proliferation, clonogenicity, and endothelial cells tube formation by hypoxic (1% O2 ) PCa cells. Interestingly, hypoxia promoted a lipogenic phenotype in PCa cells via activating acetyl-Co A carboxylase (ACC) and fatty acid synthase (FASN) that was inhibited by silibinin treatment. Importantly, silibinin treatment strongly decreased hypoxia-induced HIF-1α expression in PCa cells together with a strong reduction in hypoxia-induced NADPH oxidase (NOX) activity. HIF-1α overexpression in LNCaP cells significantly increased the lipid accumulation and NOX activity; however, silibinin treatment reduced HIF-1α expression, lipid levels, clonogenicity, and NOX activity even in HIF-1α overexpressing LNCaP cells. In vivo, silibinin feeding (200 mg/kg body weight) to male nude mice with 22Rv1 tumors, specifically inhibited tumor vascularity (measured by dynamic contrast-enhanced MRI) resulting in tumor growth inhibition without directly inducing necrosis (as revealed by diffusion-weighted MRI). Silibinin feeding did not significantly affect tumor glucose uptake measured by FDG-PET; however, reduced the lipid synthesis measured by quantitative 1 H-NMR metabolomics. IHC analyses of tumor tissues confirmed that silibinin feeding decreased proliferation and angiogenesis as well as reduced HIF-1α, FASN, and ACC levels. Together, these findings further support silibinin usefulness against PCa through inhibiting hypoxia-induced signaling. © 2016 Wiley Periodicals, Inc. ", "pmid": 27533043, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9998695, "FORESTS_PROB": 0.8566667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.96413404 }, "rule": [{ "id": 304501, "sentence_id": "275330431", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "166", "sentence": "CH& inhibits hypoxia-induced G&N α-mediated signaling, angiogenesis and lipogenesis i D&S er cells: In vitro evidence and in vivo functional imaging and metabolomics.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1817145, "V1": 34958, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596693, "V1": 48676, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817147, "V1": 34960, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 94, "end_pos": 109, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596695, "V1": 48678, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 94, "end_pos": 109, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }, { "id": 304502, "sentence_id": "27533043403", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "403", "end_pos": "573", "sentence": "Here, we analyzed CH& n (a natural CH& d) efficacy to target cell growth, angiogenesis, and metabolic changes in humanD&Sa, LNCaP, and 22Rv1 cells under hypoxic condition.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1817151, "V1": 34964, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 430, "end_pos": 439, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596699, "V1": 48682, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 430, "end_pos": 439, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817153, "V1": 34966, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 539, "end_pos": 542, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596701, "V1": 48684, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 539, "end_pos": 542, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }, { "id": 304503, "sentence_id": "27533043894", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "894", "end_pos": "1312", "sentence": "Importantl CH& nin treatment strongly decreased hypoxia-induc G&N -1α expressionD&S PCa cells together with a strong reduction in hypoxia-induced NADPH oxidase (NOX) activi G&N F-1α overexpression in LNCaP cells significantly increased the lipid accumulation and NOX activity; howe CH& binin treatment red G&N IF-1α expression, lipid levels, clonogenicity, and NOX activity ev G&N HIF-1α overexpressing LNCaP cells.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1817160, "V1": 34973, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 923, "end_pos": 932, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1817164, "V1": 34977, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1202, "end_pos": 1211, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596708, "V1": 48691, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 923, "end_pos": 932, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1596712, "V1": 48695, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1202, "end_pos": 1211, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817162, "V1": 34975, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 999, "end_pos": 1002, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596710, "V1": 48693, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 999, "end_pos": 1002, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }, { "id": 304504, "sentence_id": "275330431313", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1313", "end_pos": "1764", "sentence": "In CH& libinin feeding (200 mg/kg body weight) to male nude mice wi D&S v1 tumors, specifically i D&S ted tumor vascularity (measured by dynamic contrast-enhanced MRI) resu D&S in tumor growth inhibition without directly inducing necrosis (as revealed by diffusion-weight CH& Silibinin feeding did not significantl D&S ect tumor glucose uptake measured by FDG-PET; however, reduced the lipid synthesis measured by quantitative (1) H-NMR metabolomics.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1817167, "V1": 34980, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1347, "end_pos": 1356, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1817172, "V1": 34985, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1624, "end_pos": 1633, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596715, "V1": 48698, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1347, "end_pos": 1356, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1596720, "V1": 48703, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1624, "end_pos": 1633, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817168, "V1": 34981, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1418, "end_pos": 1424, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1817169, "V1": 34982, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1449, "end_pos": 1454, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1817170, "V1": 34983, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1524, "end_pos": 1529, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1817173, "V1": 34986, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1671, "end_pos": 1676, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596716, "V1": 48699, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1418, "end_pos": 1424, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1596717, "V1": 48700, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1449, "end_pos": 1454, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1596718, "V1": 48701, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1524, "end_pos": 1529, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1596721, "V1": 48704, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1671, "end_pos": 1676, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }, { "id": 304505, "sentence_id": "275330431765", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1765", "end_pos": "1911", "sentence": "IHC ana D&S of tumor tissues confir CH& silibinin feeding decreased proliferation and angiogenesis as well as G&N edG&N -1α, FASN, and ACC levels.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1817175, "V1": 34988, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1844, "end_pos": 1853, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596723, "V1": 48706, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1844, "end_pos": 1853, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817174, "V1": 34987, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1815, "end_pos": 1820, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596722, "V1": 48705, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1815, "end_pos": 1820, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }, { "id": 304506, "sentence_id": "275330431912", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1912", "end_pos": "2025", "sentence": "Together, these findings furthe CH& silibinin usefulnesD&Sgainst PCa through inhibiting hypoxia-induced signaling.", "original_sentence": "NA", "pmid_article": 27533043, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1817178, "V1": 34991, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1993, "end_pos": 2002, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596726, "V1": 48709, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1993, "end_pos": 2002, "entity_type": "chemical_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }, { "id": 1817179, "V1": 34992, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2022, "end_pos": 2025, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:24:43.494Z", "updated_at": "2020-10-31T15:24:43.494Z" }, { "id": 1596727, "V1": 48710, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 2022, "end_pos": 2025, "entity_type": "cancer_type_entity_p", "entity_pmid": 27533043, "created_at": "2020-10-31T15:06:27.741Z", "updated_at": "2020-10-31T15:06:27.741Z" }] }] }, { "pmid": "24615813", "peso_rules": "0.16", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 17.8, "article": { "id": 76550, "title_article": "Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.", "abstract_article": "Tumor microenvironment (TM) is an essential element in prostate cancer (PCA), offering unique opportunities for its prevention. TM includes naïve fibroblasts that are recruited by nascent neoplastic lesion and altered into 'cancer-associated fibroblasts' (CAFs) that promote PCA. A better understanding and targeting of interaction between PCA cells and fibroblasts and inhibiting CAF phenotype through non-toxic agents are novel approaches to prevent PCA progression. One well-studied cancer chemopreventive agent is silibinin, and thus, we examined its efficacy against PCA cells-mediated differentiation of naïve fibroblasts into a myofibroblastic-phenotype similar to that found in CAFs. Silibinin's direct inhibitory effect on the phenotype of CAFs derived directly from PCA patients was also assessed. Human prostate stromal cells (PrSCs) exposed to control conditioned media (CCM) from human PCA PC3 cells showed more invasiveness, with increased alpha-smooth muscle actin (α-SMA) and vimentin expression, and differentiation into a phenotype we identified in CAFs. Importantly, silibinin (at physiologically achievable concentrations) inhibited α-SMA expression and invasiveness in differentiated fibroblasts and prostate CAFs directly, as well as indirectly by targeting PCA cells. The observed increase in α-SMA and CAF-like phenotype was transforming growth factor (TGF) β2 dependent, which was strongly inhibited by silibinin. Furthermore, induction of α-SMA and CAF phenotype by CCM were also strongly inhibited by a TGFβ2-neutralizing antibody. The inhibitory effect of silibinin on TGFβ2 expression and CAF-like biomarkers was also observed in PC3 tumors. Together, these findings highlight the potential usefulness of silibinin in PCA prevention through targeting the CAF phenotype in the prostate TM. ", "pmid": 24615813, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9481952, "FORESTS_PROB": 0.68333334, "LOGITBOOST_PROB": 0.99966466, "MAXENTROPY_PROB": 0.999884, "med": 0.9077693 }, "rule": [{ "id": 307262, "sentence_id": "246158131", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "133", "sentence": "CH& prevents D&S r cell-mediated differentiation of naïve fibroblasts int D&S er-associated fibroblast phenotype by targetin G&N β2.", "original_sentence": "NA", "pmid_article": 24615813, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1732628, "V1": 14843, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831186, "V1": 48999, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1732629, "V1": 14844, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 19, "end_pos": 34, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1732630, "V1": 14845, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 91, "end_pos": 97, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831187, "V1": 49000, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 19, "end_pos": 34, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1831188, "V1": 49001, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 91, "end_pos": 97, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }] }, { "id": 307263, "sentence_id": "24615813623", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "623", "end_pos": "951", "sentence": "One well-studi D&S cer chemopreventive agent CH& nin, and thus, we examined its efficacy againD&SPCA cells-mediated differentiation of naïve fibroblasts into a myofibroblastic-phenotype similar to that found in CA CH& inin's direct inhibitory effect on the phenotype of CAFs derived directly fD&S PCA patients was also assessed.", "original_sentence": "NA", "pmid_article": 24615813, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1732640, "V1": 14855, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 669, "end_pos": 678, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1732642, "V1": 14857, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 843, "end_pos": 852, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831198, "V1": 49011, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 669, "end_pos": 678, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1831200, "V1": 49013, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 843, "end_pos": 852, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1732639, "V1": 14854, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 637, "end_pos": 643, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1732641, "V1": 14856, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 723, "end_pos": 726, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1732643, "V1": 14858, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 927, "end_pos": 930, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831197, "V1": 49010, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 637, "end_pos": 643, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1831199, "V1": 49012, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 723, "end_pos": 726, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1831201, "V1": 49014, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 927, "end_pos": 930, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }] }, { "id": 307264, "sentence_id": "246158131720", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1720", "end_pos": "1823", "sentence": "The inhibitory CH& sil G&N n on TGFβ2 expression and CAF-like biomarkers was also obser D&S PC3 tumors.", "original_sentence": "NA", "pmid_article": 24615813, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1732656, "V1": 14871, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1735, "end_pos": 1744, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831214, "V1": 49027, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1735, "end_pos": 1744, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1732658, "V1": 14873, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1814, "end_pos": 1820, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831216, "V1": 49029, "pubtatot_term": "tumors", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1814, "end_pos": 1820, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }] }, { "id": 307265, "sentence_id": "246158131833", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1833", "end_pos": "1975", "sentence": "Together, these findings highlight the potential use CH& f siD&Sinin in PCA prevention through targeting the CAF phenotype in the prostate TM.", "original_sentence": "NA", "pmid_article": 24615813, "created_at": "2020-10-31T22:53:37.085Z", "updated_at": "2020-10-31T22:53:37.085Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1732659, "V1": 14874, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1885, "end_pos": 1894, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831217, "V1": 49030, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1885, "end_pos": 1894, "entity_type": "chemical_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }, { "id": 1732660, "V1": 14875, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1898, "end_pos": 1901, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1831218, "V1": 49031, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1898, "end_pos": 1901, "entity_type": "cancer_type_entity_p", "entity_pmid": 24615813, "created_at": "2020-10-31T15:25:43.268Z", "updated_at": "2020-10-31T15:25:43.268Z" }] }] }, { "pmid": "12866029", "peso_rules": "1.0", "peso_entities": "0.60", "peso_genes": "0.0", "peso_final": 17.5, "article": { "id": 76656, "title_article": "Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.", "abstract_article": "In several recent studies, we have shown that silibinin inhibits the growth of human prostate cancer cells (PCA) both in vitro and in vivo. Here, we investigated the effect of silibinin in combination with cisplatin and carboplatin on human PCA DU145 cell growth and apoptosis. Cisplatin alone at 2 microg/ml dose produced 48% cell growth inhibition, whereas a combination with 50-100 microM silibinin resulted in 63-80% (p<0.05-0.001) growth inhibition. Similarly, compared to 68% growth inhibition at 20 microg/ml carboplatin, addition of 50-100 microM doses of silibinin caused 80-90% inhibition (p<0.005-0.001). In the studies assessing the effect of these combinations on cell cycle progression, a combination of cisplatin or carboplatin with silibinin resulted in a stronger G2-M arrest, compared to these agents alone showing a moderate G2-M and G1 arrests in case of cisplatin and silibinin, and a complete S phase arrest with carboplatin, respectively. A stronger G2-M arrest by these combinations was accompanied by a substantial decrease in the levels of cdc2, cyclin B1 and cdc25C. Silibinin/platinum compound combinations were also effective in inducing apoptosis where cisplatin and carboplatin when combined with silibinin enhanced apoptosis from 8 to 15% and from 20 to 40%, respectively. Apoptosis induction was further confirmed by PARP and caspases 3, 9 and 7 whose cleaved levels were also enhanced by combination treatment. In addition, there was a significant increase in cytochrome c release in the cytosol following treatment of DU145 cells with these combinations. Together, these results show a substantial increase in the efficacy of platinum compounds on human PCA cells, when combined with silibinin, which provide a rationale for further investigations with these combinations. ", "pmid": 12866029, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9994492, "FORESTS_PROB": 0.9033333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999994, "med": 0.9756956 }, "rule": [{ "id": 242205, "sentence_id": "128660291", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "135", "sentence": "CH& sensitizes human D&S a DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.", "original_sentence": "Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1512530, "V1": 4947, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }, { "id": 1512531, "V1": 4948, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 27, "end_pos": 45, "entity_type": "cancer_type_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242206, "sentence_id": "12866029135", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "135", "end_pos": "274", "sentence": "In several recent studies, we have shown that CH& inhibits the growth of human D&S cells (PCA) both in vitro and in vivo.", "original_sentence": "In several recent studies, we have shown that silibinin inhibits the growth of human prostate cancer cells (PCA) both in vitro and in vivo.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1512532, "V1": 4949, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 181, "end_pos": 190, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }, { "id": 1512533, "V1": 4950, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 220, "end_pos": 235, "entity_type": "cancer_type_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242207, "sentence_id": "12866029275", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "275", "end_pos": "412", "sentence": "Here, we investigated the effect of CH& in combination with cisplatin and carboplatin on human PCA DU145 cell growth and apoptosis.", "original_sentence": "Here, we investigated the effect of silibinin in combination with cisplatin and carboplatin on human PCA DU145 cell growth and apoptosis.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1512534, "V1": 4951, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 311, "end_pos": 320, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242208, "sentence_id": "12866029413", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "413", "end_pos": "589", "sentence": "Cisplatin alone at 2 microg/ml dose produced 48% cell growth inhibition, whereas a combination with 50-100 microM CH& resulted in 63-80% (p<0_05-0_001) growth inhibition.", "original_sentence": "Cisplatin alone at 2 microg/ml dose produced 48% cell growth inhibition, whereas a combination with 50-100 microM silibinin resulted in 63-80% (p<0_05-0_001) growth inhibition.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1512535, "V1": 4952, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 527, "end_pos": 536, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242209, "sentence_id": "12866029590", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "590", "end_pos": "739", "sentence": "Similarly, compared to 68% growth inhibition at 20 microg/ml carboplatin, addition of 50-100 microM doses of CH& caused 80-90% inhibition (p<0.", "original_sentence": "Similarly, compared to 68% growth inhibition at 20 microg/ml carboplatin, addition of 50-100 microM doses of silibinin caused 80-90% inhibition (p<0.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1512536, "V1": 4953, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 699, "end_pos": 708, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242210, "sentence_id": "12866029751", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "751", "end_pos": "1096", "sentence": "In the studies assessing the effect of these combinations on cell cycle progression, a combination of cisplatin or carboplatin with CH& resulted in a stronger G2-M arrest, compared to these agents alone showing a moderate G2-M and G1 arrests in case of cisplatin and CH&, and a complete S phase arrest with carboplatin, respectively.", "original_sentence": "In the studies assessing the effect of these combinations on cell cycle progression, a combination of cisplatin or carboplatin with silibinin resulted in a stronger G2-M arrest, compared to these agents alone showing a moderate G2-M and G1 arrests in case of cisplatin and silibinin, and a complete S phase arrest with carboplatin, respectively.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1512537, "V1": 4954, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 883, "end_pos": 892, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }, { "id": 1512538, "V1": 4955, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1024, "end_pos": 1033, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242211, "sentence_id": "128660291229", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1229", "end_pos": "1439", "sentence": "CH& /platinum compound combinations were also effective in inducing apoptosis where cisplatin and carboplatin when combined with CH& enhanced apoptosis from 8 to 15% and from 20 to 40%, respectively.", "original_sentence": "Silibinin/platinum compound combinations were also effective in inducing apoptosis where cisplatin and carboplatin when combined with silibinin enhanced apoptosis from 8 to 15% and from 20 to 40%, respectively.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1512542, "V1": 4959, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1229, "end_pos": 1238, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }, { "id": 1512543, "V1": 4960, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1363, "end_pos": 1372, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }, { "id": 242212, "sentence_id": "128660291725", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1725", "end_pos": "1942", "sentence": "Together, these results show a substantial increase in the efficacy of platinum compounds on human PCA cells, when combined with CH&, which provide a rationale for further investigations with these combinations.", "original_sentence": "Together, these results show a substantial increase in the efficacy of platinum compounds on human PCA cells, when combined with silibinin, which provide a rationale for further investigations with these combinations.", "pmid_article": 12866029, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1512546, "V1": 4963, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1854, "end_pos": 1863, "entity_type": "chemical_entity_p", "entity_pmid": 12866029, "created_at": "2020-10-31T14:57:56.305Z", "updated_at": "2020-10-31T14:57:56.305Z" }] }] }, { "pmid": "16205633", "peso_rules": "0.32", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 17.4, "article": { "id": 74716, "title_article": "Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.", "abstract_article": "Here, we assessed and compared the anticancer efficacy and associated mechanisms of silymarin and silibinin in human prostate cancer (PCA) PC3 cells; silymarin is comprised of silibinin and its other stereoisomers, including isosilybin A, isosilybin B, silydianin, silychristin and isosilychristin. Silymarin and silibinin (50-100 microg/ml) inhibited cell proliferation, induced cell death, and caused G1 and G2-M cell cycle arrest in a dose/time-dependent manner. Molecular studies showed that G1 arrest was associated with a decrease in cyclin D1, cyclin D3, cyclin E, cyclin-dependent kinase (CDK)4, CDK6 and CDK2 protein levels, and CDK2 and CDK4 kinase activity, together with an increase in CDK inhibitors (CDKIs) Kip1/p27 and Cip1/p21. Further, both agents caused cytoplasmic sequestration of cyclin D1 and CDK2, contributing to G1 arrest. The G2-M arrest by silibinin and silymarin was associated with decreased levels of cyclin B1, cyclin A, pCdc2 (Tyr15), Cdc2, and an inhibition of Cdc2 kinase activity. Both agents also decreased the levels of Cdc25B and cell division cycle 25C (Cdc25C) phosphatases with an increased phosphorylation of Cdc25C at Ser216 and its translocation from nucleus to the cytoplasm, which was accompanied by an increased binding with 14-3-3beta. Both agents also increased checkpoint kinase (Chk)2 phosphorylation at Thr68 and Ser19 sites, which is known to phosphorylate Cdc25C at Ser216 site. Chk2-specific small interfering RNA largely attenuated the silymarin and silibinin-induced G2-M arrest. An increase in the phosphorylation of histone 2AX and ataxia telangiectasia mutated was also observed. These findings indicate that silymarin and silibinin modulate G1 phase cyclins-CDKs-CDKIs for G1 arrest, and the Chk2-Cdc25C-Cdc2/cyclin B1 pathway for G2-M arrest, together with an altered subcellular localization of critical cell cycle regulators. Overall, we observed comparable effects for both silymarin and silibinin at equal concentrations by weight, suggesting that silibinin could be a major cell cycle-inhibitory component in silymarin. However, other silibinin stereoisomers present in silymarin also contribute to its efficacy, and could be of interest for future investigation.", "pmid": 16205633, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9977546, "FORESTS_PROB": 0.87, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999857, "med": 0.9669383 }, "rule": [{ "id": 254986, "sentence_id": "162056331", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "195", "sentence": "Silymarin and CH& n cause G1 and G2-M cell cycle arrest via distinct circuitries in human D&S r PC3 cells: a comparison of CH& n with flavanolignan mixture silymarin.", "original_sentence": "Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 12, "peso_genes": 0, "entitiesRules": [{ "id": 1580492, "V1": 32475, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 14, "end_pos": 23, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580494, "V1": 32477, "pubtatot_term": "flavanone silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 137, "end_pos": 156, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580493, "V1": 32476, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 94, "end_pos": 109, "entity_type": "cancer_type_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254987, "sentence_id": "16205633195", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "195", "end_pos": "493", "sentence": "Here, we assessed and compared the anticancer efficacy and associated mechanisms of silymarin and CH& in human D&S (D&S) PC3 cells; silymarin is comprised of CH& and its other stereoisomers, including CH&, CH&, CH&, CH& and isosilychristin.", "original_sentence": "Here, we assessed and compared the anticancer efficacy and associated mechanisms of silymarin and silibinin in human prostate cancer (PCA) PC3 cells; silymarin is comprised of silibinin and its other stereoisomers, including isosilybin A, isosilybin B, silydianin, silychristin and isosilychristin.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1580495, "V1": 32478, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 293, "end_pos": 302, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580498, "V1": 32481, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 371, "end_pos": 380, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580496, "V1": 32479, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 312, "end_pos": 327, "entity_type": "cancer_type_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580497, "V1": 32480, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 329, "end_pos": 332, "entity_type": "cancer_type_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254988, "sentence_id": "16205633494", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "494", "end_pos": "660", "sentence": "Silymarin and CH& (50-100 microg/ml) inhibited cell proliferation, induced cell death, and caused G1 and G2-M cell cycle arrest in a dose/time-dependent manner.", "original_sentence": "Silymarin and silibinin (50-100 microg/ml) inhibited cell proliferation, induced cell death, and caused G1 and G2-M cell cycle arrest in a dose/time-dependent manner.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1580503, "V1": 32486, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 508, "end_pos": 517, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254989, "sentence_id": "162056331043", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1043", "end_pos": "1210", "sentence": "The G2-M arrest by CH& and silymarin was associated with decreased levels of G&N, G&N, pCdc2 (Tyr15), G&N, and an inhibition of G&N kinase activity.", "original_sentence": "The G2-M arrest by silibinin and silymarin was associated with decreased levels of cyclin B1, cyclin A, pCdc2 (Tyr15), Cdc2, and an inhibition of Cdc2 kinase activity.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1580517, "V1": 32500, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1062, "end_pos": 1071, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254990, "sentence_id": "162056331628", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1628", "end_pos": "1731", "sentence": "G&N -specific small interfering RNA largely attenuated the silymarin and CH& -induced G2-M arrest.", "original_sentence": "Chk2-specific small interfering RNA largely attenuated the silymarin and silibinin-induced G2-M arrest.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1580528, "V1": 32511, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1701, "end_pos": 1710, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254991, "sentence_id": "162056331835", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1835", "end_pos": "2084", "sentence": "These findings indicate that silymarin and CH& modulate G1 phase cyclins-CDKs-CDKIs for G1 arrest, and the G&N - G&N -G&N / G&N pathway for G2-M arrest, together with an altered subcellular localization of critical cell cycle regulators.", "original_sentence": "These findings indicate that silymarin and silibinin modulate G1 phase cyclins-CDKs-CDKIs for G1 arrest, and the Chk2-Cdc25C-Cdc2/cyclin B1 pathway for G2-M arrest, together with an altered subcellular localization of critical cell cycle regulators.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1580529, "V1": 32512, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1878, "end_pos": 1887, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254992, "sentence_id": "162056332085", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2085", "end_pos": "2281", "sentence": "Overall, we observed comparable effects for both silymarin and CH& at equal concentrations by weight, suggesting that CH& could be a major cell cycle-inhibitory component in silymarin.", "original_sentence": "Overall, we observed comparable effects for both silymarin and silibinin at equal concentrations by weight, suggesting that silibinin could be a major cell cycle-inhibitory component in silymarin.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1580534, "V1": 32517, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2148, "end_pos": 2157, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1580535, "V1": 32518, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2209, "end_pos": 2218, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254993, "sentence_id": "162056332282", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "2282", "end_pos": "2425", "sentence": "However, other CH& stereoisomers present in silymarin also contribute to its efficacy, and could be of interest for future investigation.", "original_sentence": "However, other silibinin stereoisomers present in silymarin also contribute to its efficacy, and could be of interest for future investigation.", "pmid_article": 16205633, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1580536, "V1": 32519, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2297, "end_pos": 2306, "entity_type": "chemical_entity_p", "entity_pmid": 16205633, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "20428808", "peso_rules": "1.0", "peso_entities": "0.33", "peso_genes": "0.0", "peso_final": 16.9, "article": { "id": 74693, "title_article": "Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.", "abstract_article": "Silibinin, a naturally occurring flavanone isolated from milk thistle extract, has been shown to possess strong anticancer efficacy against both androgen-dependent and androgen-independent prostate cancer, wherein it inhibits not only cell growth, but also cell invasion and metastasis. Inhibitory effects of silibinin on prostate cancer invasion, motility and migration were previously observed in the highly bone metastatic ARCaP M cell line; however, mechanisms of such efficacy are not completely elucidated. The epithelial-to-mesenchymal transition (EMT) is a crucial step in the progression of prostate cancer, reversal or inhibition of EMT by drugs thus provides a new approach to prostate cancer therapy. In the present study, we found that silibinin treatment resulted in the up-regulation of cytokeratin-18 and down-regulation of vimentin and MMP2, which was consistent with morphologic reversal of EMT phenotype leading to be epithelial. Moreover, we found that silibinin could inhibit the nuclear factor kappaB (NF-kappaB) p50 translocation via the up-regulation of I kappaB alpha protein, and possibly subsequently down-regulated the expression of two major EMT regulators, ZEB1 and SLUG transcription factors. Overall these findings demonstrate silibinin was able to reverse EMT to suppress the invasive property of metastatic prostate cancer cells at the transcriptional level.", "pmid": 20428808, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9946671, "FORESTS_PROB": 0.9033333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999998, "med": 0.97450006 }, "rule": [{ "id": 244077, "sentence_id": "204288081", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "128", "sentence": "CH& reverses epithelial-to-mesenchymal transition in metastatic D&S r cells by targeting transcription factors.", "original_sentence": "Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1522532, "V1": 14949, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1522533, "V1": 14950, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 70, "end_pos": 85, "entity_type": "cancer_type_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244078, "sentence_id": "20428808128", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "128", "end_pos": "414", "sentence": "CH&, a naturally occurring CH& isolated from milk thistle extract, has been shown to possess strong anticancer efficacy against both androgen-dependent and androgen-independent D&S, wherein it inhibits not only cell growth, but also cell invasion and metastasis.", "original_sentence": "Silibinin, a naturally occurring flavanone isolated from milk thistle extract, has been shown to possess strong anticancer efficacy against both androgen-dependent and androgen-independent prostate cancer, wherein it inhibits not only cell growth, but also cell invasion and metastasis.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 6, "peso_genes": 1, "entitiesRules": [{ "id": 1522534, "V1": 14951, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 128, "end_pos": 137, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1522536, "V1": 14953, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 317, "end_pos": 332, "entity_type": "cancer_type_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244079, "sentence_id": "20428808415", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "415", "end_pos": "640", "sentence": "Inhibitory effects of CH& on D&S invasion, motility and migration were previously observed in the highly bone metastatic ARCaP M cell line; however, mechanisms of such efficacy are not completely elucidated.", "original_sentence": "Inhibitory effects of silibinin on prostate cancer invasion, motility and migration were previously observed in the highly bone metastatic ARCaP M cell line; however, mechanisms of such efficacy are not completely elucidated.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1522537, "V1": 14954, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 437, "end_pos": 446, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1522538, "V1": 14955, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 450, "end_pos": 465, "entity_type": "cancer_type_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244080, "sentence_id": "20428808841", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "841", "end_pos": "1076", "sentence": "In the present study, we found that CH& treatment resulted in the up-regulation of cytokeratin-18 and down-regulation of vimentin and MMP2, which was consistent with morphologic reversal of EMT phenotype leading to be epithelial.", "original_sentence": "In the present study, we found that silibinin treatment resulted in the up-regulation of cytokeratin-18 and down-regulation of vimentin and MMP2, which was consistent with morphologic reversal of EMT phenotype leading to be epithelial.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1522541, "V1": 14958, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 877, "end_pos": 886, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244081, "sentence_id": "204288081077", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1077", "end_pos": "1351", "sentence": "Moreover, we found that CH& could inhibit the nuclear factor kappaB (NF-kappaB) p50 translocation via the up-regulation of I kappaB alpha protein, and possibly subsequently down-regulated the expression of two major EMT regulators, ZEB1 and SLUG transcription factors.", "original_sentence": "Moreover, we found that silibinin could inhibit the nuclear factor kappaB (NF-kappaB) p50 translocation via the up-regulation of I kappaB alpha protein, and possibly subsequently down-regulated the expression of two major EMT regulators, ZEB1 and SLUG transcription factors.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1522542, "V1": 14959, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1101, "end_pos": 1110, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 244082, "sentence_id": "204288081352", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1352", "end_pos": "1520", "sentence": "Overall these findings demonstrate CH& was able to reverse EMT to suppress the invasive property of metastatic D&S cells at the transcriptional level.", "original_sentence": "Overall these findings demonstrate silibinin was able to reverse EMT to suppress the invasive property of metastatic prostate cancer cells at the transcriptional level.", "pmid_article": 20428808, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1522543, "V1": 14960, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1387, "end_pos": 1396, "entity_type": "chemical_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }, { "id": 1522544, "V1": 14961, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1469, "end_pos": 1484, "entity_type": "cancer_type_entity_p", "entity_pmid": 20428808, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }] }, { "pmid": "17389612", "peso_rules": "1.0", "peso_entities": "0.68", "peso_genes": "0.0", "peso_final": 15.9, "article": { "id": 76288, "title_article": "Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.", "abstract_article": "Silymarin and, one of its constituents, silibinin exert strong efficacy against prostate cancer (PCA); however, anticancer efficacy and associated mechanisms of other components of silymarin, which is a mixture of flavonolignans, are largely unknown. Here we have assessed the anticancer efficacy of two pure compounds isosilybin B and isosilybin A, isolated from silymarin, in human prostate carcinoma LNCaP and 22Rv1 cells. Isosilybin B and isosilybin A treatment resulted in growth inhibition and cell death together with a strong G(1) arrest and apoptosis in both the cell lines. In the studies examining changes in cell cycle and apoptosis regulators, isosilybin B and isosilybin A resulted in a decrease in the levels of both cyclins (D1, D3, E and A) and cyclin-dependent kinases (Cdk2, Cdk4 and cell division cycle 25A), but caused an increase in p21, p27 and p53 levels, except in 22Rv1 cells where isosilybin B caused a decrease in p21 protein level. Isosilybin B- and isosilybin A-induced apoptosis was accompanied with an increase in the cleavage of poly (ADP-ribose) polymerase, caspase-9 and caspase-3 and a decrease in survivin levels. Compared with LNCaP and 22Rv1 cells, the antiproliferative and cytotoxic potentials of isosilybin B and isosilybin A were of much lesser magnitude in non-neoplastic human prostate epithelial PWR-1E cells suggesting the transformation-selective effect of these compounds. Together, this study for the first time identified that isosilybin B and isosilybin A, two diastereoisomers isolated from silymarin, have anti-PCA activity that is mediated via cell cycle arrest and apoptosis induction.", "pmid": 17389612, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9999429, "FORESTS_PROB": 0.9633333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.99081904 }, "rule": [{ "id": 213103, "sentence_id": "173896121", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "131", "sentence": "CH& and CH& A inhibit growth, induce G1 arrest and cause apoptosis in human D&S r D&S P and 22Rv1 cells.", "original_sentence": "Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 11, "peso_genes": 0, "entitiesRules": [{ "id": 1353449, "V1": 205, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 92, "end_pos": 107, "entity_type": "cancer_type_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }, { "id": 1353450, "V1": 206, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 108, "end_pos": 113, "entity_type": "cancer_type_entity_cell", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }, { "id": 213104, "sentence_id": "17389612131", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "131", "end_pos": "381", "sentence": "Silymarin and, one of its constituents, CH& exert strong efficacy against D&S (D&S); however, anticancer efficacy and associated mechanisms of other components of silymarin, which is a mixture of CH&, are largely unknown.", "original_sentence": "Silymarin and, one of its constituents, silibinin exert strong efficacy against prostate cancer (PCA); however, anticancer efficacy and associated mechanisms of other components of silymarin, which is a mixture of flavonolignans, are largely unknown.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1353451, "V1": 207, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 171, "end_pos": 180, "entity_type": "chemical_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }, { "id": 1353452, "V1": 208, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 211, "end_pos": 226, "entity_type": "cancer_type_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }, { "id": 1353453, "V1": 209, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 228, "end_pos": 231, "entity_type": "cancer_type_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }, { "id": 213105, "sentence_id": "17389612382", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "382", "end_pos": "556", "sentence": "Here we have assessed the anticancer efficacy of two pure compounds CH& and CH&, isolated from silymarin, in human D&S and 22Rv1 cells.", "original_sentence": "Here we have assessed the anticancer efficacy of two pure compounds isosilybin B and isosilybin A, isolated from silymarin, in human prostate carcinoma LNCaP and 22Rv1 cells.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1353457, "V1": 213, "pubtatot_term": "prostate carcinoma LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 515, "end_pos": 539, "entity_type": "cancer_type_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }, { "id": 213106, "sentence_id": "17389612557", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "sim", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "557", "end_pos": "714", "sentence": "CH& and CH& treatment resulted in growth inhibition and cell death together with a strong G(1) arrest and apoptosis in both the cell lines.", "original_sentence": "Isosilybin B and isosilybin A treatment resulted in growth inhibition and cell death together with a strong G(1) arrest and apoptosis in both the cell lines.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [] }, { "id": 213107, "sentence_id": "17389612715", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "715", "end_pos": "1091", "sentence": "In the studies examining changes in cell cycle and apoptosis regulators, CH& and CH& resulted in a decrease in the levels of both cyclins (D1, D3, E and A) and cyclin-dependent kinases (G&N, G&N and cell division cycle 25A), but caused an increase in G&N, G&N and G&N levels, except in 22Rv1 cells where CH& caused a decrease in G&N protein level.", "original_sentence": "In the studies examining changes in cell cycle and apoptosis regulators, isosilybin B and isosilybin A resulted in a decrease in the levels of both cyclins (D1, D3, E and A) and cyclin-dependent kinases (Cdk2, Cdk4 and cell division cycle 25A), but caused an increase in p21, p27 and p53 levels, except in 22Rv1 cells where isosilybin B caused a decrease in p21 protein level.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "sim", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [] }, { "id": 213108, "sentence_id": "173896121092", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1092", "end_pos": "1281", "sentence": "CH& - and CH& -induced apoptosis was accompanied with an increase in the cleavage of G&N, G&N and G&N and a decrease in survivin levels.", "original_sentence": "Isosilybin B- and isosilybin A-induced apoptosis was accompanied with an increase in the cleavage of poly (ADP-ribose) polymerase, caspase-9 and caspase-3 and a decrease in survivin levels.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 213109, "sentence_id": "173896121282", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1282", "end_pos": "1552", "sentence": "Compared with D&S and 22Rv1 cells, the antiproliferative and cytotoxic potentials of CH& and CH& were of much lesser magnitude in non-neoplastic human prostate epithelial PWR-1E cells suggesting the transformation-selective effect of these compounds.", "original_sentence": "Compared with LNCaP and 22Rv1 cells, the antiproliferative and cytotoxic potentials of isosilybin B and isosilybin A were of much lesser magnitude in non-neoplastic human prostate epithelial PWR-1E cells suggesting the transformation-selective effect of these compounds.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1353474, "V1": 230, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 1296, "end_pos": 1301, "entity_type": "cancer_type_entity_cell", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }, { "id": 213110, "sentence_id": "173896121553", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1553", "end_pos": "1772", "sentence": "Together, this study for the first time identified that CH& and CH&, two diastereoisomers isolated from silymarin, have anti-D&S activity that is mediated via cell cycle arrest and apoptosis induction.", "original_sentence": "Together, this study for the first time identified that isosilybin B and isosilybin A, two diastereoisomers isolated from silymarin, have anti-PCA activity that is mediated via cell cycle arrest and apoptosis induction.", "pmid_article": 17389612, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1353479, "V1": 235, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1696, "end_pos": 1699, "entity_type": "cancer_type_entity_p", "entity_pmid": 17389612, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }] }, { "pmid": "22820499", "peso_rules": "0.19", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 15.8, "article": { "id": 76572, "title_article": "Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.", "abstract_article": "Silibinin is a natural compound isolated from milk thistle seed extracts, and has traditionally been used as a hepatoprotectant. A number of studies have also established the cancer therapeutic and chemopreventive role of silibinin in both in vitro and in vivo models. The low density lipoprotein receptor-related protein-6 (LRP6) is an essential Wnt co-receptor for the Wnt/β-catenin pathway and represents a promising target for cancer prevention and therapy. In the present study, we found that silibinin was able to repress endogenous LRP6 expression and block Wnt3A-induced LRP6 phosphorylation and Wnt/β-catenin signaling activation in HEK293 cells. Importantly, silibinin was also able to suppress endogenous LRP6 expression and phosphorylation and block Wnt/β-catenin signaling in prostate cancer PC-3 and DU-145 cells and breast cancer MDA-MB-231 and T-47D cells. Mechanistically, silibinin inhibited LRP6 promoter activity and decreased LRP6 mRNA levels in prostate and breast cancer cells. Finally, we demonstrated that silibinin displayed anticancer activity with IC(50) values comparable to those shown to suppress LRP6 expression and Wnt/β-catenin signaling activities in prostate and breast cancer cells. Our data indicate that silibinin is a novel small molecule Wnt/β-catenin signaling inhibitor by suppressing Wnt co-receptor LRP6 expression at the transcription level, and that the anti-cancer activity of silibinin is associated with its inhibitory effect on Wnt/LRP6 signaling. ", "pmid": 22820499, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9999578, "FORESTS_PROB": 0.96, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.98998946 }, "rule": [{ "id": 299450, "sentence_id": "228204991", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "242", "sentence": "CH& inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptoG&N P6 expression in human prostate an D&S er cells CH& n is a natural compound isolated from milk thistle seed extracts, and has traditionally been used as a hepatoprotectant.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1789564, "V1": 7377, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789567, "V1": 7380, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 133, "end_pos": 142, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362094, "V1": 8850, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362097, "V1": 8853, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 133, "end_pos": 142, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789566, "V1": 7379, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 112, "end_pos": 125, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362096, "V1": 8852, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 112, "end_pos": 125, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 299451, "sentence_id": "22820499263", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "263", "end_pos": "397", "sentence": "A number of studies have also established the D&S r therapeutic and chemopreventive role of CH& n in both in vitro and in vivo models.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1789569, "V1": 7382, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 355, "end_pos": 364, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362099, "V1": 8855, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 355, "end_pos": 364, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789568, "V1": 7381, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 308, "end_pos": 314, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362098, "V1": 8854, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 308, "end_pos": 314, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 299452, "sentence_id": "22820499545", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "545", "end_pos": "734", "sentence": "In the present study, we found tha CH& in was able to repress endogenouG&N P6 expression and bloc G&N 3A-induceG&N P6 phosphorylation and Wnt/β-catenin signaling activation in HEK293 cells.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1789573, "V1": 7386, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 631, "end_pos": 640, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362103, "V1": 8859, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 631, "end_pos": 640, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789572, "V1": 7385, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 564, "end_pos": 570, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362102, "V1": 8858, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 564, "end_pos": 570, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 299453, "sentence_id": "22820499921", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "921", "end_pos": "1034", "sentence": "Mechanistical CH& inin inhibiG&N LRP6 promoter activity and decreaG&N LRP6 mRNA levels in prostate D&S ncer cells.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1789585, "V1": 7398, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1023, "end_pos": 1032, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362115, "V1": 8871, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1023, "end_pos": 1032, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789579, "V1": 7392, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 922, "end_pos": 937, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789580, "V1": 7393, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 938, "end_pos": 942, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789581, "V1": 7394, "pubtatot_term": "DU-145", "db_term": "Prostate Cancer", "db_equivalence": "du-145", "mesh_id": "D011471", "term_id": "527", "start_pos": 947, "end_pos": 953, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789582, "V1": 7395, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 964, "end_pos": 977, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789583, "V1": 7396, "pubtatot_term": "MDA-MB-231", "db_term": "Breast Cancer", "db_equivalence": "mda-mb-231", "mesh_id": "D001943", "term_id": "484", "start_pos": 978, "end_pos": 988, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1789584, "V1": 7397, "pubtatot_term": "T-47D", "db_term": "Ductal Carcinoma", "db_equivalence": "t-47d", "mesh_id": "D002285", "term_id": "3232", "start_pos": 993, "end_pos": 998, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362109, "V1": 8865, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 922, "end_pos": 937, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362110, "V1": 8866, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 938, "end_pos": 942, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362111, "V1": 8867, "pubtatot_term": "DU-145", "db_term": "Prostate Cancer", "db_equivalence": "du-145", "mesh_id": "D011471", "term_id": "527", "start_pos": 947, "end_pos": 953, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362112, "V1": 8868, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 964, "end_pos": 977, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362113, "V1": 8869, "pubtatot_term": "MDA-MB-231", "db_term": "Breast Cancer", "db_equivalence": "mda-mb-231", "mesh_id": "D001943", "term_id": "484", "start_pos": 978, "end_pos": 988, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1362114, "V1": 8870, "pubtatot_term": "T-47D", "db_term": "Ductal Carcinoma", "db_equivalence": "t-47d", "mesh_id": "D002285", "term_id": "3232", "start_pos": 993, "end_pos": 998, "entity_type": "cancer_type_entity_cell", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 299454, "sentence_id": "228204991035", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1035", "end_pos": "1241", "sentence": "Finally, we demonstrated t CH& inin displayed anticancer activity with IC(50) values comparable to those shown to supprG&N LRP6 expression and Wnt/β-catenin signaling activities in prostate D&S ancer cells.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1789589, "V1": 7402, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1164, "end_pos": 1173, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362119, "V1": 8875, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1164, "end_pos": 1173, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789588, "V1": 7401, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 1113, "end_pos": 1126, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362118, "V1": 8874, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 1113, "end_pos": 1126, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }, { "id": 299455, "sentence_id": "228204991242", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1242", "end_pos": "1510", "sentence": "Our data indicate CH& binin is a novel small molecule Wnt/β-catenin signaling inhibitor by suppressing Wnt co-recG&N r LRP6 expression at the transcription level, and that the D&S cancer activi CH& ibinin is associated with its inhibitory effect oG&N t/LRP6 signaling.", "original_sentence": "NA", "pmid_article": 22820499, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1789592, "V1": 7405, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1376, "end_pos": 1385, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362122, "V1": 8878, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1376, "end_pos": 1385, "entity_type": "chemical_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }, { "id": 1789591, "V1": 7404, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 1332, "end_pos": 1345, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1362121, "V1": 8877, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 1332, "end_pos": 1345, "entity_type": "cancer_type_entity_p", "entity_pmid": 22820499, "created_at": "2020-10-31T14:44:23.549Z", "updated_at": "2020-10-31T14:44:23.549Z" }] }] }, { "pmid": "18538589", "peso_rules": "1.0", "peso_entities": "0.45", "peso_genes": "0.0", "peso_final": 15.8, "article": { "id": 60279, "title_article": "Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.", "abstract_article": "Prostate cancer (PCA) is the most common cancer diagnosed in men and the second most common cause of death due to cancers after lung cancer. Metastasis of cancer cells involves multiple processes and various cytophysiological changes, including changed adhesion capability between cells and extracellular matrix (ECM) and damaged intercellular interaction. Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effect against various malignant cell lines. In the present study, PC-3 cells were incubated with various concentrations of silibinin for different times; then, cell cytotoxicity, cell adhesion and cell motility were assessed using MTT assay, cell-matrix adhesion assay and cell migration assay, respectively. The results showed that silibinin exerted a dose- and time-dependent inhibitory effect on the viability, motility and adhesion of highly metastatic PC-3 cells. These observations indicate that silibinin can probably inhibit metastasis in PCA.", "pmid": 18538589, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9984296, "FORESTS_PROB": 0.87666667, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 0.9999758, "med": 0.9687665 }, "rule": [{ "id": 252627, "sentence_id": "185385891", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "120", "sentence": "Evaluation of CH& n on the viability, migration and adhesion of the human G&N 3) cell line.", "original_sentence": "Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.", "pmid_article": 18538589, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 9, "peso_genes": 0, "entitiesRules": [{ "id": 1568235, "V1": 20218, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 14, "end_pos": 23, "entity_type": "chemical_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 252628, "sentence_id": "18538589477", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "477", "end_pos": "660", "sentence": "CH&, a naturally occurring CH& antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effect against various malignant cell lines.", "original_sentence": "Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effect against various malignant cell lines.", "pmid_article": 18538589, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1568243, "V1": 20226, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 477, "end_pos": 486, "entity_type": "chemical_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 252629, "sentence_id": "18538589661", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "661", "end_pos": "925", "sentence": "In the present study, D&S cells were incubated with various concentrations of CH& for different times; then, cell cytotoxicity, cell adhesion and cell motility were assessed using MTT assay, cell-matrix adhesion assay and cell migration assay, respectively.", "original_sentence": "In the present study, PC-3 cells were incubated with various concentrations of silibinin for different times; then, cell cytotoxicity, cell adhesion and cell motility were assessed using MTT assay, cell-matrix adhesion assay and cell migration assay, respectively.", "pmid_article": 18538589, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1568246, "V1": 20229, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 740, "end_pos": 749, "entity_type": "chemical_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1568245, "V1": 20228, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 683, "end_pos": 687, "entity_type": "cancer_type_entity_cell", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 252630, "sentence_id": "18538589926", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "926", "end_pos": "1085", "sentence": "The results showed that CH& exerted a dose- and time-dependent inhibitory effect on the viability, motility and adhesion of highly metastatic D&S cells.", "original_sentence": "The results showed that silibinin exerted a dose- and time-dependent inhibitory effect on the viability, motility and adhesion of highly metastatic PC-3 cells.", "pmid_article": 18538589, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 7, "peso_genes": 3, "entitiesRules": [{ "id": 1568247, "V1": 20230, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 950, "end_pos": 959, "entity_type": "chemical_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1568248, "V1": 20231, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1074, "end_pos": 1078, "entity_type": "cancer_type_entity_cell", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }, { "id": 252631, "sentence_id": "185385891086", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1086", "end_pos": "1168", "sentence": "These observations indicate that CH& can probably inhibit metastasis in D&S.", "original_sentence": "These observations indicate that silibinin can probably inhibit metastasis in PCA.", "pmid_article": 18538589, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1568249, "V1": 20232, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1119, "end_pos": 1128, "entity_type": "chemical_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }, { "id": 1568250, "V1": 20233, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1164, "end_pos": 1167, "entity_type": "cancer_type_entity_p", "entity_pmid": 18538589, "created_at": "2020-10-31T15:03:36.869Z", "updated_at": "2020-10-31T15:03:36.869Z" }] }] }, { "pmid": "28042859", "peso_rules": "0.27", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 15.7, "article": { "id": 76500, "title_article": "A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.", "abstract_article": "Silibinin, extracted from milk thistle (Silybum marianum L.), has exhibited considerable preclinical activity against prostate carcinoma. Its antitumor and chemopreventive activities have been associated with diverse effects on cell cycle, apoptosis, and receptor-dependent mitogenic signaling pathways. Here we hypothesized that silibinin's pleiotropic effects may reflect its interference with epigenetic mechanisms in human prostate cancer cells. More specifically, we have demonstrated that silibinin reduces gene expression levels of the Polycomb Repressive Complex 2 (PRC2) members Enhancer of Zeste Homolog 2 (EZH2), Suppressor of Zeste Homolog 12 (SUZ12), and Embryonic Ectoderm Development (EED) in DU145 and PC3 human prostate cancer cells, as evidenced by Real Time Polymerase Chain Reaction (RT-PCR). Furthermore immunoblot and immunofluorescence analysis revealed that silibinin-mediated reduction of EZH2 levels was accompanied by an increase in trimethylation of histone H3 on lysine (Κ)-27 residue (H3K27me3) levels and that such response was, in part, dependent on decreased expression levels of phosphorylated Akt (ser473) (pAkt) and phosphorylated EZH2 (ser21) (pEZH2). Additionally silibinin exerted other epigenetic effects involving an increase in total DNA methyltransferase (DNMT) activity while it decreased histone deacetylases 1-2 (HDACs1-2) expression levels. We conclude that silibinin induces epigenetic alterations in human prostate cancer cells, suggesting that subsequent disruptions of central processes in chromatin conformation may account for some of its diverse anticancer effects.", "pmid": 28042859, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.98304397, "FORESTS_PROB": 0.96, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999495, "med": 0.98574835 }, "rule": [{ "id": 223482, "sentence_id": "280428591", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "90", "sentence": "A Novel Role of CH& n as a Putative Epigenetic Modulator in Human D&S a.", "original_sentence": "A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1410055, "V1": 56811, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 16, "end_pos": 25, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410056, "V1": 56812, "pubtatot_term": "Prostate Carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 70, "end_pos": 88, "entity_type": "cancer_type_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223483, "sentence_id": "2804285990", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "90", "end_pos": "149", "sentence": "CH&, extracted from milk thistle (Silybum marianum L.", "original_sentence": "Silibinin, extracted from milk thistle (Silybum marianum L.", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1410057, "V1": 56813, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 90, "end_pos": 99, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223484, "sentence_id": "28042859394", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "394", "end_pos": "539", "sentence": "Here we hypothesized that CH& 's pleiotropic effects may reflect its interference with epigenetic mechanisms in human D&S cells.", "original_sentence": "Here we hypothesized that silibinin's pleiotropic effects may reflect its interference with epigenetic mechanisms in human prostate cancer cells.", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1410059, "V1": 56815, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 420, "end_pos": 429, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410060, "V1": 56816, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 517, "end_pos": 532, "entity_type": "cancer_type_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223485, "sentence_id": "28042859540", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "540", "end_pos": "902", "sentence": "More specifically, we have demonstrated that CH& reduces gene expression levels of the Polycomb Repressive Complex 2 (PRC2) members G&N (G&N ), G&N ( G&N ), and G&N (EED) in DU145 and G&N human D&S cells, as evidenced by Real Time Polymerase Chain Reaction (RT-PCR).", "original_sentence": "More specifically, we have demonstrated that silibinin reduces gene expression levels of the Polycomb Repressive Complex 2 (PRC2) members Enhancer of Zeste Homolog 2 (EZH2), Suppressor of Zeste Homolog 12 (SUZ12), and Embryonic Ectoderm Development (EED) in DU145 and PC3 human prostate cancer cells, as evidenced by Real Time Polymerase Chain Reaction (RT-PCR).", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 3, "peso_genes": 3, "entitiesRules": [{ "id": 1410061, "V1": 56817, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 585, "end_pos": 594, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410068, "V1": 56824, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 818, "end_pos": 833, "entity_type": "cancer_type_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223486, "sentence_id": "28042859903", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "903", "end_pos": "1279", "sentence": "Furthermore immunoblot and immunofluorescence analysis revealed that CH& -mediated reduction of G&N levels was accompanied by an increase in trimethylation of histone H3 on lysine (Κ)-27 residue (H3K27me3) levels and that such response was, in part, dependent on decreased expression levels of phosphorylatedG&Nt (ser473) (pAkt) and phosphorylatedG&N 2 (ser21) (pEZH2).", "original_sentence": "Furthermore immunoblot and immunofluorescence analysis revealed that silibinin-mediated reduction of EZH2 levels was accompanied by an increase in trimethylation of histone H3 on lysine (Κ)-27 residue (H3K27me3) levels and that such response was, in part, dependent on decreased expression levels of phosphorylated Akt (ser473) (pAkt) and phosphorylated EZH2 (ser21) (pEZH2).", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1410069, "V1": 56825, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 972, "end_pos": 981, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223487, "sentence_id": "280428591280", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1280", "end_pos": "1478", "sentence": "Additionally CH& n exerted other epigenetic effects involving an increase in total G&N e G&N T) activity while it decreased histone deacetylases 1-2 (HDACs1-2) expression levels.", "original_sentence": "Additionally silibinin exerted other epigenetic effects involving an increase in total DNA methyltransferase (DNMT) activity while it decreased histone deacetylases 1-2 (HDACs1-2) expression levels.", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1410073, "V1": 56829, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1292, "end_pos": 1301, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }, { "id": 223488, "sentence_id": "280428591479", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1479", "end_pos": "1710", "sentence": "We conclude that CH& n induces epigenetic alterations in human D&S r cells, suggesting that subsequent disruptions of central processes in chromatin conformation may account for some of its diverse anticancer effects.", "original_sentence": "We conclude that silibinin induces epigenetic alterations in human prostate cancer cells, suggesting that subsequent disruptions of central processes in chromatin conformation may account for some of its diverse anticancer effects.", "pmid_article": 28042859, "created_at": "2020-10-31T22:42:45.284Z", "updated_at": "2020-10-31T22:42:45.284Z", "R16": "nao", "peso_frase": 2, "peso_genes": 3, "entitiesRules": [{ "id": 1410076, "V1": 56832, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1495, "end_pos": 1504, "entity_type": "chemical_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }, { "id": 1410077, "V1": 56833, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1545, "end_pos": 1560, "entity_type": "cancer_type_entity_p", "entity_pmid": 28042859, "created_at": "2020-10-31T14:48:08.558Z", "updated_at": "2020-10-31T14:48:08.558Z" }] }] }, { "pmid": "17230508", "peso_rules": "1.0", "peso_entities": "0.94", "peso_genes": "0.0", "peso_final": 15.7, "article": { "id": 76636, "title_article": "Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.", "abstract_article": "The purpose of these experiments was to assess the synergistic activity of silibinin with chemotherapy agents in clinical use against prostate cancer. Silybin-phytosome, a commercially available formulation containing silibinin, has recently been studied in a phase I clinical trial. The silibinin doses used in the present study are clinically achievable based on the preliminary phase I data. DU145, PC-3 and LNCaP prostate cancer cells were seeded in 96-well plates in triplicate. Twenty-four hours later, silibinin (10, 20 and 40 microM) and either mitoxantrone or docetaxel were added to the designated wells. Seventy-two hours post-treatment, cell viability was determined with a tetrazolium-based assay. The combination index (CI) for determination of a synergistic effect was calculated, with values of <0.9 indicating synergy and values >1.1 antagonism. Apoptosis was also assessed using a luminescent assay after 72 hr of treatment with media alone, silibinin, mitoxantrone, or silibinin plus mitoxantrone. Silibinin showed a synergistic effect with mitoxantrone, as measured by reduction in cell viability. The CI values ranged from 0.413 to 2.650 for the combination of silibinin and mitoxantrone; in contrast, treatment with docetaxel and silibinin showed little or no synergy, with CI values of 0.898-4.469. In concordance with these findings, the addition of silibinin increased the level of apoptosis compared to mitoxantrone alone, particularly in the PC-3 cells. The combination of silibinin and mitoxantrone exhibits a pattern of synergy in reducing cell viability with increased apoptosis. These data are important in the planning of future clinical applications of silibinin. ", "pmid": 17230508, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9886932, "FORESTS_PROB": 0.83666664, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.99927765, "med": 0.95615935 }, "rule": [{ "id": 266275, "sentence_id": "172305081", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "115", "sentence": "CH& synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human D&S r cells.", "original_sentence": "Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1637193, "V1": 14591, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637194, "V1": 14592, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 92, "end_pos": 107, "entity_type": "cancer_type_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266276, "sentence_id": "17230508115", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "115", "end_pos": "265", "sentence": "The purpose of these experiments was to assess the synergistic activity of CH& with chemotherapy agents in clinical use against prostate D&S .", "original_sentence": "The purpose of these experiments was to assess the synergistic activity of silibinin with chemotherapy agents in clinical use against prostate cancer.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1637195, "V1": 14593, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 190, "end_pos": 199, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637196, "V1": 14594, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 258, "end_pos": 264, "entity_type": "cancer_type_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266277, "sentence_id": "17230508266", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "266", "end_pos": "398", "sentence": "CH& -phytosome, a commercially available formulation containing CH&, has recently been studied in a phase I clinical trial.", "original_sentence": "Silybin-phytosome, a commercially available formulation containing silibinin, has recently been studied in a phase I clinical trial.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637197, "V1": 14595, "pubtatot_term": "Silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 266, "end_pos": 273, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637198, "V1": 14596, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 333, "end_pos": 342, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266278, "sentence_id": "17230508399", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "399", "end_pos": "509", "sentence": "The CH& doses used in the present study are clinically achievable based on the preliminary phase I data.", "original_sentence": "The silibinin doses used in the present study are clinically achievable based on the preliminary phase I data.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637199, "V1": 14597, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 403, "end_pos": 412, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266279, "sentence_id": "17230508599", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "599", "end_pos": "729", "sentence": "Twenty-four hours later, CH& (10, 20 and 40 microM) and either mitoxantrone or docetaxel were added to the designated wells.", "original_sentence": "Twenty-four hours later, silibinin (10, 20 and 40 microM) and either mitoxantrone or docetaxel were added to the designated wells.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637203, "V1": 14601, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 624, "end_pos": 633, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266280, "sentence_id": "17230508978", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "978", "end_pos": "1131", "sentence": "Apoptosis was also assessed using a luminescent assay after 72 hr of treatment with media alone, CH&, mitoxantrone, or CH& plus mitoxantrone.", "original_sentence": "Apoptosis was also assessed using a luminescent assay after 72 hr of treatment with media alone, silibinin, mitoxantrone, or silibinin plus mitoxantrone.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637204, "V1": 14602, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1075, "end_pos": 1084, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637205, "V1": 14603, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1103, "end_pos": 1112, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266281, "sentence_id": "172305081132", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1132", "end_pos": "1232", "sentence": "CH& showed a synergistic effect with mitoxantrone, as measured by reduction in cell viability.", "original_sentence": "Silibinin showed a synergistic effect with mitoxantrone, as measured by reduction in cell viability.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1637206, "V1": 14604, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1132, "end_pos": 1141, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266282, "sentence_id": "172305081270", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1270", "end_pos": "1426", "sentence": "650 for the combination of CH& and mitoxantrone; in contrast, treatment with docetaxel and CH& showed little or no synergy, with CI values of 0.", "original_sentence": "650 for the combination of silibinin and mitoxantrone; in contrast, treatment with docetaxel and silibinin showed little or no synergy, with CI values of 0.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637207, "V1": 14605, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1297, "end_pos": 1306, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637208, "V1": 14606, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1367, "end_pos": 1376, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266283, "sentence_id": "172305081437", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1437", "end_pos": "1595", "sentence": "In concordance with these findings, the addition of CH& increased the level of apoptosis compared to mitoxantrone alone, particularly in the G&N cells.", "original_sentence": "In concordance with these findings, the addition of silibinin increased the level of apoptosis compared to mitoxantrone alone, particularly in the PC-3 cells.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1637209, "V1": 14607, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1489, "end_pos": 1498, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266284, "sentence_id": "172305081596", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1596", "end_pos": "1724", "sentence": "The combination of CH& and mitoxantrone exhibits a pattern of synergy in reducing cell viability with increased apoptosis.", "original_sentence": "The combination of silibinin and mitoxantrone exhibits a pattern of synergy in reducing cell viability with increased apoptosis.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1637211, "V1": 14609, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1615, "end_pos": 1624, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266285, "sentence_id": "172305081725", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1725", "end_pos": "1811", "sentence": "These data are important in the planning of future clinical applications of CH&.", "original_sentence": "These data are important in the planning of future clinical applications of silibinin.", "pmid_article": 17230508, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1637212, "V1": 14610, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1801, "end_pos": 1810, "entity_type": "chemical_entity_p", "entity_pmid": 17230508, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }] }, { "pmid": "21507570", "peso_rules": "1.0", "peso_entities": "0.50", "peso_genes": "0.0", "peso_final": 15.4, "article": { "id": 76590, "title_article": "In vitro antitumor activity of silybin nanosuspension in PC-3 cells.", "abstract_article": "The present study aims to evaluate the antitumor activity of silybin nanosuspension on human prostatic carcinoma PC-3 cell line in vitro. Silybin nanosuspension was prepared by the high pressure homogenization (HPH) method. MTT assay, observation of morphological changes and apoptotic body showed that silybin nanosuspension could significantly enhance the in vitro cytotoxicity against PC-3 cells compared to the silybin solution. Flow cytometric (FCM) analysis demonstrated that silybin nanosuspension induced G1 cycle arrest and apoptosis in PC-3 cells. Thereby, the overall results suggest that the silybin nanosuspension represents a potential source of medicine for the treatment of human prostate cancer. ", "pmid": 21507570, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9235777, "FORESTS_PROB": 0.9633333, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 0.99624455, "med": 0.97078735 }, "rule": [{ "id": 249528, "sentence_id": "215075701", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "69", "sentence": "In vitro antitumor activity of CH& n nanosuspension inD&S 3 cells.", "original_sentence": "In vitro antitumor activity of silybin nanosuspension in PC-3 cells.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 12, "peso_genes": 0, "entitiesRules": [{ "id": 1552173, "V1": 4156, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 31, "end_pos": 38, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552174, "V1": 4157, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 57, "end_pos": 61, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249529, "sentence_id": "2150757069", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "69", "end_pos": "206", "sentence": "The present study aims to evaluate the antitumor activity of CH& nanosuspension on human D&S D&S cell line in vitro.", "original_sentence": "The present study aims to evaluate the antitumor activity of silybin nanosuspension on human prostatic carcinoma PC-3 cell line in vitro.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1552175, "V1": 4158, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 130, "end_pos": 137, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552176, "V1": 4159, "pubtatot_term": "prostatic carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 162, "end_pos": 181, "entity_type": "cancer_type_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552177, "V1": 4160, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 182, "end_pos": 186, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249530, "sentence_id": "21507570207", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "207", "end_pos": "292", "sentence": "CH& nanosuspension was prepared by the high pressure homogenization (HPH) method.", "original_sentence": "Silybin nanosuspension was prepared by the high pressure homogenization (HPH) method.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1552178, "V1": 4161, "pubtatot_term": "Silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 207, "end_pos": 214, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249531, "sentence_id": "21507570293", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "293", "end_pos": "501", "sentence": "MTT assay, observation of morphological changes and apoptotic body showed that CH& nanosuspension could significantly enhance the in vitro cytotoxicity against D&S cells compared to the CH& solution.", "original_sentence": "MTT assay, observation of morphological changes and apoptotic body showed that silybin nanosuspension could significantly enhance the in vitro cytotoxicity against PC-3 cells compared to the silybin solution.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1552179, "V1": 4162, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 372, "end_pos": 379, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552181, "V1": 4164, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 484, "end_pos": 491, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552180, "V1": 4163, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 457, "end_pos": 461, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249532, "sentence_id": "21507570502", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "502", "end_pos": "626", "sentence": "Flow cytometric (FCM) analysis demonstrated that CH& nanosuspension induced G1 cycle arrest and apoptosis in D&S cells.", "original_sentence": "Flow cytometric (FCM) analysis demonstrated that silybin nanosuspension induced G1 cycle arrest and apoptosis in PC-3 cells.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1552182, "V1": 4165, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 551, "end_pos": 558, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552183, "V1": 4166, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 615, "end_pos": 619, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249533, "sentence_id": "21507570627", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "627", "end_pos": "781", "sentence": "Thereby, the overall results suggest that the CH& nanosuspension represents a potential source of medicine for the treatment of human D&S.", "original_sentence": "Thereby, the overall results suggest that the silybin nanosuspension represents a potential source of medicine for the treatment of human prostate cancer.", "pmid_article": 21507570, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 5, "peso_genes": 0, "entitiesRules": [{ "id": 1552184, "V1": 4167, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 673, "end_pos": 680, "entity_type": "chemical_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1552185, "V1": 4168, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 765, "end_pos": 780, "entity_type": "cancer_type_entity_p", "entity_pmid": 21507570, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }] }, { "pmid": "25446081", "peso_rules": "0.94", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 15.4, "article": { "id": 57102, "title_article": "Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.", "abstract_article": "Radiotherapy of is well established and frequently utilized in prostate cancer (PCa) patients. However, recurrence following therapy and distant metastases are commonly encountered problems. Previous studies underline that, in addition to its therapeutic effects, ionizing radiation (IR) increases the vascularity and invasiveness of surviving radioresistant cancer cells. This invasive phenotype of radioresistant cells is an upshot of IR-induced pro-survival and mitogenic signaling in cancer as well as endothelial cells. Here, we demonstrate that a plant flavonoid, silibinin can radiosensitize endothelial cells by inhibiting expression of pro-angiogenic factors. Combining silibinin with IR not only strongly down-regulated endothelial cell proliferation, clonogenicity and tube formation ability rather it strongly (p<0.001) reduced migratory and invasive properties of PCa cells which were otherwise marginally affected by IR treatment alone. Most of the pro-angiogenic (VEGF, iNOS), migratory (MMP-2) and EMT promoting proteins (uPA, vimentin, N-cadherin) were up-regulated by IR in PCa cells. Interestingly, all of these invasive and EMT promoting actions of IR were markedly decreased by silibinin. Further, we found that potentiated effect was an end result of attenuation of IR-activated mitogenic and pro-survival signaling, including Akt, Erk1/2 and STAT-3, by silibinin.  ", "pmid": 25446081, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99746495, "FORESTS_PROB": 0.85, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99999964, "med": 0.96186614 }, "rule": [{ "id": 260737, "sentence_id": "254460811", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "106", "sentence": "CH& attenuates ionizing radiation-induced pro-angiogenic response andG&NT in D&S r cells.", "original_sentence": "Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.", "pmid_article": 25446081, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 11, "peso_genes": 1, "entitiesRules": [{ "id": 1609279, "V1": 4408, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1609281, "V1": 4410, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 83, "end_pos": 98, "entity_type": "cancer_type_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260738, "sentence_id": "25446081631", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "631", "end_pos": "774", "sentence": "Here, we demonstrate that a plant CH&, CH& can radiosensitize endothelial cells by inhibiting expression of pro-angiogenic factors.", "original_sentence": "Here, we demonstrate that a plant flavonoid, silibinin can radiosensitize endothelial cells by inhibiting expression of pro-angiogenic factors.", "pmid_article": 25446081, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 2, "entitiesRules": [{ "id": 1609287, "V1": 4416, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 676, "end_pos": 685, "entity_type": "chemical_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260739, "sentence_id": "25446081775", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "sim", "R10": "sim", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "775", "end_pos": "1056", "sentence": "Combining CH& with IR not only strongly down-regulated endothelial cell proliferation, clonogenicity and tube formation ability rather it strongly (p<0_001) reduced migratory and invasive properties of PCa cells which were otherwise marginally affected by IR treatment alone.", "original_sentence": "Combining silibinin with IR not only strongly down-regulated endothelial cell proliferation, clonogenicity and tube formation ability rather it strongly (p<0_001) reduced migratory and invasive properties of PCa cells which were otherwise marginally affected by IR treatment alone.", "pmid_article": 25446081, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 7, "peso_genes": 0, "entitiesRules": [{ "id": 1609288, "V1": 4417, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 785, "end_pos": 794, "entity_type": "chemical_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260740, "sentence_id": "254460811209", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1209", "end_pos": "1315", "sentence": "Interestingly, all of these invasive and G&N promoting actions of IR were markedly decreased by CH& .", "original_sentence": "Interestingly, all of these invasive and EMT promoting actions of IR were markedly decreased by silibinin.", "pmid_article": 25446081, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1609297, "V1": 4426, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1305, "end_pos": 1314, "entity_type": "chemical_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 260741, "sentence_id": "254460811316", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1316", "end_pos": "1492", "sentence": "Further, we found that potentiated effect was an end result of attenuation of IR-activated mitogenic and pro-survival signaling, including G&N, G&N and G&N, by CH&.", "original_sentence": "Further, we found that potentiated effect was an end result of attenuation of IR-activated mitogenic and pro-survival signaling, including Akt, Erk1/2 and STAT-3, by silibinin.", "pmid_article": 25446081, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1609301, "V1": 4430, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1482, "end_pos": 1491, "entity_type": "chemical_entity_p", "entity_pmid": 25446081, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }] }, { "pmid": "18798272", "peso_rules": "0.94", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 14.7, "article": { "id": 76281, "title_article": "Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.", "abstract_article": "Earlier studies have shown the cancer chemopreventive efficacy of silymarin and its semi-purified constituent silibinin against prostate cancer (PCa), but the efficacy of other constituents of silymarin is largely unknown. In the present study, we assessed the in vivo growth inhibitory efficacy of one such constituent isosilibinin (a 50:50 mixture of isosilybin A and isosilybin B) in comparison with silymarin and silibinin in human PCa DU145 xenograft in athymic nude mice. Isosilibinin feeding (200 mg/kg body weight per day) significantly inhibited the growth of xenograft after 53 days of treatment (p < or = 0.005), which was equally or slightly better effective than silymarin and silibinin, respectively. Treatment with isosilibinin, silymarin and silibinin was stopped after 53 days and tumor volume was measured till 77 days. After 24 days of treatments withdrawal, tumor volume remain decreased, however, it was statistically significant only with isosilibinin (p < or = 0.05), suggesting its prolonged effect. Biomarker analysis showed that isosilibinin, silymarin and silibinin treatment for 53 days significantly inhibited the immunoreactivity for proliferating cell nuclear antigen (PCNA), microvessel density (CD31) and vascular endothelial growth factor along with significant increase in apoptotic cell population. The PCNA levels in tumors remained significantly low even after 24 days of treatments withdrawal. Western blot analysis of tumor tissue suggested that these flavonolignan formulations differentially alter the expression of cell cycle regulatory molecules, cyclins and Cdks. Overall, the results of present study suggest that isosilibinin has comparatively better efficacy against PCa and should be further analyzed for its clinical utility. ", "pmid": 18798272, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9304262, "FORESTS_PROB": 0.81666666, "LOGITBOOST_PROB": 0.99999917, "MAXENTROPY_PROB": 0.9999661, "med": 0.93676454 }, "rule": [{ "id": 277590, "sentence_id": "187982721", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "123", "sentence": "Isosilibinin inhibits advanced human D&S r growth in athymic nude mice: comparison with silymarin and CH& n.", "original_sentence": "Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 13, "peso_genes": 1, "entitiesRules": [{ "id": 1693419, "V1": 20096, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 112, "end_pos": 121, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1693418, "V1": 20095, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 37, "end_pos": 52, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277591, "sentence_id": "18798272123", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "sim", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "123", "end_pos": "345", "sentence": "Earlier studies have shown the D&S chemopreventive efficacy of silymarin and its semi-purified constituent CH& against D&S (D&S), but the efficacy of other constituents of silymarin is largely unknown.", "original_sentence": "Earlier studies have shown the cancer chemopreventive efficacy of silymarin and its semi-purified constituent silibinin against prostate cancer (PCa), but the efficacy of other constituents of silymarin is largely unknown.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 6, "peso_genes": 0, "entitiesRules": [{ "id": 1693421, "V1": 20098, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 233, "end_pos": 242, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1693420, "V1": 20097, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 154, "end_pos": 160, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1693422, "V1": 20099, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 251, "end_pos": 266, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1693423, "V1": 20100, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 268, "end_pos": 271, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277592, "sentence_id": "18798272346", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "346", "end_pos": "600", "sentence": "In the present study, we assessed the in vivo growth inhibitory efficacy of one such constituent isosilibinin (a 50:50 mixture of CH& and CH& ) in comparison with silymarin and CH& in human PCa DU145 xenograft in athymic nude mice.", "original_sentence": "In the present study, we assessed the in vivo growth inhibitory efficacy of one such constituent isosilibinin (a 50:50 mixture of isosilybin A and isosilybin B) in comparison with silymarin and silibinin in human PCa DU145 xenograft in athymic nude mice.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1693426, "V1": 20103, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 540, "end_pos": 549, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277593, "sentence_id": "18798272741", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "741", "end_pos": "837", "sentence": "005), which was equally or slightly better effective than silymarin and CH&, respectively.", "original_sentence": "005), which was equally or slightly better effective than silymarin and silibinin, respectively.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1693427, "V1": 20104, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 813, "end_pos": 822, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277594, "sentence_id": "18798272838", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "838", "end_pos": "960", "sentence": "Treatment with isosilibinin, silymarin and CH& was stopped after 53 days and D&S volume was measured till 77 days.", "original_sentence": "Treatment with isosilibinin, silymarin and silibinin was stopped after 53 days and tumor volume was measured till 77 days.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1693428, "V1": 20105, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 881, "end_pos": 890, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }, { "id": 1693429, "V1": 20106, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 921, "end_pos": 926, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277595, "sentence_id": "187982721147", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1147", "end_pos": "1457", "sentence": "Biomarker analysis showed that isosilibinin, silymarin and CH& treatment for 53 days significantly inhibited the immunoreactivity for G&N (G&N ), microvessel density (G&N ) and G&N along with significant increase in apoptotic cell population.", "original_sentence": "Biomarker analysis showed that isosilibinin, silymarin and silibinin treatment for 53 days significantly inhibited the immunoreactivity for proliferating cell nuclear antigen (PCNA), microvessel density (CD31) and vascular endothelial growth factor along with significant increase in apoptotic cell population.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1693431, "V1": 20108, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1206, "end_pos": 1215, "entity_type": "chemical_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }, { "id": 277596, "sentence_id": "187982721556", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1556", "end_pos": "1731", "sentence": "Western blot analysis of D&S tissue suggested that these CH& formulations differentially alter the expression of cell cycle regulatory molecules, cyclins and Cdks.", "original_sentence": "Western blot analysis of tumor tissue suggested that these flavonolignan formulations differentially alter the expression of cell cycle regulatory molecules, cyclins and Cdks.", "pmid_article": 18798272, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1693438, "V1": 20115, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1581, "end_pos": 1586, "entity_type": "cancer_type_entity_p", "entity_pmid": 18798272, "created_at": "2020-10-31T15:12:52.382Z", "updated_at": "2020-10-31T15:12:52.382Z" }] }] }, { "pmid": "15124082", "peso_rules": "0.56", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 14.6, "article": { "id": 76649, "title_article": "Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.", "abstract_article": "The androgen-sensitive human prostate cancer cell line LNCaP expresses the estrogen receptor beta and androgen receptor and can be stimulated by androgens to secrete prostate-specific antigen (PSA). In this study we demonstrate the cancer protective potential of silibinin, a flavolignan derived from the fruits of Silybum marianum, which down-regulates the co-activator of the androgen receptor, the prostate epithelium-derived Ets transcription factor (PDEF) and consequently the secretion of PSA. LNCaP cells were treated with various concentrations of silibinin in the presence or in the absence of 5alpha-dihydrotestosterone (DHT). We used real-time RT-PCR to quantify mRNA expression of PDEF and PSA with gene-specific dual-labelled fluorescence probes. PSA secretion from LNCaP cells in conditioned media was measured with the Elecsys System 2010. Silibinin down-regulated PSA mRNA expression and PSA secretion in conditioned medium under basal and DHT (10(-8) M) stimulated conditions, which was paralleled by PDEF down-regulation. DHT alone stimulated PDEF and PSA gene expression and PSA secretion. The down-regulation of basal as well as DHT stimulated PDEF and PSA by silibinin demonstrates the antiproliferative potential of this agent. These effects underline the possible therapeutic use of silibinin in the management of prostate cancer.", "pmid": 15124082, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.8456508, "FORESTS_PROB": 0.75, "LOGITBOOST_PROB": 0.99966466, "MAXENTROPY_PROB": 0.99957484, "med": 0.8987226 }, "rule": [{ "id": 287514, "sentence_id": "151240821", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "110", "sentence": "CH& down-regulates prostate epithelium-derived Ets transcription factor in D&S r cells.", "original_sentence": "Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 10, "peso_genes": 1, "entitiesRules": [{ "id": 1739427, "V1": 21642, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }, { "id": 1739428, "V1": 21643, "pubtatot_term": "LNCaP prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 81, "end_pos": 102, "entity_type": "cancer_type_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }, { "id": 287515, "sentence_id": "15124082309", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "309", "end_pos": "609", "sentence": "In this study we demonstrate the D&S protective potential of CH&, a flavolignan derived from the fruits of Silybum marianum, which down-regulates the co-activator of the androgen receptor, the prostate epithelium-derived Ets transcription factor (G&N ) and consequently the secretion of G&N.", "original_sentence": "In this study we demonstrate the cancer protective potential of silibinin, a flavolignan derived from the fruits of Silybum marianum, which down-regulates the co-activator of the androgen receptor, the prostate epithelium-derived Ets transcription factor (PDEF) and consequently the secretion of PSA.", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1739432, "V1": 21647, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 373, "end_pos": 382, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }, { "id": 1739431, "V1": 21646, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 342, "end_pos": 348, "entity_type": "cancer_type_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }, { "id": 287516, "sentence_id": "15124082610", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "610", "end_pos": "746", "sentence": "LNCaP cells were treated with various concentrations of CH& in the presence or in the absence of 5alpha-dihydrotestosterone (DHT).", "original_sentence": "LNCaP cells were treated with various concentrations of silibinin in the presence or in the absence of 5alpha-dihydrotestosterone (DHT).", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1739435, "V1": 21650, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 666, "end_pos": 675, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }, { "id": 287517, "sentence_id": "15124082965", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "965", "end_pos": "1149", "sentence": "CH& down-regulated G&N mRNA expression and G&N secretion in conditioned medium under basal and DHT (10(-8) M) stimulated conditions, which was paralleled by G&N down-regulation.", "original_sentence": "Silibinin down-regulated PSA mRNA expression and PSA secretion in conditioned medium under basal and DHT (10(-8) M) stimulated conditions, which was paralleled by PDEF down-regulation.", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1739439, "V1": 21654, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 965, "end_pos": 974, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }, { "id": 287518, "sentence_id": "151240821219", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1219", "end_pos": "1359", "sentence": "The down-regulation of basal as well as DHT stimulated G&N and G&N by CH& demonstrates the antiproliferative potential of this agent.", "original_sentence": "The down-regulation of basal as well as DHT stimulated PDEF and PSA by silibinin demonstrates the antiproliferative potential of this agent.", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 1, "entitiesRules": [{ "id": 1739448, "V1": 21663, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1290, "end_pos": 1299, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }, { "id": 287519, "sentence_id": "151240821360", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1360", "end_pos": "1463", "sentence": "These effects underline the possible therapeutic use of CH& in the management of D&S.", "original_sentence": "These effects underline the possible therapeutic use of silibinin in the management of prostate cancer.", "pmid_article": 15124082, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1739449, "V1": 21664, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1416, "end_pos": 1425, "entity_type": "chemical_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }, { "id": 1739450, "V1": 21665, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1447, "end_pos": 1462, "entity_type": "cancer_type_entity_p", "entity_pmid": 15124082, "created_at": "2020-10-31T15:17:18.945Z", "updated_at": "2020-10-31T15:17:18.945Z" }] }] }, { "pmid": "23555889", "peso_rules": "0.77", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 13.9, "article": { "id": 76259, "title_article": "Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.", "abstract_article": "Silybin or silibinin, a flavonolignan isolated from Milk thistle seeds, is one of the popular dietary supplements and has been extensively studied for its antioxidant, hepatoprotective and anti-cancer properties. We have envisioned that potency of silybin could be further enhanced through suitable modification/s in its chemical structure. Accordingly, here, we synthesized and characterized a series of silybin derivatives namely 2,3-dehydrosilybin (DHS), 7-O-methylsilybin (7OM), 7-O-galloylsilybin (7OG), 7,23-disulphatesilybin (DSS), 7-O-palmitoylsilybin (7OP), and 23-O-palmitoylsilybin (23OP); and compared their anti-cancer efficacy using human bladder cancer HTB9, colon cancer HCT116 and prostate carcinoma PC3 cells. In all the 3 cell lines, DHS, 7OM and 7OG demonstrated better growth inhibitory effects and compared to silybin, while other silybin derivatives showed lesser or no efficacy. Next, we prepared the optical isomers (A and B) of silybin, DHS, 7OM and 7OG, and compared their anti-cancer efficacy. Isomers of these three silybin derivatives also showed better efficacy compared with respective silybin isomers, but in each, there was no clear cut silybin A versus B isomer activity preference. Further studies in HTB cells found that DHS, 7OM and 7OG exert better apoptotic activity than silibinin. Clonogenic assays in HTB9 cells further confirmed that both the racemic mixtures as well as pure optical isomers of DHS, 7OM and 7OG were more effective than silybin. Overall, these results clearly suggest that the anti-cancer efficacy of silybin could be significantly enhanced through structural modifications, and identify strong anti-cancer efficacy of silybin derivatives, namely DHS, 7OM, and 7OG, signifying that their efficacy and toxicity should be evaluated in relevant pre-clinical cancer models in rodents.", "pmid": 23555889, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9938171, "FORESTS_PROB": 0.9, "LOGITBOOST_PROB": 0.99999917, "MAXENTROPY_PROB": 0.9999986, "med": 0.9734537 }, "rule": [{ "id": 245563, "sentence_id": "235558891", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "nao", "start_pos": "1", "end_pos": "82", "sentence": "Anti-cancer efficacy of CH& n derivatives -- a structure-activity relationship.", "original_sentence": "Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 8, "peso_genes": 0, "entitiesRules": [{ "id": 1530426, "V1": 2549, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 24, "end_pos": 31, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245564, "sentence_id": "2355588982", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "sim", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "82", "end_pos": "294", "sentence": "CH& or CH&, a CH& isolated from Milk thistle seeds, is one of the popular dietary supplements and has been extensively studied for its antioxidant, hepatoprotective and anti-cancer properties.", "original_sentence": "Silybin or silibinin, a flavonolignan isolated from Milk thistle seeds, is one of the popular dietary supplements and has been extensively studied for its antioxidant, hepatoprotective and anti-cancer properties.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1530427, "V1": 2550, "pubtatot_term": "Silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 82, "end_pos": 89, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530428, "V1": 2551, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 93, "end_pos": 102, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245565, "sentence_id": "23555889295", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "295", "end_pos": "422", "sentence": "We have envisioned that potency of CH& could be further enhanced through suitable modification/s in its chemical structure.", "original_sentence": "We have envisioned that potency of silybin could be further enhanced through suitable modification/s in its chemical structure.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1530430, "V1": 2553, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 330, "end_pos": 337, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245566, "sentence_id": "23555889423", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "423", "end_pos": "809", "sentence": "Accordingly, here, we synthesized and characterized a series of CH& derivatives namely CH& (CH&), 7-O-methylsilybin (7OM), CH& (CH&), 7,23-disulphatesilybin (DSS), 7-O-palmitoylsilybin (7OP), and 23-O-palmitoylsilybin (23OP); and compared their anti-cancer efficacy using human D&S HTB9, D&S HCT116 and D&S PC3 cells.", "original_sentence": "Accordingly, here, we synthesized and characterized a series of silybin derivatives namely 2,3-dehydrosilybin (DHS), 7-O-methylsilybin (7OM), 7-O-galloylsilybin (7OG), 7,23-disulphatesilybin (DSS), 7-O-palmitoylsilybin (7OP), and 23-O-palmitoylsilybin (23OP); and compared their anti-cancer efficacy using human bladder cancer HTB9, colon cancer HCT116 and prostate carcinoma PC3 cells.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1530431, "V1": 2554, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 487, "end_pos": 494, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530432, "V1": 2555, "pubtatot_term": "2,3-dehydrosilybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 514, "end_pos": 532, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530433, "V1": 2556, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 534, "end_pos": 537, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530436, "V1": 2559, "pubtatot_term": "bladder cancer", "db_term": "Bladder Cancer", "db_equivalence": "Bladder Cancer", "mesh_id": "D001749", "term_id": "524", "start_pos": 735, "end_pos": 749, "entity_type": "cancer_type_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530437, "V1": 2560, "pubtatot_term": "colon cancer", "db_term": "Colorectal Cancer", "db_equivalence": "Colorectal Cancer", "mesh_id": "D015179", "term_id": "15585", "start_pos": 756, "end_pos": 768, "entity_type": "cancer_type_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530438, "V1": 2561, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 780, "end_pos": 798, "entity_type": "cancer_type_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245567, "sentence_id": "23555889810", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "810", "end_pos": "984", "sentence": "In all the 3 cell lines, CH&, 7OM and CH& demonstrated better growth inhibitory effects and compared to CH&, while other CH& derivatives showed lesser or no efficacy.", "original_sentence": "In all the 3 cell lines, DHS, 7OM and 7OG demonstrated better growth inhibitory effects and compared to silybin, while other silybin derivatives showed lesser or no efficacy.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1530439, "V1": 2562, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 835, "end_pos": 838, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530441, "V1": 2564, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 914, "end_pos": 921, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530442, "V1": 2565, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 935, "end_pos": 942, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245568, "sentence_id": "23555889985", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "985", "end_pos": "1103", "sentence": "Next, we prepared the optical isomers (A and B) of CH&, CH&, 7OM and CH&, and compared their anti-cancer efficacy.", "original_sentence": "Next, we prepared the optical isomers (A and B) of silybin, DHS, 7OM and 7OG, and compared their anti-cancer efficacy.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1530443, "V1": 2566, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1036, "end_pos": 1043, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530444, "V1": 2567, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1045, "end_pos": 1048, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245569, "sentence_id": "235558891104", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1104", "end_pos": "1299", "sentence": "Isomers of these three CH& derivatives also showed better efficacy compared with respective CH& isomers, but in each, there was no clear cut silybin A versus B isomer activity preference.", "original_sentence": "Isomers of these three silybin derivatives also showed better efficacy compared with respective silybin isomers, but in each, there was no clear cut silybin A versus B isomer activity preference.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1530446, "V1": 2569, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1127, "end_pos": 1134, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530447, "V1": 2570, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1200, "end_pos": 1207, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245570, "sentence_id": "235558891300", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1300", "end_pos": "1404", "sentence": "Further studies in HTB cells found that CH&, 7OM and CH& exert better apoptotic activity than CH& .", "original_sentence": "Further studies in HTB cells found that DHS, 7OM and 7OG exert better apoptotic activity than silibinin.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1530448, "V1": 2571, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1340, "end_pos": 1343, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530450, "V1": 2573, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1394, "end_pos": 1403, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245571, "sentence_id": "235558891405", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1405", "end_pos": "1571", "sentence": "Clonogenic assays in HTB9 cells further confirmed that both the racemic mixtures as well as pure optical isomers of CH&, 7OM and CH& were more effective than CH& .", "original_sentence": "Clonogenic assays in HTB9 cells further confirmed that both the racemic mixtures as well as pure optical isomers of DHS, 7OM and 7OG were more effective than silybin.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1530451, "V1": 2574, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1521, "end_pos": 1524, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530453, "V1": 2576, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1563, "end_pos": 1570, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245572, "sentence_id": "235558891572", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1572", "end_pos": "1923", "sentence": "Overall, these results clearly suggest that the anti-cancer efficacy of CH& could be significantly enhanced through structural modifications, and identify strong anti-cancer efficacy of CH& derivatives, namely CH&, 7OM, and CH&, signifying that their efficacy and toxicity should be evaluated in relevant pre-clinical D&S models in rodents.", "original_sentence": "Overall, these results clearly suggest that the anti-cancer efficacy of silybin could be significantly enhanced through structural modifications, and identify strong anti-cancer efficacy of silybin derivatives, namely DHS, 7OM, and 7OG, signifying that their efficacy and toxicity should be evaluated in relevant pre-clinical cancer models in rodents.", "pmid_article": 23555889, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1530454, "V1": 2577, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1644, "end_pos": 1651, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530455, "V1": 2578, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1762, "end_pos": 1769, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530456, "V1": 2579, "pubtatot_term": "DHS", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1790, "end_pos": 1793, "entity_type": "chemical_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }, { "id": 1530458, "V1": 2581, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1898, "end_pos": 1904, "entity_type": "cancer_type_entity_p", "entity_pmid": 23555889, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }] }, { "pmid": "16637061", "peso_rules": "0.68", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 13.9, "article": { "id": 76639, "title_article": "Prostate cancer chemoprevention by silibinin: bench to bedside.", "abstract_article": "Prostate cancer (PCA) is the most invasive malignancy and second leading cause of cancer deaths in American males. One approach to reduce PCA incidence, growth and metastasis is prevention and intervention targeted towards mitogenic and survival signaling and cell-cycle regulation. This approach is based on the rationale that overexpression of receptor tyrosine kinases (RTKs) and/or non-receptor tyrosine kinases leads to persistent autocrine stimulation of malignant cells for deregulated cell-cycle progression and uncontrolled growth. PCA progression has also been associated with transition from a paracrine to an autocrine relationship between receptors and growth ligands as this malignancy progresses to an advanced androgen-independent aggressive stage. Together, these studies suggest that targeting RTK-mediated signaling pathways along with cell-cycle regulators could be a practical and translational approach for PCA prevention and intervention. Here, we provide evidence that a naturally occurring nontoxic flavanoid, silibinin, targets the epidermal growth factor receptor (EGFR), insulin-like growth factor-1 receptor (IGF-1R) and NF-kappaB (nuclear factor-kappa B) pathways in PCA. Furthermore, it modulates cell-cycle regulators, including cyclin-dependent kinases (CDKs), Cip/Kip and cyclins for its anticancer efficacy against PCA. Silibinin inhibits growth of PCA cells from human, mouse, and rat origins, and also suppresses human prostate tumor xenograft growth in nude mice. Silibinin also inhibits PCA growth in the transgenic adenocarcinoma of mouse prostate (TRAMP) mouse model. Now, silibinin has been entered into phase I/II clinical trials in human PCA patients where preliminary observations were suggestive of its further study in a larger base of the patient population.", "pmid": 16637061, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9183125, "FORESTS_PROB": 0.78333336, "LOGITBOOST_PROB": 0.98201376, "MAXENTROPY_PROB": 0.9999993, "med": 0.9209147 }, "rule": [{ "id": 282785, "sentence_id": "166370611", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "64", "sentence": "D&S chemoprevention by CH& n: bench to bedside.", "original_sentence": "Prostate cancer chemoprevention by silibinin: bench to bedside.", "pmid_article": 16637061, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 11, "peso_genes": 0, "entitiesRules": [{ "id": 1718015, "V1": 230, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 35, "end_pos": 44, "entity_type": "chemical_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718014, "V1": 229, "pubtatot_term": "Prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1, "end_pos": 15, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }] }, { "id": 282786, "sentence_id": "166370611026", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "1026", "end_pos": "1265", "sentence": "Here, we provide evidence that a naturally occurring nontoxic flavanoid, CH&, targets the G&N (G&N ), G&N ( G&N ) and G&N ( G&N ) pathways in D&S.", "original_sentence": "Here, we provide evidence that a naturally occurring nontoxic flavanoid, silibinin, targets the epidermal growth factor receptor (EGFR), insulin-like growth factor-1 receptor (IGF-1R) and NF-kappaB (nuclear factor-kappa B) pathways in PCA.", "pmid_article": 16637061, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1718022, "V1": 237, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1099, "end_pos": 1108, "entity_type": "chemical_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718029, "V1": 244, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1261, "end_pos": 1264, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }] }, { "id": 282787, "sentence_id": "166370611419", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1419", "end_pos": "1565", "sentence": "CH& inhibits growth of D&S cells from human, mouse, and rat origins, and also suppresses human D&S xenograft growth in nude mice.", "original_sentence": "Silibinin inhibits growth of PCA cells from human, mouse, and rat origins, and also suppresses human prostate tumor xenograft growth in nude mice.", "pmid_article": 16637061, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1718032, "V1": 247, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1419, "end_pos": 1428, "entity_type": "chemical_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718033, "V1": 248, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1448, "end_pos": 1451, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718034, "V1": 249, "pubtatot_term": "prostate tumor", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1520, "end_pos": 1534, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }] }, { "id": 282788, "sentence_id": "166370611566", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1566", "end_pos": "1672", "sentence": "CH& also inhibits D&S growth in the transgenic D&S of mouse prostate (TRAMP) mouse model.", "original_sentence": "Silibinin also inhibits PCA growth in the transgenic adenocarcinoma of mouse prostate (TRAMP) mouse model.", "pmid_article": 16637061, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1718035, "V1": 250, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1566, "end_pos": 1575, "entity_type": "chemical_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718036, "V1": 251, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1590, "end_pos": 1593, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718037, "V1": 252, "pubtatot_term": "adenocarcinoma", "db_term": "Adenocarcinoma", "db_equivalence": "Adenocarcinoma", "mesh_id": "D000230", "term_id": "1274", "start_pos": 1619, "end_pos": 1633, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }] }, { "id": 282789, "sentence_id": "166370611673", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1673", "end_pos": "1870", "sentence": "Now, CH& has been entered into phase I/II clinical trials in human D&S patients where preliminary observations were suggestive of its further study in a larger base of the patient population.", "original_sentence": "Now, silibinin has been entered into phase I/II clinical trials in human PCA patients where preliminary observations were suggestive of its further study in a larger base of the patient population.", "pmid_article": 16637061, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1718038, "V1": 253, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1678, "end_pos": 1687, "entity_type": "chemical_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }, { "id": 1718039, "V1": 254, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1746, "end_pos": 1749, "entity_type": "cancer_type_entity_p", "entity_pmid": 16637061, "created_at": "2020-10-31T15:15:20.227Z", "updated_at": "2020-10-31T15:15:20.227Z" }] }] }, { "pmid": "26516160", "peso_rules": "0.55", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 13.2, "article": { "id": 76523, "title_article": "Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.", "abstract_article": "Radiotherapy, a frequent mode of cancer treatment, is often restricted by dose-related toxicity and development of therapeutic resistance. To develop a novel and selective radiosensitizer, we studied the radiosensitizing effects and associated mechanisms of silibinin in prostate cancer. The radiosensitizing effect of silibinin with ionizing radiation (IR) was assessed on radioresistant prostate cancer cell lines by clonogenic, cell cycle, cell death, and DNA repair assays. Tumor xenograft growth, immunohistochemical (IHC) analysis of tumor tissues, and toxicity-related parameters were measured in vivo. Silibinin (25 μmol/L) enhanced IR (2.5-10 Gy)-caused inhibition (up to 96%, P < 0.001) of colony formation selectively in prostate cancer cells, and prolonged and enhanced IR-caused G2-M arrest, apoptosis, and ROS production. Mechanistically, silibinin inhibited IR-induced DNA repair (ATM and Chk1/2) and EGFR signaling and attenuated the levels of antiapoptotic proteins. Specifically, silibinin suppressed IR-induced nuclear translocation of EGFR and DNA-PK, an important mediator of DSB repair, leading to an increased number of γ-H2AX (ser139) foci suggesting lesser DNA repair. In vivo, silibinin strongly radiosensitized DU145 tumor xenograft inhibition (84%, P < 0.01) with higher apoptotic response (10-fold, P < 0.01) and reduced repair of DNA damage, and rescued the mice from IR-induced toxicity and hematopoietic injury. Overall, silibinin enhanced the radiotherapeutic response via suppressing IR-induced prosurvival signaling and DSB repair by inhibiting nuclear translocation of EGFR and DNA-PK. Because silibinin is already in phase II clinical trial for prostate cancer patients, the present finding has translational relevance for radioresistant prostate cancer. ", "pmid": 26516160, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9961375, "FORESTS_PROB": 0.8833333, "LOGITBOOST_PROB": 0.99999917, "MAXENTROPY_PROB": 0.99999946, "med": 0.96986735 }, "rule": [{ "id": 250983, "sentence_id": "265161601", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "sim", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "93", "sentence": "CH& Preferentially Radiosensitizes D&S r by Inhibiting DNA Repair Signaling.", "original_sentence": "Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 11, "peso_genes": 3, "entitiesRules": [{ "id": 1560052, "V1": 12035, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560053, "V1": 12036, "pubtatot_term": "Prostate Cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 41, "end_pos": 56, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250984, "sentence_id": "26516160232", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "232", "end_pos": "380", "sentence": "To develop a novel and selective radiosensitizer, we studied the radiosensitizing effects and associated mechanisms of CH& in D&S .", "original_sentence": "To develop a novel and selective radiosensitizer, we studied the radiosensitizing effects and associated mechanisms of silibinin in prostate cancer.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1560055, "V1": 12038, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 351, "end_pos": 360, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560056, "V1": 12039, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 364, "end_pos": 379, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250985, "sentence_id": "26516160381", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "sim", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "381", "end_pos": "570", "sentence": "The radiosensitizing effect of CH& with ionizing radiation (IR) was assessed on radioresistant D&S cell lines by clonogenic, cell cycle, cell death, and DNA repair assays.", "original_sentence": "The radiosensitizing effect of silibinin with ionizing radiation (IR) was assessed on radioresistant prostate cancer cell lines by clonogenic, cell cycle, cell death, and DNA repair assays.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1560057, "V1": 12040, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 412, "end_pos": 421, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560058, "V1": 12041, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 482, "end_pos": 497, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250986, "sentence_id": "26516160930", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "sim", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "930", "end_pos": "1077", "sentence": "Mechanistically, CH& n inhibited IR-induced DNA repair (ATM and Chk1/2) and EGFR signaling and attenuated the levels of antiapoptotic proteins.", "original_sentence": "Mechanistically, silibinin inhibited IR-induced DNA repair (ATM and Chk1/2) and EGFR signaling and attenuated the levels of antiapoptotic proteins.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1560062, "V1": 12045, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 946, "end_pos": 955, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250987, "sentence_id": "265161601078", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "sim", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1078", "end_pos": "1288", "sentence": "Specifically, CH& n suppressed IR-induced nuclear translocation of EGFR and DNA-PK, an important mediator of DSB repair, leading to an increased number of γ-H2AX (ser139) foci suggesting lesser DNA repair.", "original_sentence": "Specifically, silibinin suppressed IR-induced nuclear translocation of EGFR and DNA-PK, an important mediator of DSB repair, leading to an increased number of γ-H2AX (ser139) foci suggesting lesser DNA repair.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1560063, "V1": 12046, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1091, "end_pos": 1100, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250988, "sentence_id": "265161601289", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "sim", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1289", "end_pos": "1538", "sentence": "In vivo CH& in strongly radiosensitize D&S 4 D&S or xenograft inhibition (84%, P < 0_01) with higher apoptotic response (10-fold, P < 0_01) and reduced repair of DNA damage, and rescued the mice from IR-induced toxicity an D&S ry.", "original_sentence": "In vivo, silibinin strongly radiosensitized DU145 tumor xenograft inhibition (84%, P < 0_01) with higher apoptotic response (10-fold, P < 0_01) and reduced repair of DNA damage, and rescued the mice from IR-induced toxicity and hematopoietic injury.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1560064, "V1": 12047, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1296, "end_pos": 1305, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560065, "V1": 12048, "pubtatot_term": "DU145", "db_term": "Prostate Cancer", "db_equivalence": "du-145", "mesh_id": "D011471", "term_id": "527", "start_pos": 1331, "end_pos": 1336, "entity_type": "cancer_type_entity_cell", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560066, "V1": 12049, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1337, "end_pos": 1342, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560067, "V1": 12050, "pubtatot_term": "hematopoietic injury", "db_term": "Hematologic Neoplasms", "db_equivalence": "Hematologic Neoplasms", "mesh_id": "D019337", "term_id": "558", "start_pos": 1515, "end_pos": 1535, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250989, "sentence_id": "265161601539", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1539", "end_pos": "1716", "sentence": "Overall CH& in enhanced the radiotherapeutic response via suppressing IR-induced prosurvival signaling and DSB repair by inhibiting nuclear translocation of EGFR and DNA-PK.", "original_sentence": "Overall, silibinin enhanced the radiotherapeutic response via suppressing IR-induced prosurvival signaling and DSB repair by inhibiting nuclear translocation of EGFR and DNA-PK.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1560068, "V1": 12051, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1546, "end_pos": 1555, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }, { "id": 250990, "sentence_id": "265161601717", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1717", "end_pos": "1886", "sentence": "Becaus CH& in is already in phase II clinical trial fo D&S er patients, the present finding has translational relevance for radioresistan D&S er.", "original_sentence": "Because silibinin is already in phase II clinical trial for prostate cancer patients, the present finding has translational relevance for radioresistant prostate cancer.", "pmid_article": 26516160, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1560069, "V1": 12052, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1723, "end_pos": 1732, "entity_type": "chemical_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560070, "V1": 12053, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1775, "end_pos": 1790, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }, { "id": 1560071, "V1": 12054, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1868, "end_pos": 1883, "entity_type": "cancer_type_entity_p", "entity_pmid": 26516160, "created_at": "2020-10-31T15:02:37.055Z", "updated_at": "2020-10-31T15:02:37.055Z" }] }] }, { "pmid": "29147215", "peso_rules": "1.0", "peso_entities": "0.95", "peso_genes": "0.0", "peso_final": 13.1, "article": { "id": 72785, "title_article": "Therapeutic Effect of Epigallocatechin-3-gallate (EGCG) and Silibinin on ATM Dynamics in Prostate Cancer Cell Line LNCaP.", "abstract_article": "Epigallocatechin-3-gallate (EGCG) is a major ingredient of green tea (GT) and silibinin (SB), the active component of Silymarin presumably hold a potential to prevent pathogenomics. Prostate cancer exacerbation is triggered by fusion transcripts formed because of genomic instability induced by juxtapositioning of two genes. This chimeric transcript is implicated in androgen dependent and independent prostate cancer. Tremendous work is done on the characterization of the mediators involved in the disease refractoriness, yet no study has addressed clinical management of these prostate fusion transcripts impressively. An abolished ATM dynamics challenges integrity of DNA. In agreement with this assumption, ATM and DNA-PK were impaired in LNCaP cell line to confirm a tight interaction of these mediators with the expression profile of TMPRSS2-ERG. Abolished ATM enhanced the expression of the fusion transcript. Similarly blunting of DNA-PK downregulated the expression of the fusion transcript giving a notion that DNA-PK is involved in the chromosomal translocation. LNCaP cell lines were analyzed for the effect of EGCG and SB on the expression profile of TMPRSS2-ERG. In this particular unprecedented study, treatment of the LNCaP cell line with EGCG and Silibilin recapitulated ATM expression and activity and downregulated the fusion transcript appearance. These results underscore the therapeutic effect of EGCG and SB in mitigating the exacerbation of the disease with reference to the fusion transcripts.", "pmid": 29147215, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.96867025, "FORESTS_PROB": 0.87666667, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.999859, "med": 0.961299 }, "rule": [{ "id": 261347, "sentence_id": "291472151", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "122", "sentence": "Therapeutic Effect of CH& e CH& G) and CH& n onG&NM Dynamics in D&S r Cell Line LNCaP.", "original_sentence": "Therapeutic Effect of Epigallocatechin-3-gallate (EGCG) and Silibinin on ATM Dynamics in Prostate Cancer Cell Line LNCaP.", "pmid_article": 29147215, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 12, "peso_genes": 0, "entitiesRules": [{ "id": 1612314, "V1": 7443, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 60, "end_pos": 69, "entity_type": "chemical_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612316, "V1": 7445, "pubtatot_term": "Prostate Cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 89, "end_pos": 104, "entity_type": "cancer_type_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261348, "sentence_id": "29147215122", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "122", "end_pos": "315", "sentence": "Background: CH& (CH& ) is a major ingredient of green tea (GT) and CH& (CH&, the active component of Silymarin presumably hold a potential to prevent pathogenomics.", "original_sentence": "Background: Epigallocatechin-3-gallate (EGCG) is a major ingredient of green tea (GT) and silibinin (SB), the active component of Silymarin presumably hold a potential to prevent pathogenomics.", "pmid_article": 29147215, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1612319, "V1": 7448, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 212, "end_pos": 221, "entity_type": "chemical_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612320, "V1": 7449, "pubtatot_term": "SB", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 223, "end_pos": 225, "entity_type": "chemical_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261349, "sentence_id": "291472151219", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1219", "end_pos": "1321", "sentence": "LNCaP cell lines were analyzed for the effect of CH& and CH&on the expression profile of G&N -ERG.", "original_sentence": "LNCaP cell lines were analyzed for the effect of EGCG and SB on the expression profile of TMPRSS2-ERG.", "pmid_article": 29147215, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1612331, "V1": 7460, "pubtatot_term": "SB", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1277, "end_pos": 1279, "entity_type": "chemical_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261350, "sentence_id": "291472151322", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1322", "end_pos": "1521", "sentence": "Results: In this particular unprecedented study, treatment of the LNCaP cell line with CH& and Silibilin recapitulated G&N expression and activity and downregulated the fusion transcript appearance.", "original_sentence": "Results: In this particular unprecedented study, treatment of the LNCaP cell line with EGCG and Silibilin recapitulated ATM expression and activity and downregulated the fusion transcript appearance.", "pmid_article": 29147215, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }, { "id": 261351, "sentence_id": "291472151522", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1522", "end_pos": "1685", "sentence": "Conclusions: These results underscore the therapeutic effect of CH& and CH&in mitigating the exacerbation of the disease with reference to the fusion transcripts.", "original_sentence": "Conclusions: These results underscore the therapeutic effect of EGCG and SB in mitigating the exacerbation of the disease with reference to the fusion transcripts.", "pmid_article": 29147215, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1612336, "V1": 7465, "pubtatot_term": "SB", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1595, "end_pos": 1597, "entity_type": "chemical_entity_p", "entity_pmid": 29147215, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }] }, { "pmid": "23260576", "peso_rules": "0.21", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 12.8, "article": { "id": 76261, "title_article": "Enhanced bioactivity of silybin B methylation products.", "abstract_article": "Flavonolignans from milk thistle (Silybum marianum) have been investigated for their cellular modulatory properties, including cancer chemoprevention and hepatoprotection, as an extract (silymarin), as partially purified mixtures (silibinin and isosilibinin), and as pure compounds (a series of seven isomers). One challenge with the use of these compounds in vivo is their relatively short half-life due to conjugation, particularly glucuronidation. In an attempt to generate analogues with improved in vivo properties, particularly reduced metabolic liability, a semi-synthetic series was prepared in which the hydroxy groups of silybin B were alkylated. A total of five methylated analogues of silybin B were synthesized using standard alkylation conditions (dimethyl sulfate and potassium carbonate in acetone), purified using preparative HPLC, and elucidated via spectroscopy and spectrometry. Of the five, one was monomethylated (3), one was dimethylated (4), two were trimethylated (2 and 6), and one was tetramethylated (5). The relative potency of all compounds was determined in a 72 h growth-inhibition assay against a panel of three prostate cancer cell lines (DU-145, PC-3, and LNCaP) and a human hepatoma cell line (Huh7.5.1) and compared to natural silybin B. Compounds also were evaluated for inhibition of both cytochrome P450 2C9 (CYP2C9) activity in human liver microsomes and hepatitis C virus infection in Huh7.5.1 cells. The monomethyl and dimethyl analogues were shown to have enhanced activity in terms of cytotoxicity, CYP2C9 inhibitory potency, and antiviral activity (up to 6-fold increased potency) compared to the parent compound, silybin B. In total, these data suggested that methylation of flavonolignans can increase bioactivity. ", "pmid": 23260576, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99266505, "FORESTS_PROB": 0.8933333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.99968165, "med": 0.97142 }, "rule": [{ "id": 248850, "sentence_id": "232605761", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "nao", "start_pos": "1", "end_pos": "56", "sentence": "Enhanced bioactivity of CH& B methylation products.", "original_sentence": "Enhanced bioactivity of silybin B methylation products.", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 7, "peso_genes": 2, "entitiesRules": [{ "id": 1547958, "V1": 20081, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 24, "end_pos": 33, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548174, "V1": 157, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 24, "end_pos": 33, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 248851, "sentence_id": "2326057656", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "56", "end_pos": "366", "sentence": "CH& from milk thistle (Silybum marianum) have been investigated for their cellular modulatory properties, including D&S chemoprevention and hepatoprotection, as an extract (silymarin), as partially purified mixtures ( CH& and isosilibinin), and as pure compounds (a series of seven isomers).", "original_sentence": "Flavonolignans from milk thistle (Silybum marianum) have been investigated for their cellular modulatory properties, including cancer chemoprevention and hepatoprotection, as an extract (silymarin), as partially purified mixtures (silibinin and isosilibinin), and as pure compounds (a series of seven isomers).", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1547961, "V1": 20084, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 287, "end_pos": 296, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548177, "V1": 160, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 287, "end_pos": 296, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1547960, "V1": 20083, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 183, "end_pos": 189, "entity_type": "cancer_type_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548176, "V1": 159, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 183, "end_pos": 189, "entity_type": "cancer_type_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 248852, "sentence_id": "23260576507", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "507", "end_pos": "712", "sentence": "In an attempt to generate analogues with improved in vivo properties, particularly reduced metabolic liability, a semi-synthetic series was prepared in which the hydroxy groups of CH& were alkylated.", "original_sentence": "In an attempt to generate analogues with improved in vivo properties, particularly reduced metabolic liability, a semi-synthetic series was prepared in which the hydroxy groups of silybin B were alkylated.", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 2, "entitiesRules": [{ "id": 1547962, "V1": 20085, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 687, "end_pos": 696, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548178, "V1": 161, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 687, "end_pos": 696, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 248853, "sentence_id": "23260576713", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "713", "end_pos": "954", "sentence": "A total of five methylated analogues of CH& were synthesized using standard alkylation conditions (dimethyl sulfate and potassium carbonate in acetone), purified using preparative HPLC, and elucidated via spectroscopy and spectrometry.", "original_sentence": "A total of five methylated analogues of silybin B were synthesized using standard alkylation conditions (dimethyl sulfate and potassium carbonate in acetone), purified using preparative HPLC, and elucidated via spectroscopy and spectrometry.", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1547963, "V1": 20086, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 753, "end_pos": 762, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548179, "V1": 162, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 753, "end_pos": 762, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 248854, "sentence_id": "232605761499", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1499", "end_pos": "1726", "sentence": "The monomethyl and dimethyl analogues were shown to have enhanced activity in terms of cytotoxicity, G&N inhibitory potency, and antiviral activity (up to 6-fold increased potency) compared to the parent compound, CH& .", "original_sentence": "The monomethyl and dimethyl analogues were shown to have enhanced activity in terms of cytotoxicity, CYP2C9 inhibitory potency, and antiviral activity (up to 6-fold increased potency) compared to the parent compound, silybin B.", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1547972, "V1": 20095, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1716, "end_pos": 1725, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1548188, "V1": 171, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1716, "end_pos": 1725, "entity_type": "chemical_entity_p", "entity_pmid": 23260576, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 248855, "sentence_id": "232605761727", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "sim", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1727", "end_pos": "1818", "sentence": "In total, these data suggested that methylation of CH& can increase bioactivity.", "original_sentence": "In total, these data suggested that methylation of flavonolignans can increase bioactivity.", "pmid_article": 23260576, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }] }, { "pmid": "15899838", "peso_rules": "1.0", "peso_entities": "0.81", "peso_genes": "0.0", "peso_final": 12.6, "article": { "id": 61109, "title_article": "Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.", "abstract_article": "Extracts from the seeds of milk thistle, Silybum marianum, are known commonly as silibinin and silymarin and possess anticancer actions on human prostate carcinoma in vitro and in vivo. Seven distinct flavonolignan compounds and a flavonoid have been isolated from commercial silymarin extracts. Most notably, two pairs of diastereomers, silybin A and silybin B and isosilybin A and isosilybin B, are among these compounds. In contrast, silibinin is composed only of a 1:1 mixture of silybin A and silybin B. With these isomers now isolated in quantities sufficient for biological studies, each pure compound was assessed for antiproliferative activities against LNCaP, DU145, and PC3 human prostate carcinoma cell lines. Isosilybin B was the most consistently potent suppressor of cell growth relative to either the other pure constituents or the commercial extracts. Isosilybin A and isosilybin B were also the most effective suppressors of prostate-specific antigen secretion by androgen-dependent LNCaP cells. Silymarin and silibinin were shown for the first time to suppress the activity of the DNA topoisomerase IIalpha gene promoter in DU145 cells and, among the pure compounds, isosilybin B was again the most effective. These findings are significant in that isosilybin B composes no more than 5% of silymarin and is absent from silibinin. Whereas several other more abundant flavonolignans do ultimately influence the same end points at higher exposure concentrations, these findings are suggestive that extracts enriched for isosilybin B, or isosilybin B alone, might possess improved potency in prostate cancer prevention and treatment.", "pmid": 15899838, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.989506, "FORESTS_PROB": 0.8466667, "LOGITBOOST_PROB": 0.99966466, "MAXENTROPY_PROB": 0.99974656, "med": 0.958896 }, "rule": [{ "id": 263754, "sentence_id": "158998381", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "167", "sentence": "Milk thistle and D&S r: differential effects of pure CH& s from Silybum marianum on antiproliferative end points in human D&S a cells.", "original_sentence": "Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1624493, "V1": 1891, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 17, "end_pos": 32, "entity_type": "cancer_type_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1624495, "V1": 1893, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 141, "end_pos": 159, "entity_type": "cancer_type_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263755, "sentence_id": "15899838167", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "167", "end_pos": "352", "sentence": "Extracts from the seeds of milk thistle, Silybum marianum, are known commonly as CH& and silymarin and possess anticancer actions on human D&S in vitro and in vivo.", "original_sentence": "Extracts from the seeds of milk thistle, Silybum marianum, are known commonly as silibinin and silymarin and possess anticancer actions on human prostate carcinoma in vitro and in vivo.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1624496, "V1": 1894, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 248, "end_pos": 257, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1624497, "V1": 1895, "pubtatot_term": "prostate carcinoma", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 312, "end_pos": 330, "entity_type": "cancer_type_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263756, "sentence_id": "15899838353", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "353", "end_pos": "462", "sentence": "Seven distinct CH& compounds and a CH& have been isolated from commercial silymarin extracts.", "original_sentence": "Seven distinct flavonolignan compounds and a flavonoid have been isolated from commercial silymarin extracts.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 263757, "sentence_id": "15899838463", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "463", "end_pos": "590", "sentence": "Most notably, two pairs of diastereomers, CH& and CH& and CH& and CH&, are among these compounds.", "original_sentence": "Most notably, two pairs of diastereomers, silybin A and silybin B and isosilybin A and isosilybin B, are among these compounds.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1624500, "V1": 1898, "pubtatot_term": "silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 505, "end_pos": 514, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1624501, "V1": 1899, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 519, "end_pos": 528, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263758, "sentence_id": "15899838591", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "591", "end_pos": "675", "sentence": "In contrast, CH& is composed only of a 1:1 mixture of CH& and CH& .", "original_sentence": "In contrast, silibinin is composed only of a 1:1 mixture of silybin A and silybin B.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1624504, "V1": 1902, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 604, "end_pos": 613, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1624505, "V1": 1903, "pubtatot_term": "silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 651, "end_pos": 660, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }, { "id": 1624506, "V1": 1904, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 665, "end_pos": 674, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263759, "sentence_id": "15899838889", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "889", "end_pos": "1035", "sentence": "CH& was the most consistently potent suppressor of cell growth relative to either the other pure constituents or the commercial extracts.", "original_sentence": "Isosilybin B was the most consistently potent suppressor of cell growth relative to either the other pure constituents or the commercial extracts.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [] }, { "id": 263760, "sentence_id": "158998381036", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1036", "end_pos": "1180", "sentence": "CH& and CH& were also the most effective suppressors of G&N secretion by androgen-dependent LNCaP cells.", "original_sentence": "Isosilybin A and isosilybin B were also the most effective suppressors of prostate-specific antigen secretion by androgen-dependent LNCaP cells.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }, { "id": 263761, "sentence_id": "158998381181", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1181", "end_pos": "1395", "sentence": "Silymarin and CH& were shown for the first time to suppress the activity of the DNA topoisomerase IIalpha gene promoter in DU145 cells and, among the pure compounds, CH& was again the most effective.", "original_sentence": "Silymarin and silibinin were shown for the first time to suppress the activity of the DNA topoisomerase IIalpha gene promoter in DU145 cells and, among the pure compounds, isosilybin B was again the most effective.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 2, "entitiesRules": [{ "id": 1624513, "V1": 1911, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1195, "end_pos": 1204, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263762, "sentence_id": "158998381396", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1396", "end_pos": "1515", "sentence": "These findings are significant in that CH& composes no more than 5% of silymarin and is absent from CH& .", "original_sentence": "These findings are significant in that isosilybin B composes no more than 5% of silymarin and is absent from silibinin.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1624516, "V1": 1914, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1505, "end_pos": 1514, "entity_type": "chemical_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }, { "id": 263763, "sentence_id": "158998381516", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1516", "end_pos": "1815", "sentence": "Whereas several other more abundant CH& do ultimately influence the same end points at higher exposure concentrations, these findings are suggestive that extracts enriched for CH&, or CH& alone, might possess improved potency in D&S prevention and treatment.", "original_sentence": "Whereas several other more abundant flavonolignans do ultimately influence the same end points at higher exposure concentrations, these findings are suggestive that extracts enriched for isosilybin B, or isosilybin B alone, might possess improved potency in prostate cancer prevention and treatment.", "pmid_article": 15899838, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1624520, "V1": 1918, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1774, "end_pos": 1789, "entity_type": "cancer_type_entity_p", "entity_pmid": 15899838, "created_at": "2020-10-31T15:07:53.394Z", "updated_at": "2020-10-31T15:07:53.394Z" }] }] }, { "pmid": "21166494", "peso_rules": "1.0", "peso_entities": "0.29", "peso_genes": "0.0", "peso_final": 11.8, "article": { "id": 59386, "title_article": "Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway.", "abstract_article": "Silibinin, a natural flavonoid, under phase I/II clinical trial in prostate cancer patients was aimed to evaluate its chemotherapeutic potential in human breast cancer cell MCF7 and T47D. Results showed that T47D cells were found to be more sensitive to silibinin than MCF7 as observed by proliferation, clonogenic, and apoptotic assays, which was abrogated by pan-caspase inhibitor but remained unaffected by p53 inhibitor. Apoptotic events in both cell types differ temporally and also by magnitude that involved mitochondrial and caspase-8 activation pathway. These results have relevance in understanding silibinin treatment to breast tumor.", "pmid": 21166494, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9596202, "FORESTS_PROB": 0.8566667, "LOGITBOOST_PROB": 0.98201376, "MAXENTROPY_PROB": 0.9991137, "med": 0.9493536 }, "rule": [{ "id": 271158, "sentence_id": "211664941", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "sim", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "131", "sentence": "CH& -induced apoptosis in MCF7 andD&S D human D&S a cells involves G&N 8 activation and mitochondrial pathway.", "original_sentence": "Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway.", "pmid_article": 21166494, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 12, "peso_genes": 3, "entitiesRules": [{ "id": 1662593, "V1": 5782, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662594, "V1": 5783, "pubtatot_term": "T47D", "db_term": "Breast Cancer", "db_equivalence": "t47d", "mesh_id": "D001943", "term_id": "484", "start_pos": 40, "end_pos": 44, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662595, "V1": 5784, "pubtatot_term": "breast carcinoma", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 51, "end_pos": 67, "entity_type": "cancer_type_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }] }, { "id": 271159, "sentence_id": "21166494131", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "131", "end_pos": "318", "sentence": "CH&, a natural CH&, under phase I/II clinical trial in D&S patients was aimed to evaluate its chemotherapeutic potential in human D&S cell MCF7 and T47D.", "original_sentence": "Silibinin, a natural flavonoid, under phase I/II clinical trial in prostate cancer patients was aimed to evaluate its chemotherapeutic potential in human breast cancer cell MCF7 and T47D.", "pmid_article": 21166494, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1662597, "V1": 5786, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 131, "end_pos": 140, "entity_type": "chemical_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662599, "V1": 5788, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 198, "end_pos": 213, "entity_type": "cancer_type_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662600, "V1": 5789, "pubtatot_term": "breast cancer", "db_term": "Breast Cancer", "db_equivalence": "Breast Cancer", "mesh_id": "D001943", "term_id": "484", "start_pos": 285, "end_pos": 298, "entity_type": "cancer_type_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }] }, { "id": 271160, "sentence_id": "21166494319", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "319", "end_pos": "555", "sentence": "Results showed that D&S cells were found to be more sensitive to CH& than MCF7 as observed by proliferation, clonogenic, and apoptotic assays, which was abrogated by pan-caspase inhibitor but remained unaffected by G&N inhibitor.", "original_sentence": "Results showed that T47D cells were found to be more sensitive to silibinin than MCF7 as observed by proliferation, clonogenic, and apoptotic assays, which was abrogated by pan-caspase inhibitor but remained unaffected by p53 inhibitor.", "pmid_article": 21166494, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "sim", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1662602, "V1": 5791, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 385, "end_pos": 394, "entity_type": "chemical_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662601, "V1": 5790, "pubtatot_term": "T47D", "db_term": "Breast Cancer", "db_equivalence": "t47d", "mesh_id": "D001943", "term_id": "484", "start_pos": 339, "end_pos": 343, "entity_type": "cancer_type_entity_cell", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }] }, { "id": 271161, "sentence_id": "21166494694", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "694", "end_pos": "776", "sentence": "These results have relevance in understanding CH& treatment to D&S.", "original_sentence": "These results have relevance in understanding silibinin treatment to breast tumor.", "pmid_article": 21166494, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1662605, "V1": 5794, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 740, "end_pos": 749, "entity_type": "chemical_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }, { "id": 1662606, "V1": 5795, "pubtatot_term": "breast tumor", "db_term": "Hereditary Breast and Ovarian Cancer Syndrome", "db_equivalence": "Hereditary Breast and Ovarian Cancer Syndrome", "mesh_id": "D061325", "term_id": "486", "start_pos": 763, "end_pos": 775, "entity_type": "cancer_type_entity_p", "entity_pmid": 21166494, "created_at": "2020-10-31T15:10:45.270Z", "updated_at": "2020-10-31T15:10:45.270Z" }] }] }, { "pmid": "28756013", "peso_rules": "0.82", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 11.4, "article": { "id": 76494, "title_article": "5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.", "abstract_article": "To investigate the effects of alkylation at 5-OH and 20-OH of 2,3-dehydrosilybin on prostate cancer cell proliferation, the synthetic approaches to 5- or/and 20-O-alkyl-2,3-dehydrosilybins, through a multi-step sequence from commercially available silybin, have been successfully developed. The first three reactions in the syntheses were completed through a one-pot procedure by managing anaerobic and aerobic conditions. With these synthetic methods in hand, twenty-one 2,3-dehydrosilybins, including seven 20-O-alkyl, seven 5,20-O-dialkyl, and seven 5-O-alkyl-2,3-dehydrosilybins, have been achieved for the evaluation of their biological profiles. Our WST-1 cell proliferation assay data indicate that nineteen out of the twenty-one 2,3-dehydrosilybins possess significantly improved antiproliferative potency as compared with silybin toward both androgen-sensitive (LNCaP) and androgen-insensitive prostate cancer cell lines (PC-3 and DU145). 5-O-Alkyl-2,3-dehydrosilybins were identified as the optimal subgroup that can consistently inhibit cell proliferation in three prostate cancer cell models with all IC50 values lower than 8µM. Our flow cytometry-based assays also demonstrate that 5-O-heptyl-2,3-dehydrosilybin effectively arrests the cell cycle in the G0/G1 phase and activates PC-3 cell apoptosis. ", "pmid": 28756013, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.98886096, "FORESTS_PROB": 0.8566667, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.99962294, "med": 0.9612876 }, "rule": [{ "id": 261352, "sentence_id": "287560131", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim", "start_pos": "1", "end_pos": "108", "sentence": "5- or/and CH& s: Synthesis and biological profiles on D&S r cell models.", "original_sentence": "5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 10, "peso_genes": 0, "entitiesRules": [{ "id": 1612371, "V1": 7500, "pubtatot_term": "20-O-alkyl-2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 10, "end_pos": 40, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612372, "V1": 7501, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 79, "end_pos": 94, "entity_type": "cancer_type_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261353, "sentence_id": "28756013108", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "108", "end_pos": "398", "sentence": "To investigate the effects of alkylation at 5-OH and 20-OH of CH& on prostate D&S cell proliferation, the synthetic approaches to 5- or/and CH&, through a multi-step sequence from commercially available CH&, have been successfully developed.", "original_sentence": "To investigate the effects of alkylation at 5-OH and 20-OH of 2,3-dehydrosilybin on prostate cancer cell proliferation, the synthetic approaches to 5- or/and 20-O-alkyl-2,3-dehydrosilybins, through a multi-step sequence from commercially available silybin, have been successfully developed.", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1612373, "V1": 7502, "pubtatot_term": "2,3-dehydrosilybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 170, "end_pos": 188, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612375, "V1": 7504, "pubtatot_term": "20-O-alkyl-2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 266, "end_pos": 296, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612376, "V1": 7505, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 356, "end_pos": 363, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612374, "V1": 7503, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 201, "end_pos": 207, "entity_type": "cancer_type_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261354, "sentence_id": "28756013531", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "531", "end_pos": "759", "sentence": "With these synthetic methods in hand, twenty-one CH&, including seven 20-O-alkyl, seven 5,20-O-dialkyl, and seven CH&, have been achieved for the evaluation of their biological profiles.", "original_sentence": "With these synthetic methods in hand, twenty-one 2,3-dehydrosilybins, including seven 20-O-alkyl, seven 5,20-O-dialkyl, and seven 5-O-alkyl-2,3-dehydrosilybins, have been achieved for the evaluation of their biological profiles.", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1612377, "V1": 7506, "pubtatot_term": "2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 580, "end_pos": 599, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612378, "V1": 7507, "pubtatot_term": "5-O-alkyl-2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 661, "end_pos": 690, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261355, "sentence_id": "28756013760", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "760", "end_pos": "1055", "sentence": "Our WST-1 cell proliferation assay data indicate that nineteen out of the twenty-one CH& possess significantly improved antiproliferative potency as compared with CH& toward both androgen-sensitive ( D&S ) and androgen-insensitive D&S cell lines (D&S and D&S ).", "original_sentence": "Our WST-1 cell proliferation assay data indicate that nineteen out of the twenty-one 2,3-dehydrosilybins possess significantly improved antiproliferative potency as compared with silybin toward both androgen-sensitive (LNCaP) and androgen-insensitive prostate cancer cell lines (PC-3 and DU145).", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1612379, "V1": 7508, "pubtatot_term": "2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 845, "end_pos": 864, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612380, "V1": 7509, "pubtatot_term": "silybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 939, "end_pos": 946, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612381, "V1": 7510, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 979, "end_pos": 984, "entity_type": "cancer_type_entity_cell", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612382, "V1": 7511, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1011, "end_pos": 1026, "entity_type": "cancer_type_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612383, "V1": 7512, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1039, "end_pos": 1043, "entity_type": "cancer_type_entity_cell", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612384, "V1": 7513, "pubtatot_term": "DU145", "db_term": "Prostate Cancer", "db_equivalence": "du-145", "mesh_id": "D011471", "term_id": "527", "start_pos": 1048, "end_pos": 1053, "entity_type": "cancer_type_entity_cell", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261356, "sentence_id": "287560131056", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1056", "end_pos": "1249", "sentence": "CH& were identified as the optimal subgroup that can consistently inhibit cell proliferation in three D&S cell models with all IC50 values lower than 8µM.", "original_sentence": "5-O-Alkyl-2,3-dehydrosilybins were identified as the optimal subgroup that can consistently inhibit cell proliferation in three prostate cancer cell models with all IC50 values lower than 8µM.", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 3, "peso_genes": 1, "entitiesRules": [{ "id": 1612385, "V1": 7514, "pubtatot_term": "5-O-Alkyl-2,3-dehydrosilybins", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1056, "end_pos": 1085, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612386, "V1": 7515, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1184, "end_pos": 1199, "entity_type": "cancer_type_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }, { "id": 261357, "sentence_id": "287560131250", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1250", "end_pos": "1422", "sentence": "Our flow cytometry-based assays also demonstrate that CH& n effectively arrests the cell cycle in the G0/G1 phase and activatesD&S 3 cell apoptosis.", "original_sentence": "Our flow cytometry-based assays also demonstrate that 5-O-heptyl-2,3-dehydrosilybin effectively arrests the cell cycle in the G0/G1 phase and activates PC-3 cell apoptosis.", "pmid_article": 28756013, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1612387, "V1": 7516, "pubtatot_term": "5-O-heptyl-2,3-dehydrosilybin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1303, "end_pos": 1332, "entity_type": "chemical_entity_p", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }, { "id": 1612388, "V1": 7517, "pubtatot_term": "PC-3", "db_term": "Prostate Cancer", "db_equivalence": "pc-3", "mesh_id": "D011471", "term_id": "527", "start_pos": 1401, "end_pos": 1405, "entity_type": "cancer_type_entity_cell", "entity_pmid": 28756013, "created_at": "2020-10-31T15:07:10.830Z", "updated_at": "2020-10-31T15:07:10.830Z" }] }] }, { "pmid": "22514647", "peso_rules": "1.0", "peso_entities": "0.94", "peso_genes": "0.0", "peso_final": 11, "article": { "id": 76266, "title_article": "Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.", "abstract_article": "The role of neo-angiogenesis in prostate cancer (PCA) growth and metastasis is well established, but the development of effective and non-toxic pharmacological inhibitors of angiogenesis remains an unaccomplished goal. In this regard, targeting aberrant angiogenesis through non-toxic phytochemicals could be an attractive angiopreventive strategy against PCA. The rationale of the present study was to compare the anti-angiogenic potential of four pure diastereoisomeric flavonolignans, namely silybin A, silybin B, isosilybin A and isosilybin B, which we established previously as biologically active constituents in Milk Thistle extract. Results showed that oral feeding of these flavonolignans (50 and 100 mg/kg body weight) effectively inhibit the growth of advanced human PCA DU145 xenografts. Immunohistochemical analyses revealed that these flavonolignans inhibit tumor angiogenesis biomarkers (CD31 and nestin) and signaling molecules regulating angiogenesis (VEGF, VEGFR1, VEGFR2, phospho-Akt and HIF-1α) without adversely affecting the vessel-count in normal tissues (liver, lung, and kidney) of tumor bearing mice. These flavonolignans also inhibited the microvessel sprouting from mouse dorsal aortas ex vivo, and the VEGF-induced cell proliferation, capillary-like tube formation and invasiveness of human umbilical vein endothelial cells (HUVEC) in vitro. Further studies in HUVEC showed that these diastereoisomers target cell cycle, apoptosis and VEGF-induced signaling cascade. Three dimensional growth assay as well as co-culture invasion and in vitro angiogenesis studies (with HUVEC and DU145 cells) suggested the differential effectiveness of the diastereoisomers toward PCA and endothelial cells. Overall, these studies elucidated the comparative anti-angiogenic efficacy of pure flavonolignans from Milk Thistle and suggest their usefulness in PCA angioprevention.", "pmid": 22514647, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9965985, "FORESTS_PROB": 0.94, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999998, "med": 0.9841496 }, "rule": [{ "id": 226200, "sentence_id": "225146471", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "sim3", "start_pos": "1", "end_pos": "131", "sentence": "Angiopreventive efficacy of pure CH& s from milk thistle extract against D&S r: targetingG&N F-VEGFR signaling.", "original_sentence": "Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 7, "peso_genes": 0, "entitiesRules": [{ "id": 1425619, "V1": 3857, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 82, "end_pos": 97, "entity_type": "cancer_type_entity_p", "entity_pmid": 22514647, "created_at": "2020-10-31T14:48:53.837Z", "updated_at": "2020-10-31T14:48:53.837Z" }] }, { "id": 226201, "sentence_id": "22514647492", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "492", "end_pos": "771", "sentence": "The rationale of the present study was to compare the anti-angiogenic potential of four pure diastereoisomeric CH&, namely CH&, CH&, CH& and CH&, which we established previously as biologically active constituents in Milk Thistle extract.", "original_sentence": "The rationale of the present study was to compare the anti-angiogenic potential of four pure diastereoisomeric flavonolignans, namely silybin A, silybin B, isosilybin A and isosilybin B, which we established previously as biologically active constituents in Milk Thistle extract.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1425623, "V1": 3861, "pubtatot_term": "silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 626, "end_pos": 635, "entity_type": "chemical_entity_p", "entity_pmid": 22514647, "created_at": "2020-10-31T14:48:53.837Z", "updated_at": "2020-10-31T14:48:53.837Z" }, { "id": 1425624, "V1": 3862, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 637, "end_pos": 646, "entity_type": "chemical_entity_p", "entity_pmid": 22514647, "created_at": "2020-10-31T14:48:53.837Z", "updated_at": "2020-10-31T14:48:53.837Z" }] }, { "id": 226202, "sentence_id": "22514647772", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "772", "end_pos": "930", "sentence": "Results showed that oral feeding of these CH& (50 and 100 mg/kg body weight) effectively inhibit the growth of advanced human PCA DU145 xenografts.", "original_sentence": "Results showed that oral feeding of these flavonolignans (50 and 100 mg/kg body weight) effectively inhibit the growth of advanced human PCA DU145 xenografts.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [] }, { "id": 226203, "sentence_id": "22514647931", "association_type": "polifenol-cancer", "R1": "sim", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "931", "end_pos": "1258", "sentence": "Immunohistochemical analyses revealed that these CH& inhibit D&S angiogenesis biomarkers (G&N and nestin) and signaling molecules regulating angiogenesis (G&N, G&N, G&N, phospho-G&N and G&N �) without adversely affecting the vessel-count in normal tissues (liver, lung, and kidney) of D&S r bearing mice.", "original_sentence": "Immunohistochemical analyses revealed that these flavonolignans inhibit tumor angiogenesis biomarkers (CD31 and nestin) and signaling molecules regulating angiogenesis (VEGF, VEGFR1, VEGFR2, phospho-Akt and HIF-1α) without adversely affecting the vessel-count in normal tissues (liver, lung, and kidney) of tumor bearing mice.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 1, "peso_genes": 0, "entitiesRules": [{ "id": 1425629, "V1": 3867, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1003, "end_pos": 1008, "entity_type": "cancer_type_entity_p", "entity_pmid": 22514647, "created_at": "2020-10-31T14:48:53.837Z", "updated_at": "2020-10-31T14:48:53.837Z" }, { "id": 1425636, "V1": 3874, "pubtatot_term": "tumor", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1238, "end_pos": 1243, "entity_type": "cancer_type_entity_p", "entity_pmid": 22514647, "created_at": "2020-10-31T14:48:53.837Z", "updated_at": "2020-10-31T14:48:53.837Z" }] }, { "id": 226204, "sentence_id": "225146471259", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "sim", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1259", "end_pos": "1502", "sentence": "These CH& s also inhibited the microvessel sprouting from mouse dorsal aortas ex vivo, and theG&N F-induced cell proliferation, capillary-like tube formation and invasiveness of human umbilical vein endothelial cells (HUVEC) in vitro.", "original_sentence": "These flavonolignans also inhibited the microvessel sprouting from mouse dorsal aortas ex vivo, and the VEGF-induced cell proliferation, capillary-like tube formation and invasiveness of human umbilical vein endothelial cells (HUVEC) in vitro.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }, { "id": 226205, "sentence_id": "225146471852", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "sim", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1852", "end_pos": "2020", "sentence": "Overall, these studies elucidated the comparative anti-angiogenic efficacy of pure CH& s from Milk Thistle and suggest their usefulness in PCA angioprevention.", "original_sentence": "Overall, these studies elucidated the comparative anti-angiogenic efficacy of pure flavonolignans from Milk Thistle and suggest their usefulness in PCA angioprevention.", "pmid_article": 22514647, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "sim", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [] }] }, { "pmid": "26748997", "peso_rules": "1.0", "peso_entities": "0.93", "peso_genes": "0.0", "peso_final": 10.6, "article": { "id": 76521, "title_article": "Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.", "abstract_article": "This study aims to systematically explore the alkylation effect of 7-OH in silibinin and 2,3-dehydrosilibinin on the antiproliferative potency toward three prostate cancer cell lines. Eight 7-O-alkylsilibinins, eight 7-O-alkyl-2,3-dehydrosilibinins, and eight 3,7-O-dialkyl-2,3-dehydrosilibinins have been synthesized from commercially available silibinin for the in vitro cell-based evaluation. The WST-1 cell proliferation assay indicates that nineteen out of twenty-four silibinin derivatives have significantly improved antiproliferative potency when compared with silibinin. 7-O-Methylsilibinin (2) and 7-O-ethylsilibinin (3) have been identified as the most potent compounds with 98- and 123-fold enhanced potency against LNCaP human androgen-dependent prostate cancer cell line. Among 2,3-dehydrosilibinin derivatives, 7-O-methyl-2,3-dehydrosilibinin (10) and 7-O-ethyl-2,3-dehydrosilibinin (11) have been identified as the optimal compounds with the highest potency towards both androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cell lines. 7-O-Ethyl-2,3-dehydrosilibinin (11) was demonstrated to arrest PC-3 cell cycle at the G0/G1 phase and to induce PC-3 cell apoptosis. The findings in this study suggest that antiproliferative potency of silibinin and 2,3-dehydrosilibinin can be appreciably enhanced through suitable chemical modifications on the phenolic hydroxyl group at C-7 and that introduction of a chemical moiety with the potential to improve bioavailability through a linker to 7-OH in silibinin and 2,3-dehydrosilibinin would be a feasible strategy for the development of silibinin derivatives as anti-prostate cancer agents.  ", "pmid": 26748997, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9901352, "FORESTS_PROB": 0.88, "LOGITBOOST_PROB": 0.9999546, "MAXENTROPY_PROB": 0.9985419, "med": 0.9671579 }, "rule": [{ "id": 254734, "sentence_id": "267489971", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "sim", "has_entity": "sim", "is_association": "nao", "start_pos": "1", "end_pos": "92", "sentence": "CH& derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.", "original_sentence": "Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.", "pmid_article": 26748997, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 8, "peso_genes": 0, "entitiesRules": [{ "id": 1579078, "V1": 31061, "pubtatot_term": "Silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1, "end_pos": 9, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254735, "sentence_id": "2674899792", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "92", "end_pos": "275", "sentence": "This study aims to systematically explore the alkylation effect of 7-OH in CH& and 2,3-dehydrosilibinin on the antiproliferative potency toward three D&S cell lines.", "original_sentence": "This study aims to systematically explore the alkylation effect of 7-OH in silibinin and 2,3-dehydrosilibinin on the antiproliferative potency toward three prostate cancer cell lines.", "pmid_article": 26748997, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1579079, "V1": 31062, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 167, "end_pos": 176, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1579080, "V1": 31063, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 248, "end_pos": 263, "entity_type": "cancer_type_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254736, "sentence_id": "26748997276", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "276", "end_pos": "488", "sentence": "Eight 7-O-alkylsilibinins, eight 7-O-alkyl-2,3-dehydrosilibinins, and eight 3,7-O-dialkyl-2,3-dehydrosilibinins have been synthesized from commercially available CH& for the in� vitro cell-based evaluation.", "original_sentence": "Eight 7-O-alkylsilibinins, eight 7-O-alkyl-2,3-dehydrosilibinins, and eight 3,7-O-dialkyl-2,3-dehydrosilibinins have been synthesized from commercially available silibinin for the in� vitro cell-based evaluation.", "pmid_article": 26748997, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1579081, "V1": 31064, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 438, "end_pos": 447, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254737, "sentence_id": "26748997489", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "489", "end_pos": "672", "sentence": "The WST-1� cell proliferation assay indicates that nineteen out of twenty-fou CH& in derivatives have significantly improved antiproliferative potency when compared wit CH& in.", "original_sentence": "The WST-1� cell proliferation assay indicates that nineteen out of twenty-four silibinin derivatives have significantly improved antiproliferative potency when compared with silibinin.", "pmid_article": 26748997, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1579082, "V1": 31065, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 566, "end_pos": 575, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1579083, "V1": 31066, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 661, "end_pos": 670, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }, { "id": 254738, "sentence_id": "267489971299", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1299", "end_pos": "1766", "sentence": "The findings in this study suggest that antiproliferative potency CH& inin and 2,3-dehydrosilibinin can be appreciably enhanced through suitable chemical modifications on CH& oxyl group at C-7 and that introduction of a chemical moiety with the potential to improve bioavailability through a linker to 7-OH CH& inin and 2,3-dehydrosilibinin would be a feasible strategy for the development CH& inin derivatives as anti-prost D&S ncer agents.", "original_sentence": "The findings in this study suggest that antiproliferative potency of silibinin and 2,3-dehydrosilibinin can be appreciably enhanced through suitable chemical modifications on the phenolic hydroxyl group at C-7 and that introduction of a chemical moiety with the potential to improve bioavailability through a linker to 7-OH in silibinin and 2,3-dehydrosilibinin would be a feasible strategy for the development of silibinin derivatives as anti-prostate cancer agents.", "pmid_article": 26748997, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "sim", "peso_frase": 5, "peso_genes": 1, "entitiesRules": [{ "id": 1579088, "V1": 31071, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1364, "end_pos": 1373, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1579090, "V1": 31073, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1622, "end_pos": 1631, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1579091, "V1": 31074, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1709, "end_pos": 1718, "entity_type": "chemical_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }, { "id": 1579092, "V1": 31075, "pubtatot_term": "cancer", "db_term": "Cancers", "db_equivalence": "Cancers", "mesh_id": "D009369", "term_id": "10007", "start_pos": 1748, "end_pos": 1754, "entity_type": "cancer_type_entity_p", "entity_pmid": 26748997, "created_at": "2020-10-31T15:04:27.288Z", "updated_at": "2020-10-31T15:04:27.288Z" }] }] }, { "pmid": "18435416", "peso_rules": "0.45", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 9.4, "article": { "id": 76283, "title_article": "Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.", "abstract_article": "Prostate cancer (PCa) is the leading cause of cancer-related deaths in men; urgent measures are warranted to lower this deadly malignancy. Silymarin is a known cancer chemopreventive agent, but the relative anticancer efficacy of its constituents is still unknown. Here, we compared the efficacy of 7 pure flavonolignan compounds isolated from silymarin, namely silybin A, silybin B, isosilybin A, isosilybin B, silydianin, isosilydianin, silychristin and isosilychristin, in advanced human PCa PC3 cells. Silybin A, silybin B, isosilybin A, isosilybin B, silibinin and silymarin strongly inhibited the colony formation by PC3 cells (p < 0.001), while silydianin, silychristin and isosilychristin had marginal effect (p < 0.05). Using cell growth and death assays, we identified isosilybin B as the most effective isomer. FACS analysis for cell cycle also showed that silybin A, silybin B, isosilybin A, isosilybin B, silibinin and silymarin treatment resulted in strong cell cycle arrest in PC3 cells after 72 hr of treatment, while the effect of silydianin, silychristin and isosilychristin was marginal (if any). Western blot analysis also showed the differential effect of these compounds on the levels of cell cycle regulators-cyclins (D, E, A and B), CDKs (Cdk2, 4 and Cdc2), CDKIs (p21 and p27) and other cell cycle regulators (Skp2, Cdc25A, B, C and Chk2). This study provided further evidence for differential anticancer potential among each silymarin constituent, which would have potential implications in devising better formulations of silymarin against prostate and other cancers. ", "pmid": 18435416, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9995094, "FORESTS_PROB": 0.8833333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9707107 }, "rule": [{ "id": 249777, "sentence_id": "18435416411", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "411", "end_pos": "651", "sentence": "Here, we compared the efficacy of 7 pure CH& compounds isolated from silymarin, namely CH&, CH&, CH&, CH&, CH&, isosilydianin, CH& and isosilychristin, in advanced human PCa PC3 cells.", "original_sentence": "Here, we compared the efficacy of 7 pure flavonolignan compounds isolated from silymarin, namely silybin A, silybin B, isosilybin A, isosilybin B, silydianin, isosilydianin, silychristin and isosilychristin, in advanced human PCa PC3 cells.", "pmid_article": 18435416, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 2, "peso_genes": 0, "entitiesRules": [{ "id": 1553393, "V1": 5376, "pubtatot_term": "silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 508, "end_pos": 517, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553394, "V1": 5377, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 519, "end_pos": 528, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249778, "sentence_id": "18435416652", "association_type": "polifenol-", "R1": "nao", "R2": "sim", "R3": "nao", "R4": "nao", "R5": "sim", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "652", "end_pos": "874", "sentence": "CH&, CH&, CH&, CH&, CH& and silymarin strongly inhibited the colony formation by PC3 cells (p < 0_001), while CH&, CH& and isosilychristin had marginal effect (p < 0_05).", "original_sentence": "Silybin A, silybin B, isosilybin A, isosilybin B, silibinin and silymarin strongly inhibited the colony formation by PC3 cells (p < 0_001), while silydianin, silychristin and isosilychristin had marginal effect (p < 0_05).", "pmid_article": 18435416, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1553399, "V1": 5382, "pubtatot_term": "Silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 652, "end_pos": 661, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553400, "V1": 5383, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 663, "end_pos": 672, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553403, "V1": 5386, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 702, "end_pos": 711, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }, { "id": 249779, "sentence_id": "18435416875", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "875", "end_pos": "967", "sentence": "Using cell growth and death assays, we identified CH& as the most effective isomer.", "original_sentence": "Using cell growth and death assays, we identified isosilybin B as the most effective isomer.", "pmid_article": 18435416, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 249780, "sentence_id": "18435416968", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "968", "end_pos": "1261", "sentence": "FACS analysis for cell cycle also showed that CH&, CH&, CH&, CH&, CH& and silymarin treatment resulted in strong cell cycle arrest in PC3 cells after 72 hr of treatment, while the effect of CH&, CH& and isosilychristin was marginal (if any).", "original_sentence": "FACS analysis for cell cycle also showed that silybin A, silybin B, isosilybin A, isosilybin B, silibinin and silymarin treatment resulted in strong cell cycle arrest in PC3 cells after 72 hr of treatment, while the effect of silydianin, silychristin and isosilychristin was marginal (if any).", "pmid_article": 18435416, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1553407, "V1": 5390, "pubtatot_term": "silybin A", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1014, "end_pos": 1023, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553408, "V1": 5391, "pubtatot_term": "silybin B", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1025, "end_pos": 1034, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }, { "id": 1553411, "V1": 5394, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1064, "end_pos": 1073, "entity_type": "chemical_entity_p", "entity_pmid": 18435416, "created_at": "2020-10-31T15:01:38.728Z", "updated_at": "2020-10-31T15:01:38.728Z" }] }] }, { "pmid": "21139802", "peso_rules": "0.0", "peso_entities": "1.0", "peso_genes": "0.091", "peso_final": 7.5, "article": { "id": 76594, "title_article": "Cell adhesion molecule CD44: its functional roles in prostate cancer.", "abstract_article": "CD44 is a cell adhesion glycoprotein that also governs cell signaling. Dysregulated CD44 expression characterizes most human cancers, including prostate cancer (PCa). PCa loses expression of CD44 standard (CD44s) that is present in benign epithelium, and overexpresses the novel splice variant (v) isoform, CD44v7-10. We studied CD44 in PCa for more than a decade, and in a series of papers, established its functional significance. Using retrovi-ral gene delivery to PC-3M PCa cells, we expressed luciferase-only, enforced CD44s re-expression as a fusion protein with luciferase at its C-terminus or as a protein separate from luciferase, or knocked down CD44v7-10 by RNAi. Invasion, migration, proliferation, soft agar colony formation, adhesion, Docetaxel sensitivity, and xenograft growth assays were carried out. Compared to luciferase-only PC-3M cells, all 3 treatments reduced invasion and migration. Growth and soft agar colony formation were reduced only by re-expression of CD44s as a separate or fusion protein but not CD44v7-10 RNAi. Hyaluronan and osteopontin binding were greatly strengthened by CD44s expression as a separate protein, but not a fusion protein. CD44v7-10 RNAi in PC-3M cells caused marked sensitization to Docetaxel; the 2 CD44s re-expression approaches caused minimal sensitization. In limited numbers of mouse subcutaneous xeno-grafts, all 3 alterations produced only nonsignificant trends toward slower growth compared with luciferase-only controls. In further work, we tested the effects of the anti-growth compound silibinin, a milk thistle derivative. Using a luciferase promoter construct to test for CD44 promoter activity, silibinin significantly and dose-dependently inhibited promoter activity at physiologic doses. Total CD44 RNA and CD44v7-10 RNA were significantly decreased; both were also decreased at the protein level. Phenyl-methylene hydantoins (PMH), guanidine alkaloids derived from Red Sea sponges, have the ability to increase cell-cell adhesion in prostate cancer cells and reduce invasion. Expression of CD44 total mRNA and CD44v7-10 were markedly decreased by PMH and its S-ethyl derivative. The oncogenic mi-croRNAs, miR-373 and miR-520c, which interact with CD44, were studied in prostate cancer cells and human tissues. We found that they bound the 3' untranslated region of the CD44 RNA, and suppressed CD44 in prostate cancer, by preventing the translation of CD44 RNA, rather than by degrading the RNA. Thus, stable re-expression of CD44s reduces PCa growth and invasion in vitro, and possibly in vivo, suggesting CD44's potential as gene therapy. Finally, CD44v7-10 may be a target for chemosensitization, and plays a role in nutraceutical abrogation of tumor development. In vivo effects of CD44 alteration still need to be investigated by use of orthotopic or renal capsule xenografts, which confer a different stromal microenvironment than that of the subcutaneous grafts.", "pmid": 21139802, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99767303, "FORESTS_PROB": 0.89666665, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9999996, "med": 0.97358483 }, "rule": [{ "id": 245477, "sentence_id": "211398021554", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "1554", "end_pos": "1658", "sentence": "In further work, we tested the effects of the anti-growth compound CH&, a milk thistle derivative.", "original_sentence": "In further work, we tested the effects of the anti-growth compound silibinin, a milk thistle derivative.", "pmid_article": 21139802, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1529946, "V1": 2069, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1621, "end_pos": 1630, "entity_type": "chemical_entity_p", "entity_pmid": 21139802, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }, { "id": 245478, "sentence_id": "211398021659", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1659", "end_pos": "1827", "sentence": "Using a luciferase promoter construct to test for G&N promoter activity, CH& significantly and dose-dependently inhibited promoter activity at physiologic doses.", "original_sentence": "Using a luciferase promoter construct to test for CD44 promoter activity, silibinin significantly and dose-dependently inhibited promoter activity at physiologic doses.", "pmid_article": 21139802, "created_at": "2020-10-31T22:47:25.439Z", "updated_at": "2020-10-31T22:47:25.439Z", "R16": "nao", "peso_frase": 0, "peso_genes": 3, "entitiesRules": [{ "id": 1529948, "V1": 2071, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1733, "end_pos": 1742, "entity_type": "chemical_entity_p", "entity_pmid": 21139802, "created_at": "2020-10-31T14:59:44.073Z", "updated_at": "2020-10-31T14:59:44.073Z" }] }] }, { "pmid": "11532861", "peso_rules": "0.0", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 6.8, "article": { "id": 61759, "title_article": "Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.", "abstract_article": "A number of reports have shown that the polyphenolic flavonoid silymarin (SM) is an effective anticancer agent. Agents with novel mechanisms of blocking androgen receptor (AR) function may be useful for prostate cancer prevention and therapy. Previous studies showed that silibinin (SB), the major active component of SM, could inhibit cell proliferation of a human prostate cancer cell line, LNCaP, by arresting the cell cycle at the G(1) phase without causing cell death. This study further delineates the potential molecular mechanism by which SM and SB exhibit antiproliferative effects on androgen-responsive prostate cancer cells by inhibiting function of the AR. We observed that SM and SB inhibited androgen-stimulated cell proliferation as well as androgen-stimulated secretion of both prostate-specific antigen (PSA) and human glandular kallikrein (hK2). Additionally, for the first time, we show that an immunophilin, FKBP51, is androgen regulated and that this up-regulation is suppressed by SM and SB. We further demonstrate that transactivation activity of the AR was diminished by SM and SB using gene transfer of PSA promoter and hK2 androgen-responsive element constructs. However, expression and steroid-binding ability of total AR were not affected by SM in western blotting and ligand-binding assays. Intriguingly, we found that nuclear AR levels are significantly reduced by SM and SB in the presence of androgens using western blotting assay and immunocytochemical staining. This study provides a new insight into how SM and SB negatively modulate androgen action in prostate cancer cells.", "pmid": 11532861, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9997631, "FORESTS_PROB": 0.96666664, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 1, "med": 0.9916074 }, "rule": [{ "id": 299085, "sentence_id": "11532861311", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "311", "end_pos": "522", "sentence": "Previous studies showed that CH& (SB), the major active component of SM, could inhibit cell proliferation of a human D&S cell line, LNCaP, by arresting the cell cycle at the G(1) phase without causing cell death.", "original_sentence": "NA", "pmid_article": 11532861, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1787518, "V1": 5331, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 420, "end_pos": 429, "entity_type": "chemical_entity_p", "entity_pmid": 11532861, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1347772, "V1": 41801, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 420, "end_pos": 429, "entity_type": "chemical_entity_p", "entity_pmid": 11532861, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }, { "id": 1787517, "V1": 5330, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 351, "end_pos": 366, "entity_type": "cancer_type_entity_p", "entity_pmid": 11532861, "created_at": "2020-10-31T15:21:52.987Z", "updated_at": "2020-10-31T15:21:52.987Z" }, { "id": 1347771, "V1": 41800, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 351, "end_pos": 366, "entity_type": "cancer_type_entity_p", "entity_pmid": 11532861, "created_at": "2020-10-31T14:43:38.812Z", "updated_at": "2020-10-31T14:43:38.812Z" }] }] }, { "pmid": "15523106", "peso_rules": "0.17", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 6.8, "article": { "id": 49464, "title_article": "Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.", "abstract_article": "The aberrant behavior of cancer reflects upregulation of certain oncogenic signaling pathways that promote proliferation, inhibit apoptosis, and enable the cancer to spread and evoke angiogenesis. Theoretically, it should be feasible to decrease the activity of these pathways-or increase the activity of pathways that oppose them-with noncytotoxic agents. Since multiple pathways are dysfunctional in most cancers, and cancers accumulate new oncogenic mutations as they progress, the greatest and most durable therapeutic benefit will likely be achieved with combination regimens that address several targets. Thus, a multifocal signal modulation therapy (MSMT) of cancer is proposed. This concept has already been documented by researchers who have shown that certain combinations of signal modulators-of limited utility when administered individually-can achieve dramatic suppression of tumor growth in rodent xenograft models. The present essay attempts to guide development of MSMTs for prostate cancer. Androgen ablation is a signal-modulating measure already in standard use in the management of delocalized prostate cancer. The additional molecular targets considered here include the type 1 insulin-like growth factor receptor, the epidermal growth factor receptor, mammalian target of rapamycin, NF-kappaB, hypoxia-inducible factor-1alpha, hsp90, cyclooxygenase-2, protein kinase A type I, vascular endothelial growth factor, 5-lipoxygenase, 12-lipoxygenase, angiotensin II receptor type 1, bradykinin receptor type 1, c-Src, interleukin-6, ras, MDM2, bcl-2/bclxL, vitamin D receptor, estrogen receptor-beta, and PPAR-. Various nutrients and phytochemicals suspected to have potential utility in prostate cancer prevention and therapy, but whose key molecular targets are still unknown, might reasonably be incorporated into MSMTs for prostate cancer; these include lycopene, selenium, green tea polyphenols, genistein, and silibinin. MSMTs can be developed systematically by testing various combinations of signal-modulating agents, in concentrations that can feasibly be achieved and maintained clinically, on human prostate cancer cell lines; combinations that appear promising can then be tested in xenograft models and, ultimately, in the clinic. Some signal modulators can increase response to cytotoxic drugs by upregulating effectors of apoptosis. When MSMTs fail to raise the spontaneous apoptosis rate sufficiently to achieve tumor stasis or regression, incorporation of appropriate cytotoxic agents into the regimen may improve the clinical outcome.", "pmid": 15523106, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9025426, "FORESTS_PROB": 0.8233333, "LOGITBOOST_PROB": 1, "MAXENTROPY_PROB": 0.9961493, "med": 0.9305063 }, "rule": [{ "id": 279807, "sentence_id": "155231061750", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "sim", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1750", "end_pos": "2064", "sentence": "Various nutrients and phytochemicals suspected to have potential utility in D&S prevention and therapy, but whose key molecular targets are still unknown, might reasonably be incorporated into MSMTs for D&S ; these include lycopene, selenium, green tea CH&, CH&, and CH& .", "original_sentence": "Various nutrients and phytochemicals suspected to have potential utility in prostate cancer prevention and therapy, but whose key molecular targets are still unknown, might reasonably be incorporated into MSMTs for prostate cancer; these include lycopene, selenium, green tea polyphenols, genistein, and silibinin.", "pmid_article": 15523106, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 4, "peso_genes": 0, "entitiesRules": [{ "id": 1704177, "V1": 30854, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 2054, "end_pos": 2063, "entity_type": "chemical_entity_p", "entity_pmid": 15523106, "created_at": "2020-10-31T15:13:35.409Z", "updated_at": "2020-10-31T15:13:35.409Z" }, { "id": 1704173, "V1": 30850, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1826, "end_pos": 1841, "entity_type": "cancer_type_entity_p", "entity_pmid": 15523106, "created_at": "2020-10-31T15:13:35.409Z", "updated_at": "2020-10-31T15:13:35.409Z" }, { "id": 1704174, "V1": 30851, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1965, "end_pos": 1980, "entity_type": "cancer_type_entity_p", "entity_pmid": 15523106, "created_at": "2020-10-31T15:13:35.409Z", "updated_at": "2020-10-31T15:13:35.409Z" }] }] }, { "pmid": "28391184", "peso_rules": "0.22", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 6.6, "article": { "id": 55341, "title_article": "Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells.", "abstract_article": "Accumulating evidence suggests that natural bioactive compounds, alone or in combination with traditional chemotherapeutic agents, could be used as potential therapies to fight cancer. In this study, we employed four natural bioactive compounds (curcumin, resveratrol, melatonin, and silibinin) and studied their role in redox control and ability to promote apoptosis in androgen sensitive and insensitive prostate cancer cells. Here is shown that curcumin and resveratrol promote ROS production and induce apoptosis in LNCaP and PC-3. An increase in reactive species is a trigger event in curcumin-induced apoptosis and a consequence of resveratrol effects on other pathways within these cells. Moreover, here we demonstrated that these four compounds affect differently one of the main intracellular redox regulator, the thioredoxin system. Exposure to curcumin and resveratrol promoted TRX1 oxidation and altered its subcellular location. Furthermore, resveratrol diminished TRX1 levels in PC-3 cells and increased the expression of its inhibitor TXNIP. Conversly, melatonin and silibinin only worked as cytostatic agents, reducing ROS levels and showing preventive effects against TRX oxidation. All together, this work explores the effect of compounds currently tested as chemo-preventive agents in prostate cancer therapy, on the TRX1 redox state and function. Our work shows the importance that the TRX system might have within the differences found in their mechanisms of action. These bioactive compounds trigger different responses and affect ROS production and redox systems in prostate cancer cells, suggesting the key role that redox-related pathways might play in processes like differentiation or survival in prostate cancer. ", "pmid": 28391184, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99916583, "FORESTS_PROB": 0.82666665, "LOGITBOOST_PROB": 0.99999386, "MAXENTROPY_PROB": 1, "med": 0.9564566 }, "rule": [{ "id": 266014, "sentence_id": "28391184276", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "276", "end_pos": "519", "sentence": "In this study, we employed four natural bioactive compounds ( CH&, resveratrol, melatonin, and CH& ) and studied their role in redox control and ability to promote apoptosis in androgen sensitive and insensitive D&S cells.", "original_sentence": "In this study, we employed four natural bioactive compounds (curcumin, resveratrol, melatonin, and silibinin) and studied their role in redox control and ability to promote apoptosis in androgen sensitive and insensitive prostate cancer cells.", "pmid_article": 28391184, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 2, "peso_genes": 1, "entitiesRules": [{ "id": 1636046, "V1": 13444, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 375, "end_pos": 384, "entity_type": "chemical_entity_p", "entity_pmid": 28391184, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1636047, "V1": 13445, "pubtatot_term": "prostate cancer", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 497, "end_pos": 512, "entity_type": "cancer_type_entity_p", "entity_pmid": 28391184, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266015, "sentence_id": "28391184520", "association_type": "polifenol-cancer", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim3", "start_pos": "520", "end_pos": "626", "sentence": "Here is shown that CH& and resveratrol promote ROS production and induce apoptosis in D&S and G&N .", "original_sentence": "Here is shown that curcumin and resveratrol promote ROS production and induce apoptosis in LNCaP and PC-3.", "pmid_article": 28391184, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1636049, "V1": 13447, "pubtatot_term": "LNCaP", "db_term": "Prostate Cancer", "db_equivalence": "lncap", "mesh_id": "D011471", "term_id": "527", "start_pos": 611, "end_pos": 616, "entity_type": "cancer_type_entity_cell", "entity_pmid": 28391184, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }, { "id": 266016, "sentence_id": "28391184627", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "sim", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "sim", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "627", "end_pos": "786", "sentence": "An increase in reactive species is a trigger event in CH& -induced apoptosis and a consequence of resveratrol effects on other pathways within these cells.", "original_sentence": "An increase in reactive species is a trigger event in curcumin-induced apoptosis and a consequence of resveratrol effects on other pathways within these cells.", "pmid_article": 28391184, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [] }, { "id": 266017, "sentence_id": "28391184934", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "934", "end_pos": "1032", "sentence": "Exposure to CH& and resveratrol promoted G&N oxidation and altered its subcellular location.", "original_sentence": "Exposure to curcumin and resveratrol promoted TRX1 oxidation and altered its subcellular location.", "pmid_article": 28391184, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [] }, { "id": 266018, "sentence_id": "283911841148", "association_type": "polifenol-gene", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1148", "end_pos": "1290", "sentence": "Conversly, melatonin and CH& only worked as cytostatic agents, reducing ROS levels and showing preventive effects against G&N oxidation.", "original_sentence": "Conversly, melatonin and silibinin only worked as cytostatic agents, reducing ROS levels and showing preventive effects against TRX oxidation.", "pmid_article": 28391184, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1636058, "V1": 13456, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1173, "end_pos": 1182, "entity_type": "chemical_entity_p", "entity_pmid": 28391184, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }] }, { "pmid": "26087400", "peso_rules": "0.0", "peso_entities": "1.0", "peso_genes": "0.13", "peso_final": 4.6, "article": { "id": 76529, "title_article": "Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation.", "abstract_article": "Hypoxia is an independent prognostic indicator of poor outcome in several malignancies. However, precise mechanism through which hypoxia promotes disease aggressiveness is still unclear. Here, we report that under hypoxia (1% O2), human prostate cancer (PCA) cells, and extracellular vesicles (EVs) released by these cells, are significantly enriched in triglycerides due to the activation of lipogenesis-related enzymes and signaling molecules. This is likely a survival response to hypoxic stress as accumulated lipids could support growth following reoxygenation. Consistent with this, significantly higher proliferation was observed in hypoxic PCA cells following reoxygenation associated with rapid use of accumulated lipids. Importantly, lipid utilization inhibition by CPT1 inhibitor etomoxir and shRNA-mediated CPT1-knockdown significantly compromised hypoxic PCA cell proliferation following reoxygenation. Furthermore, COX2 inhibitor celecoxib strongly reduced growth and invasiveness following hypoxic PCA cells reoxygenation, and inhibited invasiveness induced by hypoxic PCA EVs. This establishes a role for COX2 enzymatic products in the enhanced PCA growth and invasiveness. Importantly, concentration and loading of EVs secreted by PCA cells were significantly compromised under delipidized serum condition and by lipogenesis inhibitors (fatostatin and silibinin). Overall, present study highlights the biological significance of lipid accumulation in hypoxic PCA cells and its therapeutic relevance in PCA. ", "pmid": 26087400, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.99477327, "FORESTS_PROB": 0.83, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.9997092, "med": 0.9561206 }, "rule": [{ "id": 266299, "sentence_id": "260874001345", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "sim", "R12": "sim", "R13": "nao", "R14": "nao", "R15": "sim", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "1345", "end_pos": "1535", "sentence": "Importantly, concentration and loading of EVs secreted by D&S cells were significantly compromised under delipidized serum condition and by lipogenesis inhibitors (fatostatin and CH& ).", "original_sentence": "Importantly, concentration and loading of EVs secreted by PCA cells were significantly compromised under delipidized serum condition and by lipogenesis inhibitors (fatostatin and silibinin).", "pmid_article": 26087400, "created_at": "2020-10-31T22:49:41.200Z", "updated_at": "2020-10-31T22:49:41.200Z", "R16": "nao", "peso_frase": 1, "peso_genes": 3, "entitiesRules": [{ "id": 1637299, "V1": 14697, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 1524, "end_pos": 1533, "entity_type": "chemical_entity_p", "entity_pmid": 26087400, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }, { "id": 1637298, "V1": 14696, "pubtatot_term": "PCA", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 1403, "end_pos": 1406, "entity_type": "cancer_type_entity_p", "entity_pmid": 26087400, "created_at": "2020-10-31T15:09:22.338Z", "updated_at": "2020-10-31T15:09:22.338Z" }] }] }, { "pmid": "16954429", "peso_rules": "0.25", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 3.9, "article": { "id": 60561, "title_article": "Mechanisms of action of novel agents for prostate cancer chemoprevention.", "abstract_article": "Despite advances in the understanding of prostate cancer (PCa) growth and development, it is still the leading incidence of cases and the second leading cause of mortality due to cancer in men. The problem of early diagnosis compounded with the emergence of androgen independence during commonly used anti-androgen therapy of PCa, have been discouraging for optimal therapeutic response. Recently, many chemopreventive agents, including silibinin, inositol hexaphosphate, decursin, apigenin, acacetin, grape seed extract, curcumin, and epigallocatechin-3 gallate have been identified in laboratory studies, which could be useful in the management of PCa. In vivo pre-clinical studies have indicated chemopreventive effect of many such agents in PCa xenograft and transgenic mouse models. The molecular targets of these agents include cell signaling, cell-cycle regulators, and survival/apoptotic molecules, which are implicated in uncontrolled PCa growth and progression. Furthermore, angiogenic and metastatic targets, including vascular endothelial growth factor, hypoxia-inducing factor-1alpha, matrix metalloproteinase, and urokinase-type plasminogen activator are also modulated by many chemopreventive agents to suppress the growth and invasive potential of PCa. This review focuses on novel PCa chemopreventive observations in laboratory studies, which could provide the rationale for the prospective use of chemopreventive agents in translational studies.", "pmid": 16954429, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.904727, "FORESTS_PROB": 0.71, "LOGITBOOST_PROB": 0.99999917, "MAXENTROPY_PROB": 0.9999977, "med": 0.903681 }, "rule": [{ "id": 286682, "sentence_id": "16954429462", "association_type": "polifenol-cancer", "R1": "sim", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "sim", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "sim", "start_pos": "462", "end_pos": "728", "sentence": "Recently, many chemopreventive agents, including CH&, inositol hexaphosphate, decursin, CH&, CH&, grape seed extract, CH&, and CH& have been identified in laboratory studies, which could be useful in the management of D&S.", "original_sentence": "Recently, many chemopreventive agents, including silibinin, inositol hexaphosphate, decursin, apigenin, acacetin, grape seed extract, curcumin, and epigallocatechin-3 gallate have been identified in laboratory studies, which could be useful in the management of PCa.", "pmid_article": 16954429, "created_at": "2020-10-31T22:51:43.215Z", "updated_at": "2020-10-31T22:51:43.215Z", "R16": "nao", "peso_frase": 3, "peso_genes": 0, "entitiesRules": [{ "id": 1735825, "V1": 18040, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 511, "end_pos": 520, "entity_type": "chemical_entity_p", "entity_pmid": 16954429, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }, { "id": 1735830, "V1": 18045, "pubtatot_term": "PCa", "db_term": "Prostate Cancer", "db_equivalence": "Prostate Cancer", "mesh_id": "D011471", "term_id": "527", "start_pos": 724, "end_pos": 727, "entity_type": "cancer_type_entity_p", "entity_pmid": 16954429, "created_at": "2020-10-31T15:16:08.627Z", "updated_at": "2020-10-31T15:16:08.627Z" }] }] }, { "pmid": "27261177", "peso_rules": "0.0", "peso_entities": "1.0", "peso_genes": "0.0", "peso_final": 2, "article": { "id": 76512, "title_article": "3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.", "abstract_article": "Eight 3-O-alkyl-2,3-dehydrosilibinins have been synthesized from commercially available silibinin through two synthetic approaches. A one-pot reaction, starting with aerobic oxidation of silibinin followed by direct alkylation of the phenolic hydroxyl group in the subsequent 2,3-dehydrosilibinin, furnishes the desired derivatives in 11-16% yields. The three-step procedure employing benzyl ether to protect 7-OH in silibinin generates the desired derivatives in 30-46% overall yields. The antiproliferative activity of the 2,3-dehydrosilibinin derivatives against both androgen-sensitive and androgen-insensitive prostate cancer cells have been assessed using a WST-1 cell proliferation assay. All derivatives exhibited greater antiproliferative potency than silibinin, with 2,3-dehydrosilibinins each possessing a three- to five-carbon linear alkyl group to 3-OH (IC50 values in a range of 1.71-3.06μM against PC-3 and LNCaP cells) as the optimal derivatives. The optimal potency was reached with three- to five-carbon alkyl groups. Our findings suggest that 3-O-propyl-2,3-dehydrosilibinin effectively inhibits the growth of PC-3 prostate cancer cells by arresting cell cycle in the G0/G1 phase, but not by activating PC-3 cell apoptosis. ", "pmid": 27261177, "created_at": "2020-10-31T22:33:52.396Z", "updated_at": "2020-10-31T22:33:52.396Z", "SVM_PROB": 0.9922113, "FORESTS_PROB": 0.9066667, "LOGITBOOST_PROB": 0.9999999, "MAXENTROPY_PROB": 0.9999919, "med": 0.97471744 }, "rule": [{ "id": 243751, "sentence_id": "27261177109", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "109", "end_pos": "240", "sentence": "Eight 3-O-alkyl-2,3-dehydrosilibinins have been synthesized from commercially available CH& through two synthetic approaches.", "original_sentence": "Eight 3-O-alkyl-2,3-dehydrosilibinins have been synthesized from commercially available silibinin through two synthetic approaches.", "pmid_article": 27261177, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1521014, "V1": 13431, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 197, "end_pos": 206, "entity_type": "chemical_entity_p", "entity_pmid": 27261177, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 243752, "sentence_id": "27261177241", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "241", "end_pos": "458", "sentence": "A one-pot reaction, starting with aerobic oxidation of CH& followed by direct alkylation of the CH& group in the subsequent 2,3-dehydrosilibinin, furnishes the desired derivatives in 11-16% yields.", "original_sentence": "A one-pot reaction, starting with aerobic oxidation of silibinin followed by direct alkylation of the phenolic hydroxyl group in the subsequent 2,3-dehydrosilibinin, furnishes the desired derivatives in 11-16% yields.", "pmid_article": 27261177, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1521015, "V1": 13432, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 296, "end_pos": 305, "entity_type": "chemical_entity_p", "entity_pmid": 27261177, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 243753, "sentence_id": "27261177459", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "nao", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "459", "end_pos": "595", "sentence": "The three-step procedure employing benzyl ether to protect 7-OH in CH& generates the desired derivatives in 30-46% overall yields.", "original_sentence": "The three-step procedure employing benzyl ether to protect 7-OH in silibinin generates the desired derivatives in 30-46% overall yields.", "pmid_article": 27261177, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1521017, "V1": 13434, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 526, "end_pos": 535, "entity_type": "chemical_entity_p", "entity_pmid": 27261177, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }, { "id": 243754, "sentence_id": "27261177805", "association_type": "polifenol-", "R1": "nao", "R2": "nao", "R3": "nao", "R4": "nao", "R5": "nao", "R6": "nao", "R7": "nao", "R8": "nao", "R9": "nao", "R10": "nao", "R11": "nao", "R12": "nao", "R13": "nao", "R14": "nao", "R15": "nao", "HM12": "sim", "HM3": "nao", "HM4": "nao", "HM5": "nao", "HM6": "nao", "HM7": "nao", "HM8": "nao", "HM9": "nao", "HM10": "nao", "is_title": "nao", "has_entity": "sim", "is_association": "nao", "start_pos": "805", "end_pos": "1004", "sentence": "All derivatives exhibited greater antiproliferative potency than CH&, with 2,3-dehydrosilibinins each possessing a three- to five-carbon linear alkyl group to 3-OH (IC50 values in a range of 1.", "original_sentence": "All derivatives exhibited greater antiproliferative potency than silibinin, with 2,3-dehydrosilibinins each possessing a three- to five-carbon linear alkyl group to 3-OH (IC50 values in a range of 1.", "pmid_article": 27261177, "created_at": "2020-10-31T22:45:04.305Z", "updated_at": "2020-10-31T22:45:04.305Z", "R16": "nao", "peso_frase": 0, "peso_genes": 0, "entitiesRules": [{ "id": 1521019, "V1": 13436, "pubtatot_term": "silibinin", "db_term": "silybin", "db_equivalence": "silybin", "mesh_id": "C440975", "term_id": "7235", "start_pos": 870, "end_pos": 879, "entity_type": "chemical_entity_p", "entity_pmid": 27261177, "created_at": "2020-10-31T14:58:49.940Z", "updated_at": "2020-10-31T14:58:49.940Z" }] }] }]
